CORPUS CALLOSUM A M EDICAL D ICTIONARY , B IBLIOGRAPHY , AND A NNOTATED R ESEARCH G UIDE TO I NTERNET R E FERENCES
J AMES N. P ARKER , M.D. AND P HILIP M. P ARKER , P H .D., E DITORS
ii
ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright ©2004 by ICON Group International, Inc. Copyright ©2004 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1
Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised to always check product information (package inserts) for changes and new information regarding dosage and contraindications before prescribing any drug or pharmacological product. Caution is especially urged when using new or infrequently ordered drugs, herbal remedies, vitamins and supplements, alternative therapies, complementary therapies and medicines, and integrative medical treatments. Cataloging-in-Publication Data Parker, James N., 1961Parker, Philip M., 1960Corpus Callosum: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References / James N. Parker and Philip M. Parker, editors p. cm. Includes bibliographical references, glossary, and index. ISBN: 0-497-00305-8 1. Corpus Callosum-Popular works. I. Title.
iii
Disclaimer This publication is not intended to be used for the diagnosis or treatment of a health problem. It is sold with the understanding that the publisher, editors, and authors are not engaging in the rendering of medical, psychological, financial, legal, or other professional services. References to any entity, product, service, or source of information that may be contained in this publication should not be considered an endorsement, either direct or implied, by the publisher, editors, or authors. ICON Group International, Inc., the editors, and the authors are not responsible for the content of any Web pages or publications referenced in this publication.
Copyright Notice If a physician wishes to copy limited passages from this book for patient use, this right is automatically granted without written permission from ICON Group International, Inc. (ICON Group). However, all of ICON Group publications have copyrights. With exception to the above, copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs, or other materials, please contact us to request permission (E-mail:
[email protected]). ICON Group often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires confirmed permission from ICON Group International, Inc. The disclaimer above must accompany all reproductions, in whole or in part, of this book.
iv
Acknowledgements The collective knowledge generated from academic and applied research summarized in various references has been critical in the creation of this book which is best viewed as a comprehensive compilation and collection of information prepared by various official agencies which produce publications on corpus callosum. Books in this series draw from various agencies and institutions associated with the United States Department of Health and Human Services, and in particular, the Office of the Secretary of Health and Human Services (OS), the Administration for Children and Families (ACF), the Administration on Aging (AOA), the Agency for Healthcare Research and Quality (AHRQ), the Agency for Toxic Substances and Disease Registry (ATSDR), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the Healthcare Financing Administration (HCFA), the Health Resources and Services Administration (HRSA), the Indian Health Service (IHS), the institutions of the National Institutes of Health (NIH), the Program Support Center (PSC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). In addition to these sources, information gathered from the National Library of Medicine, the United States Patent Office, the European Union, and their related organizations has been invaluable in the creation of this book. Some of the work represented was financially supported by the Research and Development Committee at INSEAD. This support is gratefully acknowledged. Finally, special thanks are owed to Tiffany Freeman for her excellent editorial support.
v
About the Editors James N. Parker, M.D. Dr. James N. Parker received his Bachelor of Science degree in Psychobiology from the University of California, Riverside and his M.D. from the University of California, San Diego. In addition to authoring numerous research publications, he has lectured at various academic institutions. Dr. Parker is the medical editor for health books by ICON Health Publications. Philip M. Parker, Ph.D. Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). Dr. Parker has also been Professor at the University of California, San Diego and has taught courses at Harvard University, the Hong Kong University of Science and Technology, the Massachusetts Institute of Technology, Stanford University, and UCLA. Dr. Parker is the associate editor for ICON Health Publications.
vi
About ICON Health Publications To discover more about ICON Health Publications, simply check with your preferred online booksellers, including Barnes&Noble.com and Amazon.com which currently carry all of our titles. Or, feel free to contact us directly for bulk purchases or institutional discounts: ICON Group International, Inc. 4370 La Jolla Village Drive, Fourth Floor San Diego, CA 92122 USA Fax: 858-546-4341 Web site: www.icongrouponline.com/health
vii
Table of Contents FORWARD .......................................................................................................................................... 1 CHAPTER 1. STUDIES ON CORPUS CALLOSUM ................................................................................. 3 Overview........................................................................................................................................ 3 The Combined Health Information Database................................................................................. 3 Federally Funded Research on Corpus Callosum........................................................................... 4 E-Journals: PubMed Central ....................................................................................................... 36 The National Library of Medicine: PubMed ................................................................................ 37 CHAPTER 2. NUTRITION AND CORPUS CALLOSUM........................................................................ 83 Overview...................................................................................................................................... 83 Finding Nutrition Studies on Corpus Callosum ......................................................................... 83 Federal Resources on Nutrition ................................................................................................... 84 Additional Web Resources ........................................................................................................... 85 CHAPTER 3. ALTERNATIVE MEDICINE AND CORPUS CALLOSUM ................................................. 87 Overview...................................................................................................................................... 87 National Center for Complementary and Alternative Medicine.................................................. 87 Additional Web Resources ........................................................................................................... 93 General References ....................................................................................................................... 93 CHAPTER 4. DISSERTATIONS ON CORPUS CALLOSUM ................................................................... 95 Overview...................................................................................................................................... 95 Dissertations on Corpus Callosum .............................................................................................. 95 Keeping Current .......................................................................................................................... 96 CHAPTER 5. PATENTS ON CORPUS CALLOSUM .............................................................................. 97 Overview...................................................................................................................................... 97 Patent Applications on Corpus Callosum.................................................................................... 97 Keeping Current ........................................................................................................................ 100 APPENDIX A. PHYSICIAN RESOURCES .......................................................................................... 103 Overview.................................................................................................................................... 103 NIH Guidelines.......................................................................................................................... 103 NIH Databases........................................................................................................................... 105 Other Commercial Databases..................................................................................................... 107 APPENDIX B. PATIENT RESOURCES ............................................................................................... 109 Overview.................................................................................................................................... 109 Patient Guideline Sources.......................................................................................................... 109 Associations and Corpus Callosum............................................................................................ 111 Finding Associations.................................................................................................................. 111 APPENDIX C. FINDING MEDICAL LIBRARIES ................................................................................ 113 Overview.................................................................................................................................... 113 Preparation................................................................................................................................. 113 Finding a Local Medical Library................................................................................................ 113 Medical Libraries in the U.S. and Canada ................................................................................. 113 ONLINE GLOSSARIES................................................................................................................ 119 Online Dictionary Directories ................................................................................................... 119 CORPUS CALLOSUM DICTIONARY...................................................................................... 121 INDEX .............................................................................................................................................. 169
1
FORWARD In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."1 Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with corpus callosum is indexed in search engines, such as www.google.com or others, a non-systematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to know as much as possible about corpus callosum, using the most advanced research tools available and spending the least amount of time doing so. In addition to offering a structured and comprehensive bibliography, the pages that follow will tell you where and how to find reliable information covering virtually all topics related to corpus callosum, from the essentials to the most advanced areas of research. Public, academic, government, and peer-reviewed research studies are emphasized. Various abstracts are reproduced to give you some of the latest official information available to date on corpus callosum. Abundant guidance is given on how to obtain free-of-charge primary research results via the Internet. While this book focuses on the field of medicine, when some sources provide access to non-medical information relating to corpus callosum, these are noted in the text. E-book and electronic versions of this book are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). If you are using the hard copy version of this book, you can access a cited Web site by typing the provided Web address directly into your Internet browser. You may find it useful to refer to synonyms or related terms when accessing these Internet databases. NOTE: At the time of publication, the Web addresses were functional. However, some links may fail due to URL address changes, which is a common occurrence on the Internet. For readers unfamiliar with the Internet, detailed instructions are offered on how to access electronic resources. For readers unfamiliar with medical terminology, a comprehensive glossary is provided. For readers without access to Internet resources, a directory of medical libraries, that have or can locate references cited here, is given. We hope these resources will prove useful to the widest possible audience seeking information on corpus callosum. The Editors
1
From the NIH, National Cancer Institute (NCI): http://www.cancer.gov/cancerinfo/ten-things-to-know.
3
CHAPTER 1. STUDIES ON CORPUS CALLOSUM Overview In this chapter, we will show you how to locate peer-reviewed references and studies on corpus callosum.
The Combined Health Information Database The Combined Health Information Database summarizes studies across numerous federal agencies. To limit your investigation to research studies and corpus callosum, you will need to use the advanced search options. First, go to http://chid.nih.gov/index.html. From there, select the “Detailed Search” option (or go directly to that page with the following hyperlink: http://chid.nih.gov/detail/detail.html). The trick in extracting studies is found in the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Journal Article.” At the top of the search form, select the number of records you would like to see (we recommend 100) and check the box to display “whole records.” We recommend that you type “corpus callosum” (or synonyms) into the “For these words:” box. Consider using the option “anywhere in record” to make your search as broad as possible. If you want to limit the search to only a particular field, such as the title of the journal, then select this option in the “Search in these fields” drop box. The following is what you can expect from this type of search: •
Corpus Callosum Atrophy Is a Possible Indicator of Region- and Cell Type-Specific Neuronal Degeneration in Alzheimer Disease: A Magnetic Resonance Imaging Source: Archives of Neurology. 55: 193-198. February 1998. Summary: This journal article describes a study of region-specific corpus callosum atrophy as a possible marker for cortical neuronal loss in Alzheimer's disease (AD). The participants were 14 patients with AD, mean age 64.4 years, from a longitudinal study of the Laboratory of Neurosciences, National Institute on Aging, and 22 healthy volunteers, mean age 66.6 years. All participants had minimal white matter changes. The total cross-sectional area of the corpus callosum and areas of five callosal subregions were measured on midsagittal magnetic resonance imaging (MRI) scans. Severity of dementia was measured with the Mattis Dementia Rating Scale. The total callosal area was significantly smaller in the patients with AD, with the greatest changes
4
Corpus Callosum
in the rostrum and splenium, and relative sparing of the callosal body. Regional callosal atrophy correlated significantly with cognitive impairment, but not with age or white matter hyperintensities score, in the group with AD. The authors conclude that regionspecific callosal atrophy may serve as a marker of progressive neocortical disintegration in AD. 1 figure, 3 tables, 41 references. (AA-M).
Federally Funded Research on Corpus Callosum The U.S. Government supports a variety of research studies relating to corpus callosum. These studies are tracked by the Office of Extramural Research at the National Institutes of Health.2 CRISP (Computerized Retrieval of Information on Scientific Projects) is a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other institutions. Search the CRISP Web site at http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen. You will have the option to perform targeted searches by various criteria, including geography, date, and topics related to corpus callosum. For most of the studies, the agencies reporting into CRISP provide summaries or abstracts. As opposed to clinical trial research using patients, many federally funded studies use animals or simulated models to explore corpus callosum. The following is typical of the type of information found when searching the CRISP database for corpus callosum: •
Project Title: ACTIVE VISION IN PRIMATE CORTEX Principal Investigator & Institution: Colby, Carol L.; Neuroscience; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2002; Project Start 01-MAY-1998; Project End 30-APR-2004 Summary: The idea that vision is an active process has recently attracted considerable interest. Nowhere is the active nature of perception more evident than in the construction of a stable image of the world. As we move our eyes, new images are constantly presented to the brain yet we perceive the world as staying still. The perception stability we experience is thought to depend on a convergence of visual signals and corollary discharges reflecting the generation of voluntary eye movements. The goal of these experiments is to understand the impact of motor action on sensory processing as it relates to spatial constancy. We will ask how a specific motor act, saccadic eye movement, affects the representation of visual stimuli in primate cortex. Neurons in monkey parietal cortex have been shown to remap the presentation of a visual stimulus when the eyes move. This surprising observation has raised numerous questions about the neural mechanism underlying spatial constancy. The proposed experiments are designed to characterize the impact of the behavioral relevance of the stimulus on remapping (Aim 1); to discovered whether similar phenomena occur at earlier stages of the visual hierarchy (Aim 2); to determine how visual information is remapped from one hemisphere to the other (Aim 3); and to explore the interactions among frontal and parietal cortical stages which may underlie the process of updating spatial representations (Aim 4). Findings from these studies will provide a deeper
2 Healthcare projects are funded by the National Institutes of Health (NIH), Substance Abuse and Mental Health Services (SAMHSA), Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDCP), Agency for Healthcare Research and Quality (AHRQ), and Office of Assistant Secretary of Health (OASH).
Studies
5
understanding of the natural of spatial representation in cortex. Such an understanding is necessary as a step towards designing scientifically based diagnostics and rehabilitation programs for patients who have impair spatial functioning as a result of parietal lobe damage. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: AMPA RECEPTORS IN CALLOSAL SYNAPSES IN DEVELOPMENT Principal Investigator & Institution: Huguenard, John R.; Associate Professor; Stanford University Stanford, Ca 94305 Timing: Fiscal Year 2002; Project Start 01-JAN-2001; Project End 30-NOV-2006 Summary: (provided by applicant): The AMPA class of glutamate receptors mediate the majority of excitatory neurotransmission in the brain. These receptors are specifically implicated in the propagation of seizure activity. One member of the AMPA receptor family, the GluR2 subunit, dominates connections between excitatory neurons in the mature neocortex. The absence of this subunit alters the properties of AMPA receptors such that they become impermeable to calcium ions and show use-dependent facilitation. Down-regulations in GluR2 have been noted in a number of animal epilepsy models and in human epilepsy. This laboratory has recently demonstrated that GluR2 is functionally expressed in pyramidal neuron synaptic receptors at very low levels early in rat neocortical development. Thus it appears that in epileptic cortex there may be a recapitulation of the early postnatal phenotype of GluR2-lacking receptors, which are hypothesized to be epileptogenic in adult brain. In this proposal, whole cell voltageclamp techniques and laser-scanning caged-glutamate photolysis will be used with rat neocortical brain slices to test the generality of the finding regarding developmental GluR2 alterations in pyramidal neurons of different cortical regions and lamina. Further, the functional consequence regarding the ability of excitatory synaptic circuits to sustain repetitive, seizure-like activity will be examined. The hypothesis will be tested that decreased expression of GluR2 subunits in epileptic tissue results in a functional alteration in the synaptic receptors that would allow for increased calcium entry and post-synaptic facilitation, both of which may be important in the development of epilepsy. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: BRAIN DEVELOPMENT IN DEVELOPMENTAL DISORDERS Principal Investigator & Institution: Piven, Joseph; Professor; Psychiatry; University of North Carolina Chapel Hill Aob 104 Airport Drive Cb#1350 Chapel Hill, Nc 27599 Timing: Fiscal Year 2002; Project Start 30-SEP-1999; Project End 31-MAY-2004 Summary: Autism is a severe neuropsychiatric disorder that affects young children with a disability that often continues throughout life. Because of the severe impairment and duration of this disorder, autism often confers a profound burden on autistic individuals, their families and society. Thus, research aimed at uncovering the pathogenesis of autism and potentially leading to rational approaches to prevention or treatment is of great importance. Our research team recently reported the presence of increased total brain volume (TBV) on MRI (including increased tissue and lateral ventricular volume) in autistic individuals. These findings are consistent with multiple reports of autistic individuals showing increased rates of macrocephaly (head circumference greater than or equal to 98th percentile) and post mortem studies showing increased brain weight and size. Head circumference studies by our group and others suggest that although enlarged head size may be present at birth, macrocephaly
6
Corpus Callosum
is not present until early childhood (age 4 years). Subsequent analyses of our MRI data suggest that cortical enlargement is the result of an increase in gray matter volume, further supporting our hypothesis that the increased rate of brain growth in autism occurs prior to age 5 years. Subsequent studies by our group and others have revealed a pattern of brain size and shape changes including: enlargement of the temporal, parietal and occipital (but not frontal) cortical lobes, that appears to be localized mostly to the right side of the brain; enlargement of the total cerebellar and caudate volume (proportionate to the increase in TBV); decreased size of some subregions of the corpus callosum; and, no change in size of the hippocampus. Clarification of the timing and pattern of brain growth and organization in autism will provide important insights into the pathogenesis and neural mechanisms underlying this disorder. Therefore we propose to conduct a longitudinal MRI study of the size and shape of the brain in autistic individuals and controls at 18-35 months of age with follow-up MRI brain scans of these same subjects after 24 months to examine the pattern of brain size and shape changes over time. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: BRAIN MORBIDITY IN TREATMENT-NAIVE ALCOHOLICS Principal Investigator & Institution: Fein, George; Scientist; Neurobehavioral Research, Inc. Corte Madera, Ca 94925 Timing: Fiscal Year 2002; Project Start 01-JUN-2002; Project End 31-MAY-2007 Summary: (provided by applicant): Most studies of the impact of alcohol dependence on the brain have examined individuals in treatment. They may embody a bias, called "Berkson?s fallacy", if the association between variables (e.g., alcoholism and brain atrophy or brain function) differ between the population of alcoholics in treatment and alcoholics in the general population. We hypothesize that treatment-naive alcoholics have less psychiatric comorbidity compared to treatment samples, and that this reduced psychiatric morbidity is associated with a lessened severity of impairments in brain structure and function. The major goals of the proposed research are to determine: 1) whether treatment-naive alcoholics differ in brain structure and function from alcoholics recruited from treatment centers, 2) whether treatment-naive alcoholics differ from alcoholics recruited from treatment centers in the presence and severity of comorbid mood and externalizing disorder symptoms and traits, 3) what factors are associated with impairments in brain structure and function in treatment-naive alcoholics and in alcoholics drawn from treatment centers (including presence and severity of comorbid mood, anxiety, and externalizing disorder symptoms and traits, presence of the APOE-4 allele, premorbid headsize as a measure of functional reserve (as indexed by intracranial vault volume on MRI), and the frequency (and severity) of withdrawal symptoms), 4) whether males and females differ in these comparisons, and 5) to follow the treatmentnaive alcoholics for future longitudinal assessment of factors that predict the course of their alcoholism (especially the seeking of treatment, and changes in brain structure and function). We will study 380 subjects over five years: 220 treatment-naive alcoholdependent subjects, 80 alcohol-dependent subjects in outpatient treatment, and 80 lifetime light/non-drinker controls. The treatment sample will be drawn from outpatient treatment centers. The treatment-naive sample will be recruited from the Marin County First Offender Drinking Driver (FODD) program. The light/non-drinker controls will be recruited from the community. Brain structure will be examined using MRI, and will include segmentation of the brain into its? component tissue classes, delineation of specific structures (e.g., the hippocampus, cerebellum, and corpus callosum), and transformation of the images into a standard coordinate system (to
Studies
7
facilitate analysis of regional cortical volume differences). Functional assessment will include neuropsychological and behavioral testing and electrophysiological recordings, focusing on inhibitory/disinhibitory processes, executive functions, visuospatial abilities, gait and balance, and processing and memory of emotional stimuli. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: BRAIN POTENTIALS SEMANTIC PROCESSING AND ATTENTION Principal Investigator & Institution: Deacon, Diana L.; Adjunct Professor/Research Scientist; Psychology; City College of New York 138Th St and Convent Ave New York, Ny 10031 Timing: Fiscal Year 2002; Project Start 01-APR-1991; Project End 30-NOV-2003 Summary: The aim of this proposal is to further understanding of the nature of semantic processing in the left and right cerebral hemispheres, particularly as regards the interaction of semantic and attentional processing. The project will attempt to determine how semantic information is represented in the cerebral hemispheres, how the time courses of automatic and attentionally controlled activation might differ between the hemispheres, and how inhibition might differentially operate within and between the two hemispheres. Event-related potentials and reaction time will serve as dependent measures. The data obtained will be relevant to the study, diagnosis, and rehabilitation of individuals with language impairments due to insult to either cerebral hemisphere, as well as developmental disorders such as dyslexia in which the pattern of errors often resembles right hemisphere reading in neurological patients. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: CELL DEVELOPMENT
ADHESION
MOLECULES
IN
NERVOUS
SYSTEM
Principal Investigator & Institution: Lemmon, Vance P.; Professor; Neurosciences; Case Western Reserve University 10900 Euclid Ave Cleveland, Oh 44106 Timing: Fiscal Year 2002; Project Start 02-APR-2001; Project End 31-MAR-2006 Summary: (From the Applicant's Abstract): The neural cell adhesion molecule L1 is found on some classes of migrating neuronal precursors in the developing nervous system and on almost all projection axons in both the central nervous system and peripheral nervous system. Not surprisingly, it has been implicated in the fasciculation of axon bundles and in migration of some neural precursors in various in vitro systems. In the early 1990's it was shown that mutations in the L1 gene in humans cause severe mental retardation (corpus callosum hypoplasia, adducted thumbs, spastic paraplegia, and hydrocephalus). We have analyzed individuals with different mutations in the L1 gene and discovered that mutations that lead to a loss of L1 expression are much more severe than mutations that only alter the cytoplasmic domain of L1. However, mutations of the cytoplasmic domain are sufficient to cause axon guidance failures and mental retardation. Recently, we and others have analyzed the L1 knock-out mouse and discovered that it has a phenotype remarkably similar to humans with X-linked hydrocephalus. This includes hydrocephalus, abnormal development of the corticospinal tract, and hypoplasia of the cerebellar vermis and corpus callosum. In this project we propose to test the hypothesis that L1 mediated adhesion is essential for normal development of the cerebellar vermis and that the function of the L1 cytoplasmic domain is essential for development of the corticospinal tract. To do this we will generate new mouse lines with specific alterations in the L1 cytoplasmic domain. We will also analyze mice in which the 6th Ig domain of L1 has been removed, deleting the
8
Corpus Callosum
RGD sequence in L1, allowing us to evaluate the difference between L1 homophilic binding and L1-integrin interactions during brain development. Finally, we will undertake the first careful analysis of cerebellar development in mice with altered or absent L1. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CHILD NEGLECT--PSYCHOBIOLOGICAL CONSEQUENCES Principal Investigator & Institution: De Bellis, Michael D.; Professor; Psychiatry; Duke University Durham, Nc 27710 Timing: Fiscal Year 2002; Project Start 29-SEP-2000; Project End 31-AUG-2005 Summary: In response to the RFA # OD-99-006, titled Research on Child Neglect, we propose a 5-year cross sectional investigation to non-invasively examine the psychobiological consequences of neglect in children. Child neglect is associated with delays in and deficits of multi-system developmental achievements in behavioral, cognitive and emotional regulation. These findings may be caused by adverse brain development. To this effect, we propose to examine the effects of neglect on the development of biological stress systems, brain maturation and neuropsychological (cognitive) function of prepubertal children. Seventy neglected subjects, age 3 to 10 years, will be enrolled after a recent referral to child protective services (CPS) and who meet pre-determined study criteria for neglect. They will be compared to seventy nonmaltreated sociodemographically similar control children. We are specifically studying this age group because brain maturation measures increase robustly and linearly during this developmental period. Thus, if child neglect is associated with adverse brain development, intervention during this time period could help attenuate these hypothesized brain changes because it is a time of active brain development. 24-hour urinary catecholamine and urinary free cortisol (UFC) concentrations will assess biological stress systems. Brain maturation will be assessed with measures of MRI-based brain morphometry of cerebral volume and cortical myelination (i.e. cortical white matter volume and corpus callosum area). Neuropsychological functioning will assess brain function. Specific aims are to compare measures of biological stress systems, brain maturation, and neuropsychological function in neglected non-physically and nonsexually abused children to non-maltreated sociodemographically similar controls. We hypothesize that compared to controls, neglected non-abused children will show evidence of alterations in biological stress systems and brain maturation and poorer neuropsychological functioning. Secondary aims are to explore clinical summary variable measures of: 1) the subject's neglect, 2) environmental and emotional stimulation, 3) physical growth, and 4) measures of traumatic experiences and symptoms of PTSD, to try and identify the best clinical predictors of outcome measures of biological stress systems, brain maturation and neuropsychological function. Within the neglect group, we expect to identify a subsample with without psychopathology. We will explore these same clinical summary variable measures as well as measures of biological stress systems and brain maturation for protective factors against child psychopathology and delayed neuropsychological function in this resilient subgroup of neglected children. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: CLINICAL SCHIZOPHRENIA
SYMPTOMS
&
BRAIN
ABNORMALITIES
IN
Principal Investigator & Institution: Shenton, Martha E.; Professor; Psychiatry; Harvard University (Medical School) Medical School Campus Boston, Ma 02115
Studies
9
Timing: Fiscal Year 2002; Project Start 30-SEP-1994; Project End 30-APR-2004 Summary: (Adopted from the Applicant's Abstract): This is a competitive renewal application for an Independent Scientist award (K02). The Principal Investigator (PI) has previously been funded for a level 1 (K01) and a level (K02) award to investigate brain abnormalities and clinical symptoms in schizophrenia (SZ). Continuation of the K02 will support the PI's research efforts at a crucial time period in her career development. Activities during this time will include: (1) expanding the scope and breadth of understanding of magnetic resonance (MRI) imaging and image processing tools; (2) visiting prominent laboratories outside the current site to increase understanding of different approaches to brain imaging; (3) developing further warping techniques and shape models of regions of interest (ROI) to determine the extent to which automated ROI measures can replace manual measures; (4) presenting research findings at professional meetings to receive feedback from other investigators; (5) applying transcranial magnetic stimulation for the purpose of mapping cognitive speech areas in SZ; (6) delineating further brain abnormalities and their specificity to SZ (see RO1); (7) determining whether brain abnormalities are related to cognitive and clinical symptom clusters (see R01); (8) determining whether any, all, or only some of these abnormalities are static and/or progressive (see RO1); and, (9) determining whether shape deformations are better discriminators than volume measures (see RO1). We will evaluate MRI frontal, temporal, parietal, basal ganglia, thalamus, CSP, PT, cerebellum, fornix, corpus callosum, and sulco-gyral pattern abnormalities in chronic SZ (n=50; 1/2 more positive symptoms and 1/2 more negative symptoms), first episode psychotic patients (n=60 SZs, n=60 bipolar), and controls (n=50 for chronics; n=75 for first episodes). We will conduct MR scans at 1.5 and 3 years to determine which brain regions, in which patient groups, progress over time. It is hypothesized that SZ with more positive symptoms and formal thought disorder will demonstrate MR leftlateralized temporal lobe volume reductions, and cognitive impairments characterized by selective deficits in verbal processes, memory, and associations. In contrast, SZ with more negative/deficit symptoms will demonstrate bilateral temporal and frontal lobe volume reductions that will progress over time, and more cognitive impairments, particularly attention and working memory. Moreover, patients with a greater number and severity of neurodevelopmental abnormalities (e.g., CSP, PT, sulco-gyral pattern) will show a negative symptom pattern (see above), while patients with fewer and less severe neurodevelopmental abnormalities will shoe a positive symptom pattern (see above). We make similar predictions for first episode SZs, though we expect them to show the greatest volume reduction over time. It is expected that these abnormalities and clinical correlates to be specific to SZ and not bipolar disorder. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: COMPUTATIONAL NEUROANATOMY OF AGING USING SHAPE ANALYSIS Principal Investigator & Institution: Davatzikos, Christos; Associate Professor; Radiology; University of Pennsylvania 3451 Walnut Street Philadelphia, Pa 19104 Timing: Fiscal Year 2002; Project Start 01-AUG-1998; Project End 31-JUL-2004 Summary: (Adapted from Applicant's Abstract): The long term goal of this project is to develop the mathematical framework and the computer implementation for quantitatively analyzing brain morphology and characterizing the way it is affected by normal and diseased aging. The basis of this methodological framework is a shape transformation that adapts the morphology of one brain, which is treated as a template, to the morphology of the brain under analysis. This transformation quantifies global and
10
Corpus Callosum
local morphological characteristics of the brain under analysis, with respect to the template which serves as a measurement unit. Inter-subject and inter-population comparisons are performed by comparing the corresponding shape transformations. The first specific aim of this project is to develop and validate a geometry-based shape transformation methodology, utilizing anatomical features extracted from MR images. Special emphasis is given to the geometric analysis of the cortical sulci often demarcating the boundaries between different functional cortical regions, and to structural irregularities, such as ventricular expansion and brain atrophy, occurring with aging and brain diseases. The second specific aim is to develop and validate a framework for characterizing shape properties of brain structures, such as local tissue loss and shape abnormalities, utilizing the shape transformation above. Finally, the third specific aim of this project is to test the utility of these methodologies in brain imaging studies, by applying them to a longitudinal study of aging. The goal here is to localize subtle morphological changes occurring in the brain with aging, and to associate such morphological changes with concurrent or subsequent functional and cognitive changes, which might be predictors of Alzheimer's disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CORPUS CALLOSUM FUNCTION IN CHILDREN WITH SPINA BIFIDA Principal Investigator & Institution: Hannay, Julia H.; University of Texas Hlth Sci Ctr Houston Box 20036 Houston, Tx 77225 Timing: Fiscal Year 2002 Summary: This abstract is not available. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: CORPUS CALLOSUM IN MALTREATED CHILDREN WITH PTSD Principal Investigator & Institution: Kaufman, Joan R.; Associate Professor; Psychiatry; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2003; Project Start 04-DEC-2002; Project End 30-NOV-2007 Summary: (provided by applicant): Child abuse occurs at epidemic rates, with victims of abuse comprising a significant proportion of all child psychiatric admissions. Posttraumatic Stress Disorder (PTSD) is a common and often debilitating consequence of early child maltreatment, and currently little is known about the mechanisms that initiate and maintain the symptoms associated with this disorder. Emerging evidence in human and non-human primates suggest that the neurobiological changes associated with early stress may vary at different developmental periods. While much of the preclinical and clinical work on the effects of early stress point to the importance of the hippocampus as a key structure involved in the pathophysiology of PTSD in adults, recent findings suggest that alterations in the corpus callosum may be more prominent in juvenile samples. Consequently, in this study, assessments of the corpus callosum will be obtained using structural and diffusion tensor imaging in three groups of children: 50 maltreated children with PTSD, 50 trauma (e.g., maltreated) controls without psychopathology, and 50 normal controls with no lifetime history of intrafamilial or extrafamilial trauma and no lifetime history of psychopathology. Measures of inter-hemispheric transfer and memory function will also be obtained, together with comprehensive assessments of early trauma, social supports, current life stressors, and family loading for psychopathology. Neuroanatomical assessments will be obtained at baseline, and clinical and psychosocial assessments will be obtained at
Studies
11
six-month intervals for two years after study intake. It is hypothesized that when compared to trauma and normal controls, maltreated children with PTSD will have reduced cross sectional area of the medial and caudal portions of the corpus callosum, and reduced fractional anisotropy in these regions (e.g., poorer integrity of white matter tracts). No changes in hippocampal volume are expected. A greater loading for anxiety and depressive disorders among first-degree relatives, an absence of positive stable supports, and exposure to ongoing stressors is expected to be associated with more severe PTSD symptomatology at intake, greater persistence of symptoms at follow-up, and more marked neuroimaging abnormalities. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CROSS-CULTURAL FASD: BRAIN IMAGING (U24 CORE) Principal Investigator & Institution: Sowell, Elizabeth R.; Assistant Professor; Neurology; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2003; Project Start 30-SEP-2003; Project End 31-AUG-2006 Summary: (provided by applicant): The overarching goal of this proposed Imaging Core is to understand better the effects of prenatal alcohol exposure on the structure and function of the developing brain by facilitating the use of advanced brain image processing tools by CIFASD members. One of the key limitations in understanding the role of severe prenatal alcohol exposure on the developing brain has been the limited number of subjects studied by any single research group. It is our intent to use this opportunity to pool structural brain imaging data across multiple research sites by standardizing the imaging protocols used to acquire image data, and standardizing image analysis tools used to compare individuals with fetal alcohol spectrum disorders (FASD) to controls. We will use our expertise to provide members of the Consortium with access to relatively simple automated image analysis tools that they can use in their laboratories to assess the shape and size of the corpus callosum (CC) and other regularly shaped brain structures. More specialized tools will be developed to assess differences in brain morphology in cortical and subcortical structures and to combine functional and structural MRI data for within-project functional-structural MRI studies. Specifically, our efforts will be directed towards: 1) the standardization of image acquisition protocols and validation of methods for controlling scanner specific geometric distortion through the use of human and mechanical phantom studies; 2) the adaptation of automated image analysis tools for distribution to CIFASD members; 3) adaptation and creation of more sophisticated tools for assessment of brain shape and tissue distribution abnormalities in cortical and subcortical regions, and the refinement of tools designed to facilitate the combination of functional and structural brain imaging data; and 4) the assessment of relationships between brain image data, and data collected by the other CIFASD projects and cores. Consortium members are proposing to collect either functional or structural (or both) brain imaging data from over 470 children and adolescents with FASD and 310 control subjects. The strategies and methods developed within the Imaging Core will for the first time allow the direct comparison of data collected at various sites, dramatically increasing our power to potentially outline diagnostic criteria from brain imaging data, and ultimately to help develop intervention and treatment approaches for FASD. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
12
•
Corpus Callosum
Project Title: DEVELOPMENT OF COGNITIVE FUNCTIONS: FRONTAL LOBE Principal Investigator & Institution: Diamond, Adele D.; Professor, Department of Psychiatry; Eunice Kennedy Shriver Center; Univ of Massachusetts Med Sch Worcester Office of Research Funding Worcester, Ma 01655 Timing: Fiscal Year 2003; Project Start 10-JUN-1997; Project End 31-MAY-2004 Summary: The goals of the proposed research are three:(1) to test children with brain damage localized to frontal cortex on tests (a) which have been linked specifically to frontal cortex function through neuroanatomical and behavioral studies with infant and adult monkeys and (b) on which we know the normal developmental progression in children. Important aspects of this work will be to look for converging evidence from diverse tests all linked to the same subregion of frontal cortex, and to attempt to dissociate performance on these tests from performance on tests linked to other neural circuits. The goal is to develop non-invasive tests capable of detecting frontal cortex damage in infants and young children. Presently such damage often goes undetected for many years because of the lack of such tests. (2) to investigate the relationship of dopamine levels to performance on these tasks, and to begin to investigate the hypothesis that the fundamental maturational change which underlies the emergence of cognitive abilities dependent on frontal cortex during infancy is increasing levels of frontal cortex dopamine. To do this, children with early-treated PKU, who have no known structural brain damage but who are vulnerable to reduced levels of dopamine will be tested. Because their general cognitive functioning is good, if deficits are found they are likely to be selective. If they are selectively impaired on tests of frontal cortex function, this will be the first demonstration in humans of a cognitive deficit on frontal cortex tasks from dopamine depletion alone. Because L-dopa and the dopamine precursor, tyrosine, can be taken orally, there is an excellent chance that if deficits are found, therapeutic interventions will be possible to alleviate any impairments. (3) to better understand the abilities required for success on tasks that depend on frontal cortex function. Hypotheses will be considered that suggest that memory for space, and/or time, or for relational information in general is dissociable from memory for other information and dependent upon frontal cortex function. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: DEVELOPMENTAL STUDIES ON THE MOTOR SYSTEM Principal Investigator & Institution: Kalil, Katherine; Professor; Anatomy; University of Wisconsin Madison 750 University Ave Madison, Wi 53706 Timing: Fiscal Year 2002; Project Start 01-APR-1978; Project End 30-JUN-2003 Summary: (Adapted from the Applicant's Abstract): Interstitial axon branching is an important but little understood mechanism for establishing connections in the developing brain. During development, growth cones, the highly motile tips that explore the environment, direct growing axons into appropriate targets. However, in some tracts of the cerebral cortex, such as the corpus callosum and corticospinal tract, collateral branches extend interstitially from the axon shaft to innervate targets. In previous studies from the principal investigator's laboratory, growth cones of cortical axons were found to undergo pausing and reorganization, leaving behind active regions on the axon from which interstitial branches later developed. Local fragmentation of microtubules was also found to occur at these branch points. The goal of the work in this proposal is to understand the cellular mechanisms that underlie development of interstitial axon branches. In the first specific aim, the influence of target derived cues on branching will be studies by applying FGF-2 either by bath application or locally in the
Studies
13
form of FGF coated beads to dissociated cultures of developing sensorimotor cortex. Effects on axon outgrowth, growth cones, and branch numbers and locations will be studied by imaging cortical neurons for extended periods of time. In the second aim, reorganization of the cytoskeleton will be studied with high-resolution digital imaging during spontaneous and FGF induced cortical axon branching. Effects on the cytoskeleton and development of branches will also be studied after application of biochemical reagents that experimentally perturb microtubules and actin filaments. To analyze dynamic cytoskeletal changes in developing axon branches and in reorganizing growth cones, microtubules and actin filaments will be labeled by microinjecting cortical neurons with fluorescent probes. Local changes in intracellular calcium levels will also be monitored during branching under normal and experimental conditions. Taken together this work will elucidate mechanisms of axon branching critical for the formation of appropriate connections during development. Results from this work may also have important clinical implications for regenerative sprouting after injury. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DIFFUSION TENSOR IMAGING IN AUTISM Principal Investigator & Institution: Haznedar, M Mehmet.; Psychiatry; Mount Sinai School of Medicine of Nyu of New York University New York, Ny 10029 Timing: Fiscal Year 2002; Project Start 01-AUG-2002; Project End 31-JUL-2005 Summary: (provided by applicant): Autism may be due to an abnormal development of a neural network involving-several regions of the brain. The proposed project will be the first to directly examine white matter connectivity in autism. It has been suggested that the dysfunction in the frontal lobe may relate to the characteristic speech problems and that dysfunction in the limbic system, may be one of the mechanisms responsible for the emotional and executive function symptoms of the illness. Compared to control subjects, in the patients with autism the anterior cingulate gyrus, which is a part of the limbic system, showed decreased metabolic rate and structural changes. The anterior cingulate gyrus communicates with many other areas of the brain to coordinate complex behaviors. Communications from this area travel through the axons or white matter of the brain. The axons from the cingulate cortex form the cingulum and this sheaf of communication sweeps up and out of the cingulate. Failure of this communication bundle to systematically find its targets and instead to develop as a tangled and misrouted jumble may explain the disordered executive function and impaired emotional processing in autism. Diffusion tensor imaging makes it possible for the first time to image the direction and alignment of axons in the brain's white matter. This new technique provides a unique opportunity to directly examine quality of white matter connectivity between key brain regions. We propose to collect diffusion tensor MRI scans, anatomical MRI's and PET scans in 30 adult patients with autism spectrum illnesses and 30 healthy control subjects. In the current project along with the cingulum, we will examine the white matter organization in the cerebellar peduncles, striatum, corpus callosum and frontal white matter and will correlate our findings with the clinically distinct presentations of autism spectrum illnesses. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: EARLY STRESS AND NEURAL SUBSTRATES RELEVANT TO ADDICTION Principal Investigator & Institution: Teicher, Martin H.; Associate Professor; Mc Lean Hospital (Belmont, Ma) Belmont, Ma 02478
14
Corpus Callosum
Timing: Fiscal Year 2003; Project Start 30-SEP-2003; Project End 30-JUN-2007 Summary: (provided by applicant): Chronic repeated stress during childhood has been recognized to be a risk factor for substance abuse and addictive behaviors later in life. At the present time there is little understanding of mechanisms through which this may occur. These studies are designed to test the hypothesis that exposure to chronic repeated stressors during childhood produces a cascade of molecular and cellular events that exert enduring effects on structural and functional brain development, and that these changes are responsible for the enhanced vulnerability to substance use, addiction or relapse. Specifically, 18-22 year old subjects with a history of exposure to harsh stressful corporal punishment (n = 50) will be compared to healthy controls with no history of early stress (n = 50) MRI measures will examine the effects of stress exposure on the morphometry of the corpus callosum, amygdala and cerebellar vermis. Neuronal density/viability in the neocortex and corpus callosum will be assessed using magnetic resonance spectroscopy. The corpus callosum will also be assessed using diffusion tensor imaging to provide information on the orientation and quality of nerve fibers passing through the region. T2-relaxometry will be used to assess left-right hemisphere differences in blood flow, and extent of functional activity in the cerebellar vermis. Subjects will receive probe dose challenge of methylphenidate to test the hypothesis that exposure to chronic early stress enhances risk for substance abuse by sensitized dopamine system hemodynamic response to psychostimutants. Subjects will also be exposed to a social stress test to ascertain whether subjects with a history of early repeated stress show enhanced stress responses as late adolescents - early adults. Stress response will be assessed by fluctuations in cortisol, ACTH, vasopressin, oxytocin and heart rate during and following the stressor. Subjects with a history of exposure to repetitive early stress are predicted to have an increased cortisol and ACTH responses to stress, a diminished oxytocin response, and to require a longer recovery period to return to baseline. Overall, these studies will provide new insight into the possible effects of early stress on neural substrates that may mediate substance abuse liability. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: EXPERIMENTAL FETAL ALCOHOL SYNDROME Principal Investigator & Institution: Miller, Michael W.; Professor and Chair; Neuroscience and Physiology; Upstate Medical University Research Administration Syracuse, Ny 13210 Timing: Fiscal Year 2004; Project Start 09-SEP-1991; Project End 31-MAY-2008 Summary: (provided by applicant): The central hypothesis is that prenatal exposure to ethanol induces developmental defects that lead to permanent imbalances in the brain. These imbalances include opposing neurotransmitter systems and ligand-receptor relations. Corollary hypotheses are that the outcomes of ethanol-induced defects are focal hyper-development and mismatches between afferents and their targets. These defects can result from mistiming of developmental events. That is, proper establishment of neural structure is requisite for proper neural function, e.g., behavior and cognition. Prenatal ethanol exposure causes profound deficits in learning and behavior. Indeed, alcohol-related neurodevelopmental disorder (ARND) affects as many as two of every 100 live births. Human studies point to particular targets of ethanol teratogenicity, however, they are confounded by factors such as the timing, duration and amount of the alcohol exposure, poly-drug use, and nutrition during the pregnancy. A non-human primate model allows us to avoid these confounds and to assess the effects of in utero ethanol exposure per se. The proposed studies will use the brains of monkeys that were exposed to ethanol episodically. Preliminary data show that episodic
Studies
15
prenatal exposure to ethanol can produce two kinds of anatomical changes- decreases and increases. We will perform five studies of the effects of prenatal exposure to ethanol on the structure of the brains of adolescent non-human primates. The proposed studies will examine structures (1) that are increased in size or (2) that are poorly matched with afferent and efferent nuclei following prenatal exposure to ethanol. The effects of ethanol on interactive, overlapping systems that define neuronal communication will be determined. These systems include (3) glutamatergic (excitatory) and GABAergic (inhibitory) neurons key to cortical circuitry and (4) neurotrophins (and their receptors) that support cortical neurons and apparently underlie the subtle plasticity involved in learning and memory. (5) We will examine the effect of timing and duration of the ethanol exposure on outcomes. These will focus on brainstem nuclei with different developmental origins and sequences of gene expression. The five studies will rely on rigorous stereological analyses of light and electron immunohistochemical microscopic preparations. As a unit, they will provide insight into the etiology and outcomes of ethanol teratogenicity and an anatomical basis for ARND. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: FRMI STUDIES OF EMOTION AND COGNITION Principal Investigator & Institution: Wexler, Bruce E.; Professor; Psychiatry; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2003; Project Start 15-SEP-1996; Project End 30-JUN-2008 Summary: (provided by applicant): This is a revised application for renewal of a K02 Independent Scientist Award. During the initial award period, the PI gained expertise in functional magnetic resonance imaging (fMRI). Skill development focused on learning basic aspects of fMRI methodology, increasing knowledge of human neuroanatomy, developing activation tasks for use during fMRI with particular relevance for studying the neuropathology of schizophrenia, and learning to use the image processing and data analysis software developed at the Yale fMRI Center. Skill development during the requested K02 renewal has two goals: 1) to acquire skills necessary to study interregional structural and functional connectivity; and 2) to learn to use image analysis software developed by research groups other than the Yale group with which the PI has been working. Work done during the initial funding period has led to 18 published peer-reviewed research papers and 5 more research papers are currently under review. The PI is first author on 9 of these papers and senior author on 11. During this period he has been the primary research mentor for 9 younger researchers. They have received 1 R01 grant and 3 foundation grants on which he is the senior co-investigator, and 1 BSTART and 5 NARSAD Young Investigator Awards on which he is the primary mentor. Another R01 grant is being resubmitted after an encouraging review. The proposed research comes almost entirely from two funded R01 projects. On one the applicant is the PI; on the other he is the co-investigator and his colleague, Morris Bell, is the PI. The first R01 supports continued work using memory tests, structural MRI and fMRI to subtype schizophrenia. The second project supports continued development and evaluation of computerized exercises to treat the cognitive deficits in people with schizophrenia. Both projects provide opportunities to develop and apply skills in measurement of inter-regional brain connectivity and in use of new analytic software. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
16
•
Corpus Callosum
Project Title: GOAL DIRECTED MAGNETIC RESONANCE BRAIN MICRO IMAGING Principal Investigator & Institution: Jacobs, Russell E.; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002 Summary: Autism is a severe developmental disorder of communication. reciprocal social interaction and repetitive, odd behaviors. Asperger syndrome (AS) shares many features with autism, and may therefore have a largely overlapping, but nevertheless distinguishable pathophysiology. While evidence for a biological basis for autism is substantial little is known about the neural mechanisms underlying the behavioral abnormalities seen in this disorder. Neuropathology and neuroimaging studies have demonstrated clear CNS abnormalities seen in patients with autism. Results from neuroirnaging studies in autism and related disorders, however, have often been difficult to interpret because of clinical heterogeneity of the samples studied. confounding effects of mental retardation. lack of neuropsychological evaluations and hypotheses, and lack of appropriate controls. These factors are even more problematic in the case of AS, given its current uncertain nosological status. necessitating, therefore, careful and comprehensive characterization. The proposed investigation attempts to address these limitations by correlating morphometric studies of the brain with neuropsychological, social-emotional and family genetics data to elucidate the pathophysiological basis of these disorders. Specific Aims Collect Neuroimaging data in a large sample of high-functioning autism (HFA), Aspergers (AS) and control subjects. 1. Perform comprehensive morphmetic assessments using structural MRI data to test the following hypotheses: A. The volume of the amygdala is reduced in HFA compared to matched unaffected controls. B. The volume of select frontal lobe regions is reduced in HFA. C. Brain size is significantly larger in HFA. D. Individuals with HFA have a greater frequency of neurodevelopmental abnormalities (e.g. abnormally thickened cortex). E. The cross-sectional area of posterior regions of the corpus callosum are reduced in HFA F. The neocerebellar vermis is reduced in size in HFA. 2. Stratify the HFA and AS patients using structural MRI data to identify more homogenous diagnostic subtypes. 3. Examine structure -function relationships to test hypotheses that deficits in social-emotional processing and executive functioning correlate with structural MRI findings in the amygdala and frontal cortices. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: HEMISPERIC: SPECIALIZATION AND INTERACTION Principal Investigator & Institution: Zaidel, Eran; Professor; Psychology; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002; Project Start 01-DEC-1983; Project End 31-MAR-2004 Summary: (Adapted from the Investigator's Abstract) The proposed research program aims to unravel the persisting mystery of hemispheric specialization and interhemispheric interaction in the human mind/brain. We will carry out coordinated experiments with normal subjects, hemisphere damaged patients, and split brain patients, using convergent behavioral and physiological methods. The program addresses general issues in cognitive neuroscience concerning modularity, intermodular communication, and control of parallel processing in independent modules. A core set of three lateralized behavioral experiments will investigate (1) hemispheric specialization and interdependence, (2) explicit and implicit interhemispheric transfer, and (3) interhemispheric control of parallel processing. Each experimental paradigm
Studies
17
includes an intrahemispheric component for studying hemispheric independence, and an interhemispheric component for studying interhemispheric interaction and control. The same behavioral experiments will be administered to patients with (1) complete cerebral commissurotomy, (2) agenesis of the corpus callosum, and (3) partial callosotomy, both pre- and post-surgically. The first paradigm is dichotic listening to words and accents. It measures complementary left hemispheric specialization for linguistic phonetic analysis and right hemisphere specialization for social/pragmatic aspects of communication. The second paradigm is lexical decision of lateralized targets with distractors in the opposite visual hemifield. It measures independent word recognition, independent error monitoring in the two hemispheres, and implicit priming across the hemispheres. The third paradigm is perceptual matching of letters by shape or by name within and between the hemispheres. It measures the ability of the hemispheres to process information in parallel in complex tasks. Together, the three experimental paradigms developed in this proposal provide a compact but comprehensive and exquisitely sensitive battery of tests of interhemispheric relations. This battery can then be used for studying individual or group differences in interhemispheric relations in normal and pathological populations, such as acquired aphasia, congenital dyslexia and schizophrenia. Results promise better understanding and possible control and reversal of pathology due to abnormal cerebral activation or impaired interhemispheric communication. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: IN VIVO 31P SPECTROSCOPY AND MRI IN ADHD Principal Investigator & Institution: Stanley, Jeffrey A.; Psychiatry; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2003; Project Start 28-JUL-2003; Project End 30-JUN-2006 Summary: (provided by applicant): The neurodevelopmental disorder, attention deficit hyperactive disorder (ADHD), is one of the most prevalent childhood behavioral disorders, affecting approximately 3% to 9% of the population. ADHD is first diagnosed in children with symptoms of inattention, hyperactivity and impulsivity. Numerous genetic, neuroimaging, molecular and neurochemical studies have provided a greater understanding of the neuropathophysiology of ADHD; however, there are many unanswered questions about ADHD. In vivo phosphorus magnetic resonance spectroscopy (31P MRS) is a noninvasive technique that can directly assess the metabolism of membrane phospholipids (MPL) and high-energy phosphates in multiple, localized brain regions. Preliminary results show significant alterations in MPL metabolism and high-energy phosphate utilization in regions associated with the neural networks of attention [prefrontal (PF), basal ganglia and superior temporal] of children and adolescents with ADHD compared to controls. When compared to normal neurodevelopmental data, these alterations appear to deviate from the naturally occuring changes. Additionally, MPL metabolites correlated with sustained attention performance in the PF and inferior parietal of both ADHD and control subjects. In all, these biochemical alterations in ADHD provide evidence of a deficit in regions responsible for the function of attention that are due to underdeveloped neuronal processes and synapses. It is, however, unclear if these alterations have a nonprogressive behavior and as a result also would be present at a relatively earlier stage of illness prior to medication treatment. Therefore, the purpose of this study is to assess cross-sectionally in vivo 31P metabolite differences from 7 different brain regions between 32 medication-naive children with ADHD and 32 healthy age- and gendermatched controls, using a multi-voxel acquisition schemes. MRI structural
18
Corpus Callosum
measurements of total grey and white matter volumes and of key structures also will be obtained. Additionally, metabolite levels for each right and left brain region of interest will be correlated with percent grey and white matter and cerebral spinal fluid in the same region and with the structural measurements. While one would not expect new treatments to emerge directly from this study's findings, the increased molecular/biochemical knowledge of ADHD will anchor future efforts to develop specific somatic treatments for ADHD. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: INTERGRATED METHODS FOR MEASURING NEUROANATOMY IN AUTISM Principal Investigator & Institution: Duncan, James S.; Professor; Diagnostic Radiology; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2002; Project Start 01-JUN-1996; Project End 31-AUG-2004 Summary: Autism is a complex disorder of early onset, involving odd and repetitive movements, severe social disability, deficits in social cognition, and disruption of language. While the multiple signs and symptoms in autism suggest several different brain systems are likely involved in its pathobiology, it remains the fact that most efforts aimed at the analysis of neuroanatomical structure related to autism from (primarily Magnetic Resonance (MR) images have been limited to the measurement of rather gross features, such as overall brain size and cross sectional area, or measurements of the corpus callosum and cerebellar vermis, using fairly small samples. These limitations are in large part because, to date, manual and computer-assisted, semi-automated segmentation/measurement of neuroanatomy is a tedious, labor-intensive, and costly process, subject to human variability. The research proposed here is aimed at the further development of an image analysis strategy that will accurately, reproducibly, robustly and efficiently analyze neuroanatomical structure relevant to autism from 3D high resolution MR images. At the core of this effort are unique mathematical approaches to: i.) segment cortical structure using coupled differential equations to simultaneously locate the gray/white and gray/CSF surfaces; ii.) segment subcortical structure by adding shape and inter-structure spatial relationship priors to an approach that integrates boundary finding and region growing; and iii.) nonlinearly register regional neuroanatomical structure to create atlases and match them to segmented information for the purpose of labeling cortical gyri and guiding the subcortical segmentation process. A key feature of the approach is that the final labeling and measurement that is performed is done by carefully focusing on individual regions of the brain, one at a time. The accuracy and robustness of the individual algorithm components to imaging parameters, field inhomogeneities and noise will be demonstrated by validating segmentation, registration, labeling and measurement algorithm results from synthetic data created using an MR image simulator against gold standard source images. The utility of the image analysis strategy for deriving robust, accurate measures in a variety of cortical and subcortical brain regions relevant to autism will be evaluated by running the algorithm on a cohort of 30 normal control and 30 subjects having autism and/or related conditions, sampled from a large, well characterized and separately NIH-funded subject database. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
•
19
Project Title: MECHANISMS OF AXONAL SPROUTING IN THE ADULT STRIATUM Principal Investigator & Institution: Chesselet, Marie-Francoise S.; Charles H. Markham Professor of Neurolog; Neurology; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002; Project Start 06-JUL-2000; Project End 30-JUN-2004 Summary: (Verbatim from the Applicant's Abstract): Anatomical plasticity, for example the sprouting of spared axons after a lesion, is likely to play a critical role in functional recovery after brain injury or neurodegeneration. However the mechanisms of anatomical plasticity in the adult brain remain poorly understood. Recent experimental results demonstrated a lesion-specific axonal sprouting from the homotypic contralateral cortex in the dorsolateral (motor) striatum of adult rats after lesions of the sensorimotor cortex. This axonal sprouting was observed after lesions induced by thermocoagulation of pial blood vessels, which produce a local ischemia in the cortex, but not after aspiration lesions. The goal of the present study is to determine the cellular and molecular mechanisms involved in this sprouting of corticospinal axons. We will take advantage of the fact that comparable cortical lesions made either by thermocoagulation or by aspiration have different effects on axonal sprouting in the striatum. This will allow us to identify those cellular and molecular mechanisms that are specifically associated with the robust anatomical plasticity seen after ischemic lesions. Recent data from our laboratory have shown that both lesions induce markedly different changes in neuronal activity and patterns of gene expression in the contralateral cortex. In a first set of experiments, we will further identify genes that are likely to be critical for the axonal sprouting by comparing patterns of mRNA expression after the two types of lesions. This will be done first by large scale screening with a DNA micoarray method, followed by confirmation with RT-PCR and mapping at the cellular level with in situ hybridization histochemistry and immunohistochemistry. In a second set of experiments we will block the changes in cellular activity in the cortex contralateral to the lesion to elucidate its role in 1) the molecular changes observed after the lesion 2) axonal sprouting. This multidisciplinary approach will allow us to identify the contribution of key molecular and cellular effects to axonal sprouting in the motor striatum. The results will help to understand the mechanisms responsible for differences in anatomical plasticity after various types of brain injury in the adult. This has relevance for the treatment of stroke and neurodegenerative diseases, two major health concern and leading causes of disability. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: MICROSTRUCTURAL BRAIN WHITE MATTER IN AGING & HIV Principal Investigator & Institution: Smith, Clifford A.; Rush University Medical Center Chicago, Il 60612 Timing: Fiscal Year 2003; Project Start 30-SEP-2003; Project End 31-AUG-2006 Summary: (provided by applicant): Diffusion tensor imaging (DTI) is an emerging technique combining magnetic resonance imaging (MRI) diffusion-weighted pulse sequences with tensor mathematics to encode molecular diffusion in 3-dimensions. Microstructural white matter integrity is known to decrease with increasing age, as well as with HIV-infection. Healthy aging and HIV-infection are associated with a pattern of cognitive deficits that are remarkably similar. Microstructural white matter changes may account for these changes, although the specific relationship to HIV-infection and aging remains to be evaluated. This study is designed to characterize the nature and extent of
20
Corpus Callosum
microstructural white matter disease associated with aging and HIV-1 infection and to clarify the association between the identified white matter changes associated with HIVinfection and healthy aging to concurrent neurocognitive performance. We will employ a four group, naturalistic design (30 young HIV-seropositive subjects, 30 older seropositive subjects, 30 young healthy controls, and 30 healthy older controls). In addition to completing a battery of cognitive tests known to be sensitive to frontal lobe and corpus callosal function, subjects will receive MRI and high resolution DTI scans evaluating both whole brain white matter and specific areas of interest (frontal forceps and corpus callosum). We will test the interactive and simple effects of HIV-infection and aging on structure and function with the following aims: Aim 1: To examine the relationship of aging and HIV-1 infection on white matter microstructural integrity. This will be accomplished by employing high-resolution diffusion tensor magnetic resonance imaging to evaluate subtle white matter disease through both whole brain analysis and the evaluation of specific regions of interest (frontal forceps and corpus callosum). Aim 2: To evaluate the relationship of aging, HIV-1 infection, and cognitive behaviors associated with frontal lobe functioning. This will be accomplished by comparing group performance on a number of neuropsychological measures of putative frontal lobe function. Aim 3: To examine the regional relationship between measures of frontal lobe function and interhemispheric transfer and microstructural white matter integrity. This will be accomplished by relating markers of white matter microstructure (fractional anisotropy and mean diffusivity) to concurrent neurocognitive performance. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MIDLINE GLIA AND THE DEVELOPMENT OF THE CORPUS CALLOSUM Principal Investigator & Institution: Richards, Linda J.; Associate Professor; Anatomy and Neurobiology; University of Maryland Balt Prof School Baltimore, Md 21201 Timing: Fiscal Year 2002; Project Start 01-JUL-1999; Project End 30-APR-2003 Summary: (Adapted from the applicant's abstract): This application proposes to examine the role that three glial cell populations play in the development of the corpus callosum. One of these populations form the glial sling, a group of cells that underlie the corpus callosum forming a "bridge" between the two hemispheres. Two newly discovered populations are the glial wedge, a group of cells near the midline that are proposed to deflect cortical axons medially and the indusium griseum, a group of glial cells located dorsal to the callosum. The three specific aims proposed in this new application are as follows: (1) characterize the role Emx1 plays in regulating the expression of guidance molecules derived from the glial sling; (2) determine whether two other midline glial populations are also important for midline guidance of cortical axons; and (3) examine the development of midline glial cells in mouse mutants exhibiting an acallosal phenotype i.e. the netrin-1 and DCC mutant mice. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: MODELS INTERACTIONS
OF
NORMAL
&
POSTSTROKE
HEMISPHERIC
Principal Investigator & Institution: Reggia, James A.; Professor; Computer Science; University of Maryland College Pk Campus College Park, Md 20742 Timing: Fiscal Year 2002; Project Start 20-SEP-1996; Project End 31-JUL-2005 Summary: Current understanding of the origins of cerebral specialization and of hemispheric interactions is fairly limited. For example, it is unclear which recognized
Studies
21
cortical asymmetries lead to lateralization, whether the net influence of one hemisphere on the other is excitatory or inhibitory, and to the extent to which the intact contralateral hemisphere contributes to recovery following a cortical lesion such as a stroke. The longterm goal of this work is to gain a better understanding of these issues by developing and studying neural models of emergent hemispheric lateralization and of hemispheric interactions as those models recover from simulated cortical lesions. The models consist of networks of paired left and right cortical regions connected by a simulated corpus callosum. The specific aims are: 1. to test the hypothesis that models have excitatory callosal connections and indirect interhemispheric competition can better explain data from biological/behavioral experiments than previous models; 2. to determine how learning one behavioral task can influence the direction/extent of another task's lateralization; 3. to determine how multiple underlying hemispheric asymmetries in a single model interact, altering the direction/extent of lateralization produced by each alone; and 4. to examine lateralization and post-lesion hemispheric interactions in a neurobiologically-grounded model of associative word learning that is directly comparable to behavioral, clinical and functional imaging data. This is the first systematic attempt to better understand cerebral specialization and transcallosal diaschisis using computational models. The results will directly relate to ongoing experimental work, have important implications for current theories of the mechanisms underlying hemispheric functional asymmetries and post-stroke recovery, and may suggest new therapeutic concepts for stroke patients. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MOTOR LEARNING AND MEMORY IN HEALTH AND DISEASE Principal Investigator & Institution: Shadmehr, Reza; Biomedical Engineering; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2003; Project Start 01-APR-1999; Project End 31-MAR-2007 Summary: (provided by applicant): When one moves their hand from one point to another, the brain guides the arm by relying on neural structures that estimate physical dynamics of the task and transform the desired motion into motor commands. If our hand is holding an object, the subtle changes in the dynamics of the arm are taken into account by these neural structures and this is reflected in the altered motor commands. These observations have suggested that in generating motor commands, the brain strongly relies on internal models that predict physical dynamics of the external world. The internal models are learned with practice, and appear to be a fundamental part of voluntary motor control. However, we know very little about which neural structures in the brain are involved in formation of internal models for motor control and how they learn to represent these models. Our aim here is to combine behavioral and mathematical tools to infer how humans learn internal models, and how the process is affected when there is damage to specific motor structures in the brain. We approach the problem by considering a task where physical dynamics of reaching movements are altered. As people practice the task, we ask how did an error that was experienced in a given movement affect subsequent movements? We arrive at a generalization function that mathematically describes how the brain changes the internal model in response to an error. The shape of the generalization function predicts the receptive field of the elements that took part in representing the internal model with respect to movement kinematics. We study these generalization functions in position, velocity, and acceleration space of the arm. Preliminary results demonstrate a remarkable similarity between these behaviorally inferred bases and typical tuning properties of cells in the primary motor cortex. This suggests that tuning properties of these cells might be
22
Corpus Callosum
reflected in human behavior in the way that we learn and generalize patterns of force. We extend the studies to include generalization from one arm to the other. We further extend the studies to movements where dynamics are not dependent only on arm kinematics, but also on other cues: external cues where dynamics are linked to an arbitrary spatial or color cue, internal cues where dynamics depends on position of a movement with in a sequence. We compare how damage to the brain in Huntington's disease vs. cerebellar disease affects this learning. However, motor memories are not static. Their functional properties change within hours after a task is learned. We ask how this change affects the generalization function. Is the brain different in the way it responds to an error after a memory has consolidated vs. early in the learning phase? Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEAR INFRARED PROBE FOR LOCALIZATION IN DBS Principal Investigator & Institution: Giller, Cole A.; Associate Professor; Neurological Surgery; University of Texas Sw Med Ctr/Dallas Dallas, Tx 753909105 Timing: Fiscal Year 2002; Project Start 30-SEP-2000; Project End 31-AUG-2004 Summary: (Adapted from the Applicant's Abstract): Localization of gray matter/white matter borders is critical to the accurate placement of electrodes for deep brain stimulation (DBS). These neuroanatomical borders are traditionally identified using CT and MR imaging, aided by microelectrode recording (MER) techniques. This project will evaluate the ability of an intracranial probe utilizing near-infrared (NIR) spectroscopy to identify differences between gray and white matter to localize small targets as required for placement of DBS leads and other stereotactic surgeries. Localization with the NIR probe will be validated with standard MER techniques as well as with perioperative imaging. The time required for use of the NIR probe will be compared to that of MER. If validated, use of this NIR probe would lessen the difficulty of intraoperative localization. There will be three specific aims: (1) the NIR probe will first be used in a rodent model, where pilot data has verified the ability to accurately detect the white matter track of the corpus callosum. Sites with different white matter thickness will be used to test the resolution of the probe, and NIR data will be compared to post-mortem localization of the probe in histologic sections; (2) an NIR probe has been designed for simultaneous microelectrode recording that will be tested in the rodent model to acquire NIR and MER data simultaneously. This probe will then be used in rodents and humans to more precisely define the ability of the NIR probe to provide localization of the fine layers of gray and white matter. In humans, particular attention will be given to localization of layers at the base of the thalamus and pallidum that is required for definitive placement of DBS electrodes; and (3) refine the development of the NIR method. The proposed studies seek to validate and further develop a new method for precise localization of important subcortical structures commonly encountered in stereotactic surgery for Parkinson's disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: NEUROANATOMIC/PSYCHOLOGIC ANALYSES OF FAS/FAE DEFICITS Principal Investigator & Institution: Streissguth, Ann P.; Psychiatry and Behavioral Scis; University of Washington Grant & Contract Services Seattle, Wa 98105 Timing: Fiscal Year 2003; Project Start 01-AUG-1996; Project End 30-APR-2006 Summary: (provided by applicant): This research proposes to extend the successful work already completed in quantifying the neuroanatomic abnormalities underlying
Studies
23
neuropsychological deficits among people with brain damage caused by prenatal alcohol exposure. Although Fetal Alcohol Syndrome (FAS) is a distinct diagnostic entity, it conceals substantial variability of deficits. Many individuals with substantial prenatal alcohol exposure exhibit dysfunctional behaviors that appear to be CNS-based, but do not have facial manifestations of FAS. These features are sometimes referred to as possible fetal alcohol effects (FAE). In prior work, we developed and demonstrated a new method of shape analysis targeting the corpus callosum (CC) that was above 80% accurate in separating FAS/FAE from controls, using a symmetrical four-quadrant data set of male and female adolescents and adults across three diagnostic groups: FAS, FAE, and age/sex matched non-exposed controls. Using newly developed methods, we now propose to reanalyze these magnetic resonance images for additional brain structures, targeting the cerebellum, and to compare these images with the full battery of neuropsychological tests obtained on our 180 subjects. We hypothesize that these new image analyses will reveal significant differences in mean or variance of brain form between FAS/FAE and controls, that FAS and FAE will not differ from each other, and that distinct profiles of association will be observed between neuroanatomy and neuropsychology. Over three years, we will pursue four aims: (1.) To quantify new morphological data from existing magnetic resonance images, to examine additional curves and shapes on and near the cerebellum that will be combined with CC and gray/white matter volumes in detecting FAS/FAE; (2.) To examine the behavioral phenotype of FAS/FAE, using already collected data augmented with new scores from existing data, to study the other three quadrants of subjects for profiles of Executive Function and Motor Function deficits that were related to different CC shape anomalies in adult males; (3.) To conclude the full four-quadrant neuroanatomic/neuropsychologic analysis, using the new data on cerebellar shape and size combined with the augmented behavioral phenotype data; (4.) To develop a datadriven diagnostic protocol based on the principles already demonstrated and utilizing entire data sets from both imaging and behavior. This will be the first systematic study to move directly from state-of-the-art image analysis techniques and neuropsychological testing, to a diagnostic protocol with practical utility, filling a compelling need for diagnosing fetal alcohol brain damage in adolescents and adults and in the absence of the typical facial characteristics. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEUROANATOMICAL AND NEUROFUNCTIONAL CORRELATES OF COGNITIVE COMPETENCE Principal Investigator & Institution: Hopkins, William D.; Professor; Georgia State University University Plaza Atlanta, Ga 30303 Timing: Fiscal Year 2002 Summary: The proposed studies will examine the neurobiological basis of cognitive functions from a comparative perspective. Both structural and functional differences in brain organization will be investigated in relation to various cognitive functions in primates. The focus of this application is on the emergence of hemispheric specialization in relation to the evolution of overall brain organization and cognitive functions from a comparative primate perspective Specifically, in addition to global changes in size and neocortical organization, the brain has become increasingly lateralized in both function and structure in primate evolution. One aim of the proposed studies is comparatively to examine global brain organization and lateralization relation to cognitive in monkeys and chimpanzees. Neuroanatomic and cognitive data will be collected in the same subjects and will therefore will resolve the existing problem of mixing data sets from
24
Corpus Callosum
different investigators. A second aim of this study is to derive measures of functional asymmetry in monkeys and chimpanzees for specific cognitive functions and to map these performance asymmetries onto structural features of asymmetry. A third aim of this research is to determine localized and lateralized cognitive functions in monkeys and chimpanzees using rapid-sequence transcranial magnetic stimulation (rTMS). In addition, individual and species variation in lateralized cognitive functions using rTMS will be correlated with area differences in corpus callosum morphology and neuroanatomical asymmetry. In part, this determination will be made by disrupting attention, executive functioning, or symbolic processing by stimulating specific regions of the cortex in monkeys and chimpanzees. Of particular interest will be the determination of whether langauge-trained chimpanzees have the functional equivalent of Broca's and Wernicke's areas. These studies will elucidate distal mechanisms involved in the evolution of human cognition including language and will provide for a better understanding of neural mechanisms involved in higher-order cognitive functions. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEUROANATOMY OF ADULT ADHD: AN MRI MORPHOMETRIC STUDY Principal Investigator & Institution: Seidman, Larry J.; Massachusetts General Hospital 55 Fruit St Boston, Ma 02114 Timing: Fiscal Year 2002; Project Start 01-MAR-2002; Project End 28-FEB-2007 Summary: During the last 10-15 years, it has been gradually recognized that Attention Deficit Hyperactivity Disorder (ADHD) persists into late adolescence and adult life in a substantial number of cases. While there are pockets of information which provide clues to neurobiologic abnormalities in ADHD at different age periods (structural brain abnormalities in boys, small samples demonstrating functional brain abnormalities in adults), there is very little systematic neurobiological information on ADHD throughout life. In particular, there is a paucity of neurobiological research in adults with the syndrome. The identification and integration of neuropsychological, neuroanatomical, and functional brain abnormalities in ADHD is crucial for identifying neurobiological mechanisms and improving treatment. Such information is necessary to help clarify the neurodevelopmental evolution of the disorder, treatment response, and the meaning of the disorder to patients, families and clinicians. In light of evidence of clinical continuity between pediatric and adult ADHD, we expect similarities in brain dysfunction across the life cycle. We hypothesize that a key brain abnormality in ADHD involves frontalstriatal circuitry reflected in neurocognitive deficits in attention and executive functions (especially working memory and inhibition). A primary goal of this study is to identify brain and neuropsychological abnormalities in ADHD across life, focusing on inhibition, working memory and vigilance, and the brain structures responsible for these functions. We propose to use state-of-the- art morphometric and functional measures (Counting Stroop, "Two- back" and CPT) of magnetic resonance images (MRI) to evaluate adults with ADHD and their ADHD children. These tools will allow a comprehensive and highly detailed analysis of the brain circuitry putatively abnormal in ADHD: dorsolateral and orbital prefrontal cortex, caudate and pallidum, nucleus accumbens, thalamus, anterior cingulate, cerebellum, and corpus callosum. Because ADHD is very heterogeneous, with substantial psychiatric and cognitive comorbidity (i.e., learning disabilities), it is crucial to study a large enough sample to gain a comprehensive understanding of the disorder (n=140 ADHD adults, n=120 adult controls; 75 ADHD offspring, 75 control offspring). The proposed study will enable us to evaluate the effects of comorbidity, family history, gender, and genetic factors on brain abnormalities in
Studies
25
ADHD. Finally, the feasibility and cost effectiveness of the proposed study is quite high because it builds on a large, systematic, ongoing study (MH 57934) which will provide all clinical data on ADHD, and on ongoing relationships between investigators. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEUROBIOLOGY OF AUTISM & RELATED CONDITIONS Principal Investigator & Institution: Levitt, Jennifer; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002 Summary: New neuroscientific methods are required to better define the relationships of aberrant brain morphology in schizophrenia. Focusing on structures as part of complex functional circuitry is extremely important for isolating pathology in schizophrenic brains. Mapping variability in isolated structures is however necessary to reveal the unique variability within populations and to provide a quantitative measurement of anatomical displacement in diseased brains. Such methods promise to answer questions about the relationships between neuroanatornical structures in schizophrenia and in normal controls. For example, the corpus callosum may not differ across populations by conventional morphometric measurements, including area, length and width. However, analysis of shape, curvature and variability within the structure may reveal that the callosum, is displaced in the vertical axis in schizophrenic patients as compared to normal controls. The curvature too may be different. Such findings imply that the callosum is displaced by the underlying anatomy and this displacement is unique to schizophrenic brains. Furthermore, the altered location of a structure may reciprocally affect the displacement of other structures. Sirnilarly, analysis of regions of variability within the lateral ventricles may reveal subtle complex differences between populations whether or not there is ventricular enlargement. These methods can also point to otherwise indistinguishable asymmetries in neuroanatomy. Variability and displacement maps can therefore provide distinct hypothese s about morphological changes in schizophrenic patients and elucidate the developmental changes that may be causal to the syndrome. These methods along with traditional structural parameter analysis and tissue segmentation can give us invaluable insight into pathological processes in schizophrenia. Such findings can, (1) support links between neuroanatomical abnormalities and behavior; (2) provide clues to timing in anomalous neurodevelopment; (3) guide us to the regions where neuroanatomy is maximally displaced; (4) allow us to follow the progression of neuroanatomical changes in individual schizophrenic patients over time; (5) compare regions of variability between schizophrenia subgroups and their differences from normal populations. Specific neuroanatomic loss of volume may also be located by the relationships of displacement within functional circuitry. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: NEURODEVELOPMENT AND EXPERIENCE: BEHAVIOR, QEEG AND MRI Principal Investigator & Institution: Als, Heidelise; Children's Hospital (Boston) Boston, Ma 021155737 Timing: Fiscal Year 2002; Project Start 01-MAR-2000; Project End 28-FEB-2004 Summary: The period from 28 to 30 weeks gestation is one of significant neurological reorganization, initiating the beginning of fetal behavioral individually and maintenance of extrauterine survival. Infants born at this transitional stage, the fastest
26
Corpus Callosum
growing and largest segment of the PT infant (PT) population, later on exhibit unexpectedly significant brain dysfunction and remain at risk well into school age. Up to 52 percent of such infants present with deficits in psychomotor, cognitive, and attentional function, emotional vulnerability and substandard school performance, all thought to be due to a central deficit in processing complex information and attributable to association cortical frontal systems. It is postulated that such a central deficit may result from increased vulnerability of cerebral white matter during the last trimester of gestation, its phase of most rapid development. Persistent stress due to inappropriate sensory stimulation is thought to contribute to such alteration of early brain structure and function. The aim of the proposed study is to identify specific adaptations of the PT brain in the last 12 weeks of gestation to the transient experience of the NICU environment in order to estimate the potential of such experience in remodeling neuroanatomical structure and neurodevelopmental function. A prospective randomized clinical trial will be conducted. Sixty medically healthy PTs born between 28 and 30 weeks will be randomly assigned to one of two treatment conditions, representing measurably different NICU experiences, standard care (SC) and developmental care (DC). They will be compared to 30 healthy full-term infants (FT). All 90 infants will be assessed at 42 w postconceptional age in three neurodevelopmental domains, neurobehavioral function (APIB; Prechtl), neuroelectrophysiological function (qEEG; FVER), and neuroanatomic structure (3D-MRI; DTI). Specific regions of interest investigated will be the early maturing occipital lobe and the later maturing frontal lobe and corpus callosum structures. It is hypothesized that PTs who receive DC will demonstrate regionally specific brain enhancement within domain compared to PTs who receive SC. Furthermore, such PTs will be more similar to FTs that PTs who receive SC. MANOVA will be employed by domain in order to test this hypothesis. Canonical correlations will be used to examine the relationships among and within the domains. It is anticipated that the proposed study will demonstrate for the first time the effect of experience on the remodeling of higher order neurofunctional and neuro structural processes, and will suggest and approach for later deficit amelioration, relevant to the largest segment of the PT population. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEUROIMAGING STUDIES OF AUTISM SPECTRUM CONDITIONS Principal Investigator & Institution: Schultz, Robert T.; Associate Professor; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2002; Project Start 20-SEP-2002; Project End 31-MAY-2007 Summary: Autism spectrum disorders (ASDs) affect multiple functional systems, including reciprocal social behavior, communication and behavioral regulation. This suggests that multiple brain systems are involved in their pathobiology. This project will use high resolution structural MRI and diffusion tensor imaging (DTI) on participants recruited through the Family Genetics study (Project 2) in order to test several current hypotheses about neural systems affected by ASDs. Our preliminary studies show significant brain volume increases, as well as some regionally specific increases and decreases in ASDs. The literature in these areas is not always consistent, and it seems likely that heterogeneity due to ASD subtypes contributes to uncertainty in this area. By adding to our already large, well characterized sample, we will be in good position to stratify subjects along more informative dimensions, which may involve use of Family Genetics data. We rely heavily on results from our ongoing fMRl studies to guide our selection of brain regions for morphometric analyses. DTI will be used to test the integrity of cerebral white matter. Recent studies have suggested that white matter
Studies
27
abnormalities may figure prominently in the pathobiology of the ASDs. We propose to collect MRI data on 120 persons with an ASD, and 50 controls, yielding a combined total of 95 persons with high functioning autism (HFA), 95 persons with Asperger syndrome (AS) and 30 persons with PDD NOS to test the following hypotheses: - Brain volume is increased in persons with an ASD - Cerebral white matter volume is increased in persons with an ASD - Fractional anisotropy is reduced throughout the cerebral white matter, and at boundaries to key gray matter nodes in our model of the social brain Cross sectional area and fractional anisotropy of the genu and splenium of the corpus callosum is reduced in persons with an ASD, and - The gray matter volume of specific areas of the medial prefrontal cortex, fusiform gyrus, superior temporal sulcus and the amygdala are significantly altered in persons with an ASD. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEUROLOGIC & COGNITIVE ANALYSIS OF CALLOSOTOMY PATIENTS Principal Investigator & Institution: Gazzaniga, Michael S.; Director and Professor; Psychological & Brain Scis; Dartmouth College 11 Rope Ferry Rd. #6210 Hanover, Nh 03755 Timing: Fiscal Year 2004; Project Start 01-JAN-1993; Project End 29-FEB-2008 Summary: (provided by applicant): The corpus callosum, which connects the two cerebral hemispheres, is the largest fiber tract in the human brain. This fiber tract is severed in patients who undergo complete callosotomy, resulting in a disconnection of the hemispheres at the cortical level. Lateralized testing of these patients can reveal dramatic hemispheric differences in perceptual and cognitive processing, yet paradoxically, their behavior often appears fully integrated. The purpose of this proposal is to investigate the role of the corpus callosum and non-callosal mechanisms in interhemispheric integration. It has been suggested that intrahemispheric processing is more efficient than interhemispheric processing and therefore processing will tend to occur within one hemisphere when task demands are low. As task demands increase, however, research has demonstrated that the other hemisphere is increasingly recruited, requiring integration of information and resources between the two hemispheres. To determine the role of the corpus callosum in interhemispheric integration, we plan to continue behavioral testing of complete callosotomy patients. In addition, we are expanding our patient population to include those with partial lesions of the corpus callosum in order to characterize the role of callosal subregions in interhemispheric integration. Proposed experiments also incorporate new methodologies, specifically, diffusion tensor imaging, functional neuroimaging and electrophysiological recording of neural activity. Our research proposal centers on four specific aims. The first aim is to investigate the role of specific callosal regions in the binding of visual features into unified object representations. The second aim is to explore the effect of hemispheric specialization and task difficulty on the deployment of processing resources. The third aim is to investigate the effect of hemispheric differences in spatial representation on the integration of perception and movement between the two hemispheres. The fourth aim explores the extent to which the disconnected hemispheres are able to monitor and respond to processing events in the other hemisphere. Taken together, this research will provide important insights into the specialized roles of the two hemispheres and the ways in which they interact via the corpus callosum and non-callosal mechanisms Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
28
•
Corpus Callosum
Project Title: PHOTO-INDUCIBLE TRANSCRIPTIONAL REGULATORS Principal Investigator & Institution: Koh, John T.; Associate Professor; Chemistry and Biochemistry; University of Delaware Newark, De 19716 Timing: Fiscal Year 2004; Project Start 01-MAR-2004; Project End 28-FEB-2008 Summary: (provided by applicant): Many gene products critically involved in development elicit their effects through their unique spatial and temporal patterning in tissues. The complexity of these developmental processes is highlighted by neurogenesis, which involves the actions of dozens of temporally and spatially patterned molecular guidance cues. The co-spatial presentation of multiple molecular cues involved in the guidance of neurons makes controlled study of these molecular interactions in vivo a formidable challenge. We have recently developed a new method to control the spatial and temporal expression of genes in cultured cells (in vitro) in a light-directed manner using photo-caged agonists of nuclear hormone receptors. This method will be used to investigate the effects of spatially and temporally patterned axon guidance cues that cannot be adequately addressed by any current method. NgCAM is the avian homolog of mammalian L1, a biomedically important protein associated with the X-linked mental retardation syndrome CRASH (Corpus callosum agenesis, Retardation, Abducted thumbs, Spastic paraplegia, Hydrocephalus). NgCAM is an important cell surface protein that is involved in guiding axons during brain development. The ability of spatially discrete patterns of NgCAM to direct neurite outgrowth when presented in a biologically relevant manner on cell surfaces in cultured cell monolayers will be explored. The ability of both binary (on/off) patterns and gradients of NgCAM to direct and influence axon extension will be investigated through controlled in vitro co-culture experiments. The unique ability of this light-activated expression system to create transient expression patterns will be used to dissect the role of NgCAM in promoting axon extension versus sustaining extended axons. "Moving" patterns of expressed NgCAM will be used to assess the ability of NgCAM to redirect axons once extended. Because many events in neurogenesis involve the combined actions of multiple genes expressed within the same tissue, light-activated gene expression will be further developed to permit the independent cospatial control of multiple genes products in vitro. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: REPAIR AND REGENERATION OF CENTRAL VISUAL PATHWAYS Principal Investigator & Institution: Barres, Ben A.; Assistant Professor; Neurobiology; Stanford University Stanford, Ca 94305 Timing: Fiscal Year 2002; Project Start 22-JAN-1996; Project End 31-DEC-2003 Summary: We propose to investigate why central visual pathways fail to regenerate after injury and how their repair can be enhanced. We will focus on the mechanisms that normally control the survival and growth of retinal ganglion cells (RGCs) and their axons. The rat optic nerve, which mainly consists of RGC axons, astrocytes, and myelinating oligodendrocytes, will be used as a model system. The survival of RGCs and their axons is normally controlled by peptide signals such as brain-derived neurotrophic factor (BDNF), that are released by neighboring cells-tectal target neurons and optic nerve glia-and retrogradely transported to the RGC soma. When RGC axons are cut, their axons degenerate and the RGCs themselves undergo apoptosis, because they fail to get needed survival signals. In addition, we have recently found that electrical activity of RGCs is necessary for responsiveness to these peptide trophic signals and that axotomized RGCs quickly lose responsiveness to peptide trophic
Studies
29
signals. These findings raise a question: do RGC axons fail to regenerate after injury primarily because RGCs fail to receive and respond to signals necessary to promote their survival and growth? Alternative hypotheses are that RGCs lose the ability to regenerate axons with age or that regrowing axons are inhibited by myelin and other inhibitors. We have developed methods to purify and culture to greater than 99.5 percent purity rodent RGCs, optic nerve astrocytes and oligodendrocytes. RGCs are presently the only CNS neuron that can be highly purified and cultured in defined serum-free conditions, providing us with an unusually good opportunity to investigate the signals that normally promote their survival and growth and how these mechanisms go awry after injury. We have also recently shown that bcl-2 expression is sufficient to promote the survival of purified RGCs in culture in the absence of peptide signals. We will use these methods to ask: (1) What extrinsic signals promote axon growth of surviving RGCs?, (2) Is there an effect of intrinsic neuronal age on the rate of axonal growth of surviving RGCs?, (3) Are surviving RGCs inhibited by myelin and semaphorins?, (4) How do electrical activity and CAMP elevation control trophic responsiveness of RGCs and does axotomy decrease RGC electrical activity?, and (5) Will surviving RGCs regenerate their axons in vivo? Our ultimate goal is to understand why RGCs fail to survive and regenerate after axotomy. This could suggest new ways of promoting their regeneration after injury in ocular diseases including glaucoma, retinal ischemia, optic neuritis, ischemia and neuropathy. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SYNDROME
SCHIZOPHRENIA
PREDISPOSITION
IN
22Q11
DELETION
Principal Investigator & Institution: Shashi, Vandana; Pediatrics; Wake Forest University Health Sciences Winston-Salem, Nc 27157 Timing: Fiscal Year 2004; Project Start 05-MAR-2004; Project End 28-FEB-2006 Summary: (provided by investigator): Schizophrenia is increasingly viewed as a neurodevelopmental disorder, but prospective studies of the etiology and premorbid manifestations are hampered by the lack of a homogeneous study population. Chromosome 22q11 deletion syndrome (22q11DS) is an autosomal dominant microdeletion syndrome, associated with congenital abnormalities, cognitive impairment and a markedly increased incidence (40%) of schizophrenia and other major psychoses in late adolescence/adulthood. Due to the relatively recent discovery of the relationship between 22q11DS and psychosis - there is little knowledge regarding the pathogenesis and the clinical course of psychoses in these individuals. We hypothesize that a subset of nonpsychotic children with 22q11DS will exhibit elevated rates of schizophrenic-like cognitive/behavioral/neurodevelopmental deficits. Theoretical evidence suggests that such deficits in nonpsychotic individuals predict a heightened risk of psychosis in late adolescence/adulthood. We propose a cross-sectional study on 35 children with 22q11DS and 35 age and gender matched healthy control subjects. The study will assess medical status, pedigree data, neurodevelopmental history, intellectual ability, psychometric/biobehavioral/neurocognitive measures of risk for schizophrenia and structural brain abnormalities by morphometric analyses. Our preliminary data on 13 children with 22q11DS and 13 control subjects indicate that children with 22q11DS exhibit higher rates of deficits in sustained attention and executive functioning. On brain MRI, midline deviations such as cavum septum pellucidum/vergae are common (7/13 patients). The corpus callosum (CC) area and the area of the isthmus of the CC are increased in the 22q11DS patients. On correlating the neuropsychological and MRI findings, increasing size of the genu of the CC is associated with decreasing verbal IQ
30
Corpus Callosum
and verbal learning and memory. Thus, our findings are suggestive of increased rates of neuropsychological and neuroanatomical abnormalities in children with 22q11DS. Further characterization of these abnormalities in the proposed cross-sectional study will form the basis of a future longitudinal study of risk for schizophrenia and other psychoses in these children. The successful characterization of schizophrenic-like deficits should facilitate the identification of individuals at high-risk. The strengths of the proposed study are that we would examine vulnerability associated with a specific genetic abnormality, integrate measures from a variety of medical and psychological domains, and ascertain a sample for longitudinal study of risk for developing schizophrenia and related disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SEX SCHIZOPHRENIA II
&
STRUCTURAL
BRAIN
ABNORMALITIES
IN
Principal Investigator & Institution: Goldstein, Jill M.; Psychiatry; Harvard University (Medical School) Medical School Campus Boston, Ma 02115 Timing: Fiscal Year 2002; Project Start 15-JUL-1997; Project End 30-JUN-2005 Summary: (Adapted from applicant's abstract): The investigators are proposing a 5-year competing continuation study to test the hypothesis that one's sex modifies brain volume abnormalities in schizophrenia (SCZ) in areas that are normally sexually dimorphic and places males at higher risk for more severe cognitive consequences than females with SCZ. Based on preliminary findings in MH56956 and others' work, they predict that males and females will differ in volumetric reductions in specific cortical regions and their associated areas in the corpus callosum, differences will contribute to explaining more severe verbal learning/memory deficits in males. Further predictions that these "sex-specific " cortical reductions in SCZ will more likely be associated with prenatal insults than with peri/postnatal insults. Finally, we will test whether prenatal insults result in similar sex-specific cortical volumetric reductions in subjects with SCZ compared with affective psychoses. A unique opportunity to test the hypotheses using subjects who were originally ascertained from a community sample of pregnancies from the Providence and Boston cohorts of the National Collaborative Perinatal Project (NCPP). Pregnancies were followed prospectively, bloods were drawn from mothers, and the children were regularly evaluated up to age 7. Serologic assays of exposures are currently being conducted at no cost to this proposal. From the NCPP sample, the investigators have been conducting a case-control study, in which they will have systematically located, recruited and diagnosed 123 DSM-IV psychotic cases, approximately 60 percent with SCZ and 40 percent with affective psychoses, who are now 3340 years of age. Subjects and their parents are evaluated clinically, and family history information (i.e. potential genetic vulnerability) is obtained. Cases are individually matched to normal controls based on age, sex, ethnicity, study site, and history of obstetric insults. In the proposed study, expectations to successfully reascertain 105 of these cases and 105 matched controls to conduct structural magnetic resonance imaging (MRI) and a cognitive battery focused on the components of verbal learning/memory. The investigators are using a sophisticated parcellation technique of MR scans that reliably identifies gray and white matter in cortical and subcortical regions. The tests of the hypotheses will provide us with knowledge about the relationships between brain morphology and cognition in SCZ, how one's sex may modify these relationships, the potential role of the timing of insults in producing these abnormalities, and whether the impact of sex is disease-specific or shared by another
Studies
31
illness, suggesting some robust properties of the normal female and male brain in the face of disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: VARIABILITY
SPINA
BIFIDA:
COGNITIVE
AND
NEUROBIOLOGICAL
Principal Investigator & Institution: Fletcher, Jack M.; Professor; Pediatrics; University of Texas Hlth Sci Ctr Houston Box 20036 Houston, Tx 77225 Timing: Fiscal Year 2002; Project Start 20-MAR-1998; Project End 28-FEB-2005 Summary: Spina bifida meningomyelocele is the major severely disabling birth defect in North America, but our knowledge of the factors responsible for neurobehavioral outcome is fragmentary. The program project aims to make these fragments coherent. The overall objective of this program project is to identify sources of variability-genetic, environmental, and CNS-that explain variations in the neurobehavioral outcomes of children with spina bifida meningomyelocele and hydrocephalus (SBH). To accomplish this objective, we propose to evaluate 583 children with spina bifida and 159 controls in five projects and three cores at two primary data collection sites: the University of Texas-Houston Medical School and the Hospital for Sick Children, Toronto. Project 1 (Genetics; Northrup, P.I.) evaluates genetic factors associated with spina bifida and related neural tube defects in Hispanic and Caucasian cohorts. Approximately 100 candidate genes will be tested and a genome-wide search will be initiated that permits testing of 150 of 330 possible markers. Projects 2 (Early Learning; Landry, P.I.) is a longitudinal study of infants with SBH from 7-36 months of age. This study addresses the relationship of core neurobiological deficits and the environment in producing early learning deficits in children with SBH. Project 3 (Cerebellum; Dennis, P.I.) evaluates the role of cerebellum/midbrain dysmorphology in producing the motor, spatial, and attentional deficits associated with SBH. Project 4 (Corpus Callosum; Hannay, P.I.) examines the corpus callosum anomalies characteristic of SBH in relationship to interhemispheric transmission and hemispheric specialization. Project 5 (Discourse and Academic Skills; Barnes, P.I. evaluates factors producing deficits in discourse, reading comprehension, and math in children with SBH. These 5 projects are supported by an Administrative Services Core (A; Fletcher, P.I.), Subject Recruitment and Evaluation Core (B; Fletcher, P.I.), and Database, Computer, and Statistics Core (C; Francis, P.I.) Core B provides for comprehensive medical, neuroimaging and psychometric evaluations of each child. Core C provides databases, project-specific data analyses, and overall data analyses. Altogether, this comprehensive program project should facilitate an integrated, multi-disciplinary understanding of spina bifida, a common and significantly handicapping disability. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: STRUCTURAL AND SPECTROSCOPIC BRAIN MRI IN AUTISM Principal Investigator & Institution: Brandt, Michael E.; Director; University of Texas Hlth Sci Ctr Houston Box 20036 Houston, Tx 77225 Timing: Fiscal Year 2002; Project Start 01-MAR-2002; Project End 28-FEB-2003 Summary: Increasingly, clinical and non-human primate studies suggest that dysfunction in identified neural networks linking the limbic structures and the prefrontal cortex results in behavioral and emotional patterns that resemble autism. Neuroimaging techniques to date have not consistently identified brain abnormalities associated with autism. This likely due to heterogeneity of autistic populations,
32
Corpus Callosum
inadequate control populations and limitations of previous imaging techniques themselves. This project will use technological advances in structural and spectroscopic magnetic resonance imaging (sMRI and 1/H-MRSI and 1/H- MRSI) to investigate abnormalities in identified limbic-prefrontal neural networks and determine their association with autism. Seventy-two children and adolescents with autism aged 7;0 to 18;11 years and a group comparable in age, gender and IQ without autism will receive high resolution sMRI. From the MR images, total and separate brain tissue (white matter/gray matter, cerebrospinal fluid) volume measurements will be performed (a) on the different structures of the limbic regions, i.e. the amygdala and hippocampus and (b) on two regions of the prefrontal cortex, i.e., the orbitofrontal and dorsolateral white/gray matter volume differences in orbitofrontal cortex of all autistic people as compared to control subjects; that volumetric differences in the structures of the MORB/AMYG circuit will correlate more strongly with neuropsychological test indices measuring functions of the amygdala and the orbitofrontal cortex, and clinical and behavioral measures of autistic symptoms (e.g. severity of autism), than with IQ measures; and that the dorsolateral prefrontal-hippocampal (DL/HIPPO) circuit will be more severely affected in low-functioning children and adolescents with autism than in high-functioning children and adolescents with autism and controls. In addition, a subgroup of subjects including 20 young high- functioning children and adolescents persons with autism, age 11; 0 to 18; 11 years and 20 controls matched for age, gender, IQ, and handedness will receive 1/H-MRSI to assess the chemical composition for identified cerebral areas. In addition, all monkeys with infant and adult lesions in defined cerebral structures will be behaviorally tested (Project III) and imaged using the same technique to identify brain regions affected by the early versus late damage to the amygdala or orbitofrontal cortex. We hypothesize that abnormalities seen in higherfunctioning children and adolescents with autism will be localized in the MORB/AMYG circuit, and those seen in the DL/HIPPO circuit will be associated with intellectual impairment; abnormalities of NAA reflecting alterations in neuronal integrity of the M-ORB-AMYG in autistic people will more strongly correlate with clinical and behavioral traits of autism as well as with scores on neuropsychological tasks measuring function of the M- ORB/AMYG circuit (Project I); in monkeys, we hypothesize that an early (infantile) lesion within the M-ORB/AMYG circuit (Project III) will have functional ramifications in other neural circuits (DL/HIPPO) and that the same lesion performed in adulthood will not have the same widespread impact. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: STRUCTURAL MR ANALYSES OF DRUG EXPOSED BRAINS Principal Investigator & Institution: Kosofsky, Barry E.; Associate Professor of Neurology; Massachusetts General Hospital 55 Fruit St Boston, Ma 02114 Timing: Fiscal Year 2004; Project Start 01-JUN-2004; Project End 28-FEB-2009 Summary: (provided by applicant): Our group proposes experiments to utilize automated segmentation tools that have been utilized on Adult MRIs to analyze a set of structural MR scans obtained from children exposed to cocaine in utero. The analysis will include both shape and contour analysis of subcortical structures, as well as the analyses of cortical structures including measurement of cortical volume, surface area, thickness, and folding pattern of the entire cortex parcellated in to specific cortical areas. By forming a collaborative imaging alliance at Brown University, our proposal will be focused on studying structural MR data from cocaine and alcohol exposed 8 to 12-yearolds. To date he and his imaging group have collected data from 14 such individuals, which we have analyzed and provide pilot data from, thereby demonstrating the
Studies
33
feasibility and analytic power of the proposed studies. The biologic hypotheses to be tested on the drug exposed population, supported by per preliminary data, is that cocaine and alcohol induced alterations in brain development produce specific alterations in the size and shape of particular subcortical structures, and in the volume and folding pattern of particular cortical areas. Our study of shape analysis has initially focus on the corpus callosum, which in previous studies by others was shown to be altered in shape as a result of prenatal exposure to alcohol. Our morphometric studies have focused on particular cortical (orbito-frontal, frontal, and anterior cingulate) and subcortical (caudate, putamen) structures that we hypothesize are specifically altered by prenatal exposure to cocaine, with resulting functional deficits in attention, reactivity, and responsivity. We additionally propose experiments to validate our automated segmentation and morphometric methods to identify cocaine and alcohol-induced differences in the size, shape and contour brain structures of exposed children. By developing and applying such tools we will not only address a clinically important problem, but we will develop methods that will be of general value to others pursuing pediatric neuroimaging studies. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: STRUCTURAL STUDIES IN THE CENTRAL NERVOUS SYSTEM Principal Investigator & Institution: Peters, Alan; Boston University Medical Campus 715 Albany St, 560 Boston, Ma 02118 Timing: Fiscal Year 2002 Summary: In this resubmission, Project 5 of the original proposal has been deleted, but the study of the age-related changes in layer 1 of cerebral cortex has been retained and is now included in this Project. This Project will define the structural changes that occur with age in the central nervous system. By using middle aged monkeys we will determine when these changes first occur, and because all monkeys are behaviorally tested, we will relate structural changes to cognition. The study of layer 1 is retained because we have found that the age-related thinning and the loss of synapses from layer 1 is the most obvious change in the cortex, and in area 46 we have shown that these changes correlate with both age and cognitive decline. We need to know if these changes are ubiquitous, and so we propose to examine layer 1 in entorhinal cortex and in area 17 to ascertain if age produces similar changes in these cortices and if they also correlate with cognitive decline. We need to know if these changes are ubiquitous, and so we propose to examine layer 1 in entorhinal cortex in area 17 to ascertain if age produces similar changes in these cortices and if they also correlate with cognitive decline. Another major goal is to further pursue the breakdown of myelin sheaths we have shown to occur with age: we believe that this breakdown brings about cognitive decline through alterations in conduction rates, affecting timing in neuronal circuits. The two model systems we have chosen to examine myelin breakdown brings about cognitive decline through alterations in conduction rates, affecting timing in neuronal circuits. The two model systems we have chosen to examine myelin sheaths, nerve fiber loss, and active phagocytosis undertaken by both astrocytes and microglial cells. We will also examine the splenium of the corpus callosum, the vertical nerve fiber bundles in area 46, the optic radiations, and the fornix, for additional information about age-related nerve fiber changes and loss with age. Our data on the myelin breakdown in the cerebral cortex and the splenium will be correlated state of the myelin sheaths whose composition is being examined in Project 2. Another aim is to use antibodies to label microglial cells and oligodendrocytes to determine how these neuroglial types respond to age changes in white matter. We will determine when microglial cells first become
34
Corpus Callosum
activated and whether some fiber pathways are more affected than others. For oligodendrocytes, it is intended to determine if they increase in frequency with age, in response to the breakdown of their myelin sheaths. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: STRUCTURAL SUBSTRATES OF SYNAPSE PLASTICITY Principal Investigator & Institution: Greenough, William T.; Swanlund Professor of Psychology,; Psychology; University of Illinois Urbana-Champaign Henry Administration Bldg Champaign, Il 61820 Timing: Fiscal Year 2002; Project Start 01-AUG-1983; Project End 30-NOV-2005 Summary: (provided by applicant): While neuroscience has made rapid advances with regard to the molecular biology of the brain, the lack of knowledge at more molar levels has sometimes been disarmingly surprising, as in the belated recognition of postdevelopmental neurogenesis in at least some regions of the adult brain. Our knowledge of the plasticity of nonneural cells in the CNS is even more limited than our knowledge of neuronal plasticity, aside from studies of single gene mutations and pathology. It is clear from our work that astrocytes, oligodendrocytes and vascular tissue exhibit morphological plasticity in response to experience that often quantitatively equals or exceeds the plasticity seen in neuronal measures such as dendritic field dimensions and synapse numbers. We have found, for example, dramatic increases in myelination of the corpus callosum in adult rats exposed to a complex environment. There is abundant evidence that these supporting cells can affect information processing by neurons in significant ways such as modulating synaptic efficacy in response to propagated calcium waves in astrocytes, selectively increasing axonal conduction and altering gene expression patterns in the neurons they envelop. Moreover, while there is controversy regarding post-developmental neurogenesis in regions outside of the dentate gyrus and basal forebrain-olfactory bulb, there is wide agreement that glial and vascular tissue continue to proliferate into adulthood in at least most brain regions in which this has been investigated. Indeed a principal difficulty in demonstrating neurogenesis has been differentiating it from proliferation of glial and vascular tissues. Yet we know very little about proliferation and plasticity of these support tissues and how they might contribute to brain function. This research proposes to examine the effects of experience upon neurogenesis and non-neuronal cells of the cerebral cortex, to sort out regulatory effects upon proliferation and hypertrophy and the neural mechanisms mediating these regulatory effects. The experiential manipulation to be used, exposure to a complex physical and social environment, has dramatic effects on cerebral cortical organization, nearly doubling, for example, vascular volume per neuron, compared to that of rats reared in individual laboratory cages. Studies are proposed to investigate the effects of experience upon the proliferation and modification of oligodendrocytes, astrocytes, microglia and vasculature in the context of experience effects upon the plasticity of neurons and their synapses, using DNA-labeling, protein-impregnating and optical and electron microscopic methods. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: THE BIOLOGICAL BASIS OF ALCOHOL INDUCED BRAIN DAMAGE Principal Investigator & Institution: Meyerhoff, Dieter J.; Associate Professor; Northern California Institute Res & Educ 4150 Clement Street (151-Nc) San Francisco, Ca 941211545
Studies
35
Timing: Fiscal Year 2002; Project Start 01-AUG-1996; Project End 31-JUL-2006 Summary: (Provided by applicant): Long-term chronic alcohol abuse is associated with structural brain changes and neuro-cognitive impairment. Few studies have shown a convincing correlation between these phenomena and it appears likely that neurosubstrates other than structural alterations underlie the cognitive changes associated with heavy drinking and recovery. The overall goal of this project is to test the hypothesis that axonal/dendritic and membrane phospholipid ( and possibly perfusion) changes in white matter underlie the reversible structural and neurocognitive changes associated with long-term chronic alcohol abuse and recovery. Subjects: 50 light drinkers (LD) and 100 heavy drinkers. LD will be studied at baseline and 9-12 months later, HD will be studied at entry into alcohol abuse treatment (to capture the full extent of brain damage due to heavy drinking), at 2-4 weeks of abstinence, and at 9-12 months after treatment entry during abstinence or relapse. Measurements: Cognition by neuropsychological testing; brain structures by MRI, axonal/dendritic and neuronal viability by 1H MR spectroscopic imaging (N-acetyl aspartate, a putative neuronal/axonal marker); lipids by choline-containing compounds (Cho) and myoinositol (ml) and by phosphorus-31 MRS (via membrane phospholipids and their breakdown products and precursors); regional cerebral blood flow will be measured with exploratory spin-tagged perfusion MRI. The specific focus of the study will be on white matter, but cortical and subcortical gray matter, cerebellum, hippocampus, corpus callosum, and brain stem, intracranial volume and volumes of various brain nuclei will also be assessed. We expect that initially low regional NAA and phospholipid measures and initially high Cho and mI measures correlate with specific measures of cognitive impairment and that these outcome measures will recover during abstinence in association with cognitive improvements; relapse will arrest structural, metabolic, and cognitive improvements. The significance of these results is several fold: First, this project will develop non invasive outcome measures which provide objective quantitative measurements of alcohol-induced brain damage. This may be useful in future clinical trials in which drugs or treatments are used to reduce drinking, or to monitor effects of drugs aimed at reducing brain damage, or facilitating recovery. Second, these results may also provide information, which can lead to the development of specific drug treatments, aimed at preventing brain damage at the neuron or membrane or at facilitating recovery. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: THE ROLE OF FILAMIN IN PERIVENTRICULAR HETEROTOPIAS Principal Investigator & Institution: Sheen, Volney L.; Beth Israel Deaconess Medical Center St 1005 Boston, Ma 02215 Timing: Fiscal Year 2002; Project Start 16-JUL-2001; Project End 30-JUN-2006 Summary: (provided by applicant): Developmental disorders of the human cerebral cortex comprise 15-40 percent of epilepsy cases, most notably intractable pediatric seizures. These disorders have deleterious affects on both the psychological and physical well being of individuals. Identification of the causative genes and characterization of their function will provide necessary insight into the neuropathology of epilepsy as well as extend the current understanding of normal cortical development. Through such a genetic approach, recent findings have shown that mutations in the actin-binding protein filamin I (FLN1) are implicated in the human x-linked disorder, periventricular heterotopia and epilepsy (PVH). This neurogenetic disorder is characterized by the failure of subsets of neurons to migrate from the ventricle during corticogenesis, in association with thinning of the corpus callosum and cerebellar
36
Corpus Callosum
hypoplasia. While the filamin proteins are known to regulate cell stability, protrusion and motility across various biologic systems, their potential functions within the central nervous system has only just come to light with the recent association of FLNI to PVH. Thus, the overall goal of this proposal is to analyze the roles of FLN1 and a highly homologous protein, FLN3, in relation to neurogenesis, neuronal migration, and subsequent differentiation. Specific Aim 1 will characterize the temporal and spatial pattern of filamin protein and mRNA expression, to test the hypothesis that the actinbinding proteins localize to appropriate neuronal populations during periods of ongoing cortical neurogenesis, migration and axonal outgrowth. Specific Aim 2 will identify protein-protein interactions between FLN1, FLN3 and other novel and known developmental genes, to test the hypothesis that filamin proteins are involved in signal transduction pathways essential to cortical development. Specific Aim 3 will directly evaluate the functional significance of such interactions through generation of dominant-negative and overexpression constructs. FLN1 mutant mice will also provide an animal model with which to study filamin interactions during the various stages of neuronal development. The candidate has completed training in both medical and graduate programs. His residency training is in Neurology, and he earned his doctoral degree in Neuroscience studying neocortical transplantation paradigms in effecting neuronal specification, migration and directed differentiation during both cortical development and following targeted neuronal degeneration. He now seeks further training under the mentorship of Dr. Chris Walsh, whose research interests center on genetic approaches toward understanding fundamental mechanisms governing development of the cerebral cortex. It is the candidate's intention to combine these newly acquired molecular and genetic approaches with his prior training in transplantation to pursue an academic career in Neurology and the Neurosciences, primarily in the field of cortical development and malformations as they pertain to epilepsy. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
E-Journals: PubMed Central3 PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “corpus callosum” (or synonyms) into the search box. This search gives you access to full-text articles. The following is a sample of items found for corpus callosum in the PubMed Central database: •
3 4
Impact of in utero exposure to EtOH on corpus callosum development and paw preference in rats: protective effects of silymarin. by Moreland N, La Grange L, Montoya R.; 2002; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=137600 Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.
With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age. 5 The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print.
Studies
•
37
Ontophyletics of the nervous system: development of the corpus callosum and evolution of axon tracts. by Katz MJ, Lasek RJ, Silver J.; 1983 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=390192
The National Library of Medicine: PubMed One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals. To generate your own bibliography of studies dealing with corpus callosum, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “corpus callosum” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for corpus callosum (hyperlinks lead to article summaries): •
A case of Hoyeraal-Hreidarsson syndrome: delayed myelination and hypoplasia of corpus callosum are other important signs. Author(s): Akaboshi S, Yoshimura M, Hara T, Kageyama H, Nishikwa K, Kawakami T, Ieshima A, Takeshita K. Source: Neuropediatrics. 2000 June; 31(3): 141-4. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10963101
•
A French accent after corpus callosum infarct. Author(s): Hall DA, Anderson CA, Filley CM, Newcombe J, Hughes RL. Source: Neurology. 2003 May 13; 60(9): 1551-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12743256
•
A new X-linked syndrome with agenesis of the corpus callosum, mental retardation, coloboma, micrognathia, and a mutation in the Alpha 4 gene at Xq13. Author(s): Graham JM Jr, Wheeler P, Tackels-Horne D, Lin AE, Hall BD, May M, Short KM, Schwartz CE, Cox TC. Source: American Journal of Medical Genetics. 2003 November 15; 123A(1): 37-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14556245
6
PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.
38
Corpus Callosum
•
A study of three cases of familial related agenesis of the corpus callosum. Author(s): Finlay DC, Peto T, Payling J, Hunter M, Fulham WR, Wilkinson I. Source: J Clin Exp Neuropsychol. 2000 December; 22(6): 731-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11320432
•
A Turkish case of subcortical/subependymal heterotopia associated with corpus callosum dysgenesis, craniofacial dysmorphism, severe eye abnormalities, and growth-mental retardation. Author(s): Caksen H, Tuncer O, Atas B, Demirok A, Unal O, Ikbal M, Odabas D. Source: Genet Couns. 2003; 14(3): 343-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14577680
•
Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophrenia. Author(s): Diwadkar VA, DeBellis MD, Sweeney JA, Pettegrew JW, Keshavan MS. Source: Schizophrenia Research. 2004 April 1; 67(2-3): 277-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14984888
•
Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia. Author(s): Keshavan MS, Diwadkar VA, Harenski K, Rosenberg DR, Sweeney JA, Pettegrew JW. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 2002 June; 72(6): 757-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12023420
•
Acute infarct of the corpus callosum: appearance on diffusion-weighted MR imaging and MR spectroscopy. Author(s): Riedy G, Melhem ER. Source: Journal of Magnetic Resonance Imaging : Jmri. 2003 August; 18(2): 255-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12884339
•
Agenesis and dysgenesis of the corpus callosum. Author(s): Davila-Gutierrez G. Source: Semin Pediatr Neurol. 2002 December; 9(4): 292-301. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12523553
•
Agenesis of corpus callosum - a rare case. Author(s): Desai AK, Bhide AG, Bhalerao SA. Source: Journal of Postgraduate Medicine. 1999 January-March; 45(1): 20-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10734328
Studies
39
•
Agenesis of corpus callosum: clinical description and etiology. Author(s): Marszal E, Jamroz E, Pilch J, Kluczewska E, Jablecka-Deja H, Krawczyk R. Source: Journal of Child Neurology. 2000 June; 15(6): 401-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10868784
•
Agenesis of corpus callosum: prenatal diagnosis and prognosis. Author(s): Moutard ML, Kieffer V, Feingold J, Kieffer F, Lewin F, Adamsbaum C, Gelot A, Campistol I Plana J, van Bogaert P, Andre M, Ponsot G. Source: Child's Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery. 2003 August; 19(7-8): 471-6. Epub 2003 July 04. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12845459
•
Agenesis of the corpus callosum, camptodactyly and obesity. Author(s): Verloes A, Lesenfants S. Source: Clinical Dysmorphology. 2000 April; 9(2): 107-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10826621
•
Agenesis of the corpus callosum. Author(s): Kelkar P, Lovblad KO, O'Callaghan B, Remonda L, Schroth G. Source: Jbr-Btr. 2000 February; 83(1): 16. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10769503
•
Arteriovenous malformation of the genu of the corpus callosum. Author(s): Bendavid OJ, Khoshyomn S, Wilson JT. Source: Pediatric Neurosurgery. 2004 January-February; 40(1): 49-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15007233
•
Associated brain abnormalities in patients with corpus callosum anomalies. Author(s): Tekgul H, Dizdarer G, Yalman O, Sener N, Yunten N, Tutuncuoglu S. Source: Turk J Pediatr. 1999 April-June; 41(2): 173-80. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10770655
•
Association of partial trisomy 9 (9pter-->q22.3) with corpus callosum dysgenesis, bilateral subependymal cysts, and ventriculomegaly. Author(s): Chen CP, Hsu CH, Lin SP, Ho CS, Lee CC, Wang W. Source: Prenatal Diagnosis. 2003 June; 23(6): 519-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12813773
40
Corpus Callosum
•
Association of severe autosomal recessive osteopetrosis and Dandy-Walker syndrome with agenesis of the corpus callosum. Author(s): Ben Hamouda H, Sfar MN, Braham R, Ben Salah M, Ayadi A, Soua H, Hamza H, Sfar MT. Source: Acta Orthop Belg. 2001 December; 67(5): 528-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11822087
•
Atrophy of the corpus callosum correlates with white matter lesions in patients with cerebral ischaemia. Author(s): Meguro K, Constans JM, Courtheoux P, Theron J, Viader F, Yamadori A. Source: Neuroradiology. 2000 June; 42(6): 413-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10929300
•
Axonal pathfinding mechanisms at the cortical midline and in the development of the corpus callosum. Author(s): Richards LJ. Source: Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas / Sociedade Brasileira De Biofisica. [et Al.]. 2002 December; 35(12): 1431-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12436186
•
Bilateral crossed optic ataxia in a corpus callosum lesion. Author(s): Gaymard B, Rivaud S, Rigolet MH, Pierrot-Deseilligny C. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 1993 March; 56(3): 323-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8459256
•
Bilateral representation of language function. Agenesis of corpus callosum by Wada and PET activation. Author(s): Komaba Y, Senda M, Ohyama M, Mori T, Ishii K, Mishina M, Kitamura S, Terashi A. Source: Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 1998 October; 8(4): 246-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9780860
•
Bilateral sensorineural deafness, partial agenesis of the corpus callosum, and arachnoid cysts in two sisters. Author(s): Hendriks YM, Laan LA, Vielvoye GJ, van Haeringen A. Source: American Journal of Medical Genetics. 1999 September 10; 86(2): 183-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10449658
Studies
41
•
Binocular depth perception and the corpus callosum. Author(s): Mitchell DE, Blakemore C. Source: Vision Research. 1970 January; 10(1): 49-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5435012
•
Blepharophimosis, iris coloboma, microgenia, hearing loss, postaxial polydactyly, aplasia of corpus callosum, hydroureter, and developmental delay. Author(s): Buntinx I, Majewski F. Source: American Journal of Medical Genetics. 1990 July; 36(3): 273-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1694631
•
Brain dysfunction during motor activation and corpus callosum alterations in schizophrenia measured by cerebral blood flow and magnetic resonance imaging. Author(s): Gunther W, Petsch R, Steinberg R, Moser E, Streck P, Heller H, Kurtz G, Hippius H. Source: Biological Psychiatry. 1991 March 15; 29(6): 535-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1905162
•
Brain malformation associated with neural tube defects. Report of three cases of partial agenesis of the corpus callosum and myelomeningocele. Author(s): Ruggiero R, Mongini T, Colangelo M, Schiffer D, Ambrosio A. Source: Journal of Neuroradiology. Journal De Neuroradiologie. 1987; 14(3): 287-92. English, French. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3440881
•
Butterfly lesion of the corpus callosum due to Schilder's disease. Author(s): Kiernan MC, Vonau M, Bullpitt PR, Tohver E, Milder DG. Source: Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 2001 July; 8(4): 367-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11437583
•
Cavernous angioma of the corpus callosum mimicking an astrocytic tumor--case report. Author(s): Harada S, Niimi M, Murakami K, Nakamura T. Source: Neurol Med Chir (Tokyo). 2001 July; 41(7): 349-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11487999
•
Characterization of sexual dimorphism in the human corpus callosum. Author(s): Dubb A, Gur R, Avants B, Gee J. Source: Neuroimage. 2003 September; 20(1): 512-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14527611
42
Corpus Callosum
•
Clinical and diagnostic profile of agenesis of the corpus callosum. Author(s): Shevell MI. Source: Journal of Child Neurology. 2002 December; 17(12): 896-900. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12593462
•
Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11). Author(s): Winner B, Uyanik G, Gross C, Lange M, Schulte-Mattler W, Schuierer G, Marienhagen J, Hehr U, Winkler J. Source: Archives of Neurology. 2004 January; 61(1): 117-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14732628
•
Clinical, neuroimaging and cytogenetic findings in 20 patients with corpus callosum dysgenesis. Author(s): dos Santos AC, Midleton SR, Fonseca RL, dos Santos SR, Llerena JC Jr, Vargas FR. Source: Arquivos De Neuro-Psiquiatria. 2002 June; 60(2-B): 382-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12131936
•
Cognitive, behavioral, and psychiatric symptoms in two children with agenesis of the corpus callosum: case report. Author(s): Parraga HC, Parraga MI, Jensen AR. Source: International Journal of Psychiatry in Medicine. 2003; 33(1): 107-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12906349
•
Communicative deficits in agenesis of the corpus callosum: nonliteral language and affective prosody. Author(s): Paul LK, Van Lancker-Sidtis D, Schieffer B, Dietrich R, Brown WS. Source: Brain and Language. 2003 May; 85(2): 313-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12735947
•
Congenital asymmetric crying facies and agenesis of corpus callosum. Author(s): Voudris KA, Skardoutsou A, Vagiakou EA. Source: Brain & Development. 2003 March; 25(2): 133-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12581812
•
Congenital hereditary endothelial dystrophy and band keratopathy in an infant with corpus callosum agenesis. Author(s): Akhtar S, Bron AJ, Meek KM, Bennett K. Source: Cornea. 2001 July; 20(5): 547-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11413417
Studies
43
•
Corpus callosum abnormalities in psychopathic antisocial individuals. Author(s): Raine A, Lencz T, Taylor K, Hellige JB, Bihrle S, Lacasse L, Lee M, Ishikawa S, Colletti P. Source: Archives of General Psychiatry. 2003 November; 60(11): 1134-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14609889
•
Corpus callosum and posterior fossa development in monozygotic females: a morphometric MRI study of Turner syndrome. Author(s): Fryer SL, Kwon H, Eliez S, Reiss AL. Source: Developmental Medicine and Child Neurology. 2003 May; 45(5): 320-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12729146
•
Corpus callosum atrophy in adolescents with antecedents of moderate perinatal asphyxia. Author(s): Maneru C, Junque C, Salgado-Pineda P, Serra-Grabulosa JM, Bartres-Faz D, Ramirez-Ruiz B, Bargallo N, Tallada M, Botet F. Source: Brain Injury : [bi]. 2003 November; 17(11): 1003-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14514451
•
Corpus callosum atrophy, white matter lesions, and frontal executive dysfunction in normal aging and Alzheimer's disease. A community-based study: the Tajiri Project. Author(s): Meguro K, Constans JM, Shimada M, Yamaguchi S, Ishizaki J, Ishii H, Yamadori A, Sekita Y. Source: Int Psychogeriatr. 2003 March; 15(1): 9-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12834197
•
Corpus callosum development in childhood-onset schizophrenia. Author(s): Keller A, Jeffries NO, Blumenthal J, Clasen LS, Liu H, Giedd JN, Rapoport JL. Source: Schizophrenia Research. 2003 July 1; 62(1-2): 105-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12765750
•
Corpus callosum in first-episode patients with schizophrenia--a magnetic resonance imaging study. Author(s): Bachmann S, Pantel J, Flender A, Bottmer C, Essig M, Schroder J. Source: Psychological Medicine. 2003 August; 33(6): 1019-27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12946086
•
Corpus callosum shape and neuropsychological deficits in adult males with heavy fetal alcohol exposure. Author(s): Bookstein FL, Streissguth AP, Sampson PD, Connor PD, Barr HM. Source: Neuroimage. 2002 January; 15(1): 233-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11771992
44
Corpus Callosum
•
Corpus callosum signal intensity in patients with bipolar and unipolar disorder. Author(s): Brambilla P, Nicoletti M, Sassi RB, Mallinger AG, Frank E, Keshavan MS, Soares JC. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 2004 February; 75(2): 2215. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14742592
•
Corpus callosum, pons, and cortical white matter in alcoholic women. Author(s): Pfefferbaum A, Rosenbloom M, Serventi KL, Sullivan EV. Source: Alcoholism, Clinical and Experimental Research. 2002 March; 26(3): 400-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11923595
•
Corpus callosum: microsurgical anatomy and MRI. Author(s): Goncalves-Ferreira AJ, Herculano-Carvalho M, Melancia JP, Farias JP, Gomes L. Source: Surgical and Radiologic Anatomy : Sra. 2001; 23(6): 409-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11963623
•
Corpus callosum: musician and gender effects. Author(s): Lee DJ, Chen Y, Schlaug G. Source: Neuroreport. 2003 February 10; 14(2): 205-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12598730
•
D-2-Hydroxyglutaric aciduria with absence of corpus callosum and neonatal intracranial haemorrhage. Author(s): Wang X, Jakobs C, Bawle EV. Source: Journal of Inherited Metabolic Disease. 2003; 26(1): 92-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12872850
•
Decline in corpus callosum volume among pediatric patients with medulloblastoma: longitudinal MR imaging study. Author(s): Palmer SL, Reddick WE, Glass JO, Gajjar A, Goloubeva O, Mulhern RK. Source: Ajnr. American Journal of Neuroradiology. 2002 August; 23(7): 1088-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12169462
•
Decrease in genu of the corpus callosum in medication-naive, early-onset dysthymia and depressive personality disorder. Author(s): Lyoo IK, Kwon JS, Lee SJ, Han MH, Chang CG, Seo CS, Lee SI, Renshaw PF. Source: Biological Psychiatry. 2002 December 15; 52(12): 1134-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12488058
Studies
45
•
Decreased interhemispheric EEG coherence during sleep in agenesis of the corpus callosum. Author(s): Nielsen T, Montplaisir J, Lassonde M. Source: European Neurology. 1993; 33(2): 173-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8467828
•
Demyelination and axonal degeneration in corpus callosum assessed by analysis of transcallosally mediated inhibition in multiple sclerosis. Author(s): Hoppner J, Kunesch E, Buchmann J, Hess A, Grossmann A, Benecke R. Source: Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 1999 April; 110(4): 748-56. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10378748
•
Desynchronization of cortical rhythms following cutaneous stimulation: effects of stimulus repetition and intensity, and of the size of corpus callosum. Author(s): Stancak A, Svoboda J, Rachmanova R, Vrana J, Kralik J, Tintera J. Source: Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 2003 October; 114(10): 1936-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14499756
•
Determination of indices of the corpus callosum associated with normal aging in Japanese individuals. Author(s): Takeda S, Hirashima Y, Ikeda H, Yamamoto H, Sugino M, Endo S. Source: Neuroradiology. 2003 August; 45(8): 513-8. Epub 2003 July 22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12879325
•
Development of the corpus callosum in childhood, adolescence and early adulthood. Author(s): Keshavan MS, Diwadkar VA, DeBellis M, Dick E, Kotwal R, Rosenberg DR, Sweeney JA, Minshew N, Pettegrew JW. Source: Life Sciences. 2002 March 8; 70(16): 1909-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12005176
•
Development of the human corpus callosum during childhood and adolescence: a longitudinal MRI study. Author(s): Giedd JN, Blumenthal J, Jeffries NO, Rajapakse JC, Vaituzis AC, Liu H, Berry YC, Tobin M, Nelson J, Castellanos FX. Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. 1999 May; 23(4): 571-88. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10390717
46
Corpus Callosum
•
Development of the human fetal corpus callosum: a high-resolution, cross-sectional sonographic study. Author(s): Achiron R, Achiron A. Source: Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2001 October; 18(4): 343-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11778993
•
Developmental dyslexia: re-evaluation of the corpus callosum in male adults. Author(s): Robichon F, Bouchard P, Demonet J, Habib M. Source: European Neurology. 2000; 43(4): 233-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10828655
•
Dichotic listening and corpus callosum magnetic resonance imaging in relapsingremitting multiple sclerosis with emphasis on sex differences. Author(s): Gadea M, Marti-Bonmati L, Arana E, Espert R, Casanova V, Pascual A. Source: Neuropsychology. 2002 April; 16(2): 275-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11949719
•
Diffusion anisotropy in the corpus callosum. Author(s): Chepuri NB, Yen YF, Burdette JH, Li H, Moody DM, Maldjian JA. Source: Ajnr. American Journal of Neuroradiology. 2002 May; 23(5): 803-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12006281
•
Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease. Author(s): Hanyu H, Asano T, Sakurai H, Imon Y, Iwamoto T, Takasaki M, Shindo H, Abe K. Source: Journal of the Neurological Sciences. 1999 August 1; 167(1): 37-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10500260
•
Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury. Author(s): Takayama H, Kobayashi M, Sugishita M, Mihara B. Source: Clinical Neurology and Neurosurgery. 2000 September; 102(3): 135-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10996710
•
Direction information coordinated via the posterior third of the corpus callosum during bimanual movements. Author(s): Eliassen JC, Baynes K, Gazzaniga MS. Source: Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale. 1999 October; 128(4): 573-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10541755
Studies
47
•
Division of the corpus callosum into subregions. Author(s): Peters M, Oeltze S, Seminowicz D, Steinmetz H, Koeneke S, Jancke L. Source: Brain and Cognition. 2002 October; 50(1): 62-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12372352
•
Do we consider Andermann syndrome in infants with agenesis of corpus callosum. Author(s): Deda G, Caksen H, Icagasioglu D. Source: Genet Couns. 2003; 14(2): 249-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12872822
•
Dominance of one hand and one brain hemisphere. III. Function of corpus callosum and of partially crossing of afferent and efferent pathways. Interhemispheric disconnection syndrome. Author(s): Hrbek J. Source: Acta Univ Palacki Olomuc Fac Med. 1976; 80: 41-59. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1053407
•
Dysgenesis of corpus callosum in Lenz-Majewski hyperostotic dwarfism. Author(s): Saraiva JM. Source: American Journal of Medical Genetics. 2000 March 20; 91(3): 198-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10756342
•
Ectodermal dysplasia, primary hypothyroidism, and agenesis of the corpus callosum: variable expression of a single syndrome? Author(s): Silengo M, Silvestro L, Capizzi G, Lerone M, Seri M, Rosaia L, Romeo G. Source: Journal of Medical Genetics. 1998 February; 35(2): 157-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9507398
•
Ectopic craniopharyngioma: presentation of a case arising from the corpus callosum. Author(s): Sangiovanni G, Tancioni F, Tartara F, Gaetani P, Rindi G, Passeri F, Rodriguez y Baena R. Source: Acta Neurochirurgica. 1997; 139(4): 379-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9202784
•
Ectrodactyly, diaphragmatic hernia, congenital heart defect, and agenesis of the corpus callosum. Author(s): Saal HM, Bulas DI. Source: Clinical Dysmorphology. 1995 July; 4(3): 246-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7551162
48
Corpus Callosum
•
Effect of luminance on successiveness discrimination in the absence of the corpus callosum. Author(s): Forster B, Corballis PM, Corballis MC. Source: Neuropsychologia. 2000; 38(4): 441-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10683394
•
Effective binocular integration at the midline requires the corpus callosum. Author(s): Saint-Amour D, Lepore F, Lassonde M, Guillemot JP. Source: Neuropsychologia. 2004; 42(2): 164-74. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14644103
•
Effects of corpus callosum section on secondary bilaterally synchronous interictal EEG discharges. Author(s): Spencer SS, Spencer DD, Williamson PD, Mattson RH. Source: Neurology. 1985 December; 35(12): 1689-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4069359
•
Effects of early and late transection of the corpus callosum in children. A study of tactile and tactuomotor transfer and integration. Author(s): Lassonde M, Sauerwein H, Geoffroy G, Decarie M. Source: Brain; a Journal of Neurology. 1986 October; 109 ( Pt 5): 953-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3779375
•
Effects of handedness and sex on the morphology of the corpus callosum: a study with brain magnetic resonance imaging. Author(s): Habib M, Gayraud D, Oliva A, Regis J, Salamon G, Khalil R. Source: Brain and Cognition. 1991 May; 16(1): 41-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1854469
•
Electroanatomy of the corpus callosum radiation according to the facts of stereotactic stimulation in man. Author(s): Schaltenbrand G, Spuer H, Wahren W. Source: Z Neurol. 1970; 198(1): 79-92. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4099399
•
Electroencephalographic asymmetry with midline cyst and deficient corpus callosum. Case report. Author(s): Green JB, Russell DJ. Source: Neurology. 1966 June; 16(6): 541-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5296015
Studies
49
•
Electrophysiological assessment of functional corpus callosum integrity in internal hydrocephalus. Author(s): Rosler KM, Nirkko AC, Hess CW. Source: Muscle & Nerve. 1995 July; 18(7): 787-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7783773
•
Endoscope-assisted microsurgery of the corpus callosum. Author(s): Guerrero MH, Cohen AR. Source: Minimally Invasive Neurosurgery : Min. 2003 February; 46(1): 54-6. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12640586
•
Epignathus, double pituitary and agenesis of corpus callosum. Author(s): Bale PM, Reye RD. Source: The Journal of Pathology. 1976 November; 120(3): 161-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1003267
•
Epileptic seizures and lipoma of the corpus callosum. Author(s): Grasso E, Gerbino Promis PC, Cognazzo A, Seliak D, Zagnoni P. Source: Italian Journal of Neurological Sciences. 1982 July; 3(2): 139-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7118526
•
Episodic aphemia and epileptic focus in nondominant hemisphere: relieved by section of corpus callosum. Author(s): Williamson PD, Spencer DD, Spencer SS, Novelly R, Mattson RH. Source: Neurology. 1985 July; 35(7): 1069-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3925369
•
Episodic hyperhidrosis, hypothermia, and agenesis of corpus callosum. Author(s): LeWitt PA, Newman RP, Greenberg HS, Rocher LL, Calne DB, Ehrenkranz JR. Source: Neurology. 1983 September; 33(9): 1122-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6684246
•
Evaluation of the corpus callosum in clumsy children born prematurely: a functional and morphological study. Author(s): Mercuri E, Jongmans M, Henderson S, Pennock J, Chung YL, de Vries L, Dubowitz L. Source: Neuropediatrics. 1996 December; 27(6): 317-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9050050
50
Corpus Callosum
•
Evidence for atrophy of the corpus callosum in Alzheimer's disease. Author(s): Vermersch P, Scheltens P, Barkhof F, Steinling M, Leys D. Source: European Neurology. 1994; 34(2): 83-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8174599
•
Excision of a cirsoid arteriovenous malformation of the corpus callosum in a 16-yearold boy. Case report. Author(s): Milhorat TH. Source: Journal of Neurosurgery. 1970 September; 33(3): 339-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5457645
•
Extent and limits of cerebral adjustment to early section or congenital absence of the corpus callosum. Author(s): Lassonde M, Sauerwein H, McCabe N, Laurencelle L, Geoffroy G. Source: Behavioural Brain Research. 1988 September 15; 30(2): 165-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3166715
•
Factors shaping the corpus callosum. Author(s): Stryker MP, Antonini A. Source: The Journal of Comparative Neurology. 2001 May 14; 433(4): 437-40. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11304709
•
Failure of metacontrol: breakdown in behavioural unity after lesion of the corpus callosum and inferomedial frontal lobes. Author(s): Jason GW, Pajurkova EM. Source: Cortex. 1992 June; 28(2): 241-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1499310
•
Failure to demonstrate sexual dimorphism of the corpus callosum in childhood. Author(s): Bell AD, Variend S. Source: Journal of Anatomy. 1985 December; 143: 143-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3870720
•
Familial progressive sensorimotor neuropathy with agenesis of the corpus callosum (Andermann syndrome): a clinical, neuroradiological and histopathological study. Author(s): Deleu D, Bamanikar SA, Muirhead D, Louon A. Source: European Neurology. 1997; 37(2): 104-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9058066
Studies
51
•
Familial spastic paraplegia with mental impairment and thin corpus callosum. Author(s): Nakamura A, Izumi K, Umehara F, Kuriyama M, Hokezu Y, Nakagawa M, Shimmyozu K, Izumo S, Osame M. Source: Journal of the Neurological Sciences. 1995 July; 131(1): 35-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7561945
•
Familial white matter hypoplasia, agenesis of the corpus callosum, mental retardation and growth deficiency: a new distinctive syndrome. Author(s): Curatolo P, Cilio MR, Del Giudice E, Romano A, Gaggero R, Pessagno A. Source: Neuropediatrics. 1993 April; 24(2): 77-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8327066
•
Fasciculus callosus longitudinalis (bundle of Probst) and its relation to the corpus callosum. Author(s): Stefanko SZ. Source: Patol Pol. 1980 April-June; 31(2): 263-72. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7422388
•
Fetal ventriculomegaly, agenesis of the corpus callosum and chromosomal translocation--case report. Author(s): Amato M, Howald H, von Muralt G. Source: Journal of Perinatal Medicine. 1986; 14(4): 271-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3546665
•
Fiber composition of the human corpus callosum. Author(s): Aboitiz F, Scheibel AB, Fisher RS, Zaidel E. Source: Brain Research. 1992 December 11; 598(1-2): 143-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1486477
•
Fine mapping the candidate region for peripheral neuropathy with or without agenesis of the corpus callosum in the French Canadian population. Author(s): Howard HC, Dube MP, Prevost C, Bouchard JP, Mathieu J, Rouleau GA. Source: European Journal of Human Genetics : Ejhg. 2002 July; 10(7): 406-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12107814
•
Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? Author(s): Tennison M. Source: Ajnr. American Journal of Neuroradiology. 1999 January; 20(1): 131-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10348730
52
Corpus Callosum
•
Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? Author(s): Kim SS, Chang KH, Kim ST, Suh DC, Cheon JE, Jeong SW, Han MH, Lee SK. Source: Ajnr. American Journal of Neuroradiology. 1999 January; 20(1): 125-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9974067
•
Focal lesion in the splenium of the corpus callosum on FLAIR MR images: a common finding with aging and after brain radiation therapy. Author(s): Pekala JS, Mamourian AC, Wishart HA, Hickey WF, Raque JD. Source: Ajnr. American Journal of Neuroradiology. 2003 May; 24(5): 855-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12748085
•
Forms and measures of adult and developing human corpus callosum: is there sexual dimorphism? Author(s): Clarke S, Kraftsik R, Van der Loos H, Innocenti GM. Source: The Journal of Comparative Neurology. 1989 February 8; 280(2): 213-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2925893
•
Frameshift mutation of the zinc finger homeo box 1 B gene in syndromic corpus callosum agenesis (Mowat-Wilson syndrome). Author(s): Sztriha L, Espinosa-Parrilla Y, Gururaj A, Amiel J, Lyonnet S, Gerami S, Johansen JG. Source: Neuropediatrics. 2003 December; 34(6): 322-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14681759
•
Frontonasal dysplasia with corpus callosum lipoma. Author(s): Grover SB, Charan KA, Saxena NC. Source: Indian Pediatrics. 1999 April; 36(4): 398-401. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10717702
•
Frontonasal dysplasia, lipoma of the corpus callosum and tetralogy of Fallot. Author(s): Meguid NA. Source: Clinical Genetics. 1993 August; 44(2): 95-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8275566
•
Functioning of the corpus callosum in children with early hydrocephalus. Author(s): Hannay HJ. Source: Journal of the International Neuropsychological Society : Jins. 2000 March; 6(3): 351-61. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10824507
Studies
53
•
Functions of the corpus callosum: observations from callosotomy performed for intractable epilepsy. Author(s): Censori B, Del Pesce M, Provinciali L, Quattrini A, Mancini S, Papo I. Source: Boll Soc Ital Biol Sper. 1989 January; 65(1): 53-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2757819
•
Fusiform aneurysmal dilatation of pericallosal artery. A sign of lipoma of corpus callosum. Author(s): Eldevik OP, Gabrielsen TO. Source: Acta Radiologica. Supplementum. 1976; 347: 71-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=207151
•
Gelastic epilepsy, hypothalamic hamartoma, precocious puberty, and agenesis of the corpus callosum: a new association. Author(s): Alikchanov AA, Petrukhin AS, Mukhin KYu, Nikanorov AYu. Source: Brain & Development. 1998 June; 20(4): 239-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9661969
•
Gender- and age-related differences in the morphology of the corpus callosum. Author(s): Suganthy J, Raghuram L, Antonisamy B, Vettivel S, Madhavi C, Koshi R. Source: Clinical Anatomy (New York, N.Y.). 2003 September; 16(5): 396-403. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12903061
•
Gender differences in corpus callosum size in first-episode schizophrenics. Author(s): Hoff AL, Neal C, Kushner M, DeLisi LE. Source: Biological Psychiatry. 1994 June 15; 35(12): 913-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8080890
•
Gender differences in the corpus callosum of neonates. Author(s): Hwang SJ, Ji EK, Lee EK, Kim YM, Shin da Y, Cheon YH, Rhyu IJ. Source: Neuroreport. 2004 April 29; 15(6): 1029-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15076728
•
Genetic epidemiology of sensorimotor polyneuropathy with or without agenesis of the corpus callosum in northeastern Quebec. Author(s): De Braekeleer M, Dallaire A, Mathieu J. Source: Human Genetics. 1993 April; 91(3): 223-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8386695
54
Corpus Callosum
•
Genetic regulation of regional microstructure of the corpus callosum in late life. Author(s): Pfefferbaum A, Sullivan EV, Carmelli D. Source: Neuroreport. 2001 June 13; 12(8): 1677-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11409738
•
Genitourinary malformations associated with agenesis of the corpus callosum. Author(s): Franco I, Kogan S, Fisher J, Rifkinson-Mann S, Reda E, Levitt S, Roseman B. Source: The Journal of Urology. 1993 May; 149(5): 1119-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8483226
•
Geometric morphometrics of corpus callosum and subcortical structures in the fetalalcohol-affected brain. Author(s): Bookstein FL, Sampson PD, Streissguth AP, Connor PD. Source: Teratology. 2001 July; 64(1): 4-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11410908
•
Giant interhemispheric cysts associated with agenesis of the corpus callosum. Author(s): Mori K. Source: Journal of Neurosurgery. 1992 February; 76(2): 224-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1730951
•
Gorlin's syndrome with a thin corpus callosum and a third ventricular cyst. Author(s): Kantarci M, Ertas U, Alper F, Sutbeyaz Y, Karasen RM, Onbas O. Source: Neuroradiology. 2003 June; 45(6): 390-2. Epub 2003 May 17. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12756507
•
Greig cephalopolysyndactyly syndrome with dysgenesis of the corpus callosum in a Bedouin family. Author(s): Marafie MJ, Temtamy SA, Rajaram U, al-Awadi SA, el-Badramany MH, Farag TI. Source: American Journal of Medical Genetics. 1996 December 18; 66(3): 261-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8985483
•
Handedness and corpus callosum morphology. Author(s): Preuss UW, Meisenzahl EM, Frodl T, Zetzsche T, Holder J, Leinsinger G, Hegerl U, Hahn K, Moller HJ. Source: Psychiatry Research. 2002 November 30; 116(1-2): 33-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12426032
Studies
55
•
Hemispheric asymmetry and corpus callosum morphometry: a magnetic resonance imaging study. Author(s): Dorion AA, Chantome M, Hasboun D, Zouaoui A, Marsault C, Capron C, Duyme M. Source: Neuroscience Research. 2000 January; 36(1): 9-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10678527
•
Hereditary motor and sensory neuropathy with agenesis of the corpus callosum. Author(s): Dupre N, Howard HC, Mathieu J, Karpati G, Vanasse M, Bouchard JP, Carpenter S, Rouleau GA. Source: Annals of Neurology. 2003 July; 54(1): 9-18. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12838516
•
Hereditary spastic paraplegia associated with thin corpus callosum. Author(s): Teive HA, Iwamoto FM, Della Coletta MV, Camargo CH, Bezerra RD, Minguetti G, Werneck LC. Source: Arquivos De Neuro-Psiquiatria. 2001 September; 59(3-B): 790-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11593284
•
Hereditary spastic paraplegia with a thin corpus callosum and thalamic involvement in Japan. Author(s): Ueda M, Katayama Y, Kamiya T, Mishina M, Igarashi H, Okubo S, Senda M, Iwabuchi K, Terashi A. Source: Neurology. 1998 December; 51(6): 1751-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9855541
•
Hereditary spastic paraplegia with thin corpus callosum and cataract: a clinical description of two siblings. Author(s): Okuda B, Iwamoto Y, Tachibana H. Source: Acta Neurologica Scandinavica. 2002 October; 106(4): 222-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12225319
•
High myopia, hypertelorism, iris coloboma, exomphalos, absent corpus callosum, and sensorineural deafness: report of a case and further evidence for autosomal recessive inheritance. Author(s): Avunduk AM, Aslan Y, Kapicioglu Z, Elmas R. Source: Acta Ophthalmologica Scandinavica. 2000 April; 78(2): 221-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10794262
56
Corpus Callosum
•
High risk pregnancy in a patient with angioma of the corpus callosum. Author(s): Azzena A, Vasoin F, Braghetto M, Vettorato F, Pitton MA, Dalla Pieta G, Salmaso R. Source: Clin Exp Obstet Gynecol. 1995; 22(2): 165-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7781185
•
Hippocampal malrotation with normal corpus callosum in a child with Opitz syndrome. Author(s): Fitoz S, Atasoy C, Deda G, Erden I, Akyar S. Source: Clinical Imaging. 2003 March-April; 27(2): 75-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12639770
•
Hippocampal malrotation with normal corpus callosum: a new entity? Author(s): Barsi P, Kenez J, Solymosi D, Kulin A, Halasz P, Rasonyi G, Janszky J, Kaloczkai A, Barcs G, Neuwirth M, Paraicz E, Siegler Z, Morvai M, Jerney J, Kassay M, Altmann A. Source: Neuroradiology. 2000 May; 42(5): 339-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10872153
•
Holoprosencephaly and agenesis of the corpus callosum: frequency of associated malformations. Author(s): Jellinger K, Gross H, Kaltenback E, Grisold W. Source: Acta Neuropathologica. 1981; 55(1): 1-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7348001
•
Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study. Author(s): Biegon A, Eberling JL, Richardson BC, Roos MS, Wong ST, Reed BR, Jagust WJ. Source: Neurobiology of Aging. 1994 July-August; 15(4): 393-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7969715
•
Human corpus callosum: a stable mathematical model of regional neuroanatomy. Author(s): Cowell PE, Allen LS, Kertesz A, Zalatimo NS, Denenberg VH. Source: Brain and Cognition. 1994 May; 25(1): 52-66. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8043266
•
Hypergraphia, verbal aspontaneity and post-stroke depression secondary to right cyngulate and corpus callosum infarction. Author(s): Carota A, Annoni JM, Combremont P, Clarke S, Bogousslavsky J. Source: Journal of Neurology. 2003 April; 250(4): 508-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12760393
Studies
57
•
Hypoplasia of the cerebellar vermis and corpus callosum in thrombocytopenia with absent radius syndrome on MRI studies. Author(s): MacDonald MR, Schaefer GB, Olney AH, Patton DF. Source: American Journal of Medical Genetics. 1994 March 1; 50(1): 46-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7512789
•
Hypoplasia of the corpus callosum and growth hormone deficiency in the XXXXY syndrome. Author(s): Haeusler G, Frisch H, Guchev Z, Hadziselimovic F, Neuhold A, Vormittag W. Source: American Journal of Medical Genetics. 1992 September 15; 44(2): 230-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1456296
•
Hypoplasia of the corpus callosum and obsessive-compulsive symptoms. Author(s): Farchione TR, Lorch E, Rosenberg DR. Source: Journal of Child Neurology. 2002 July; 17(7): 535-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12269734
•
Hypoplasia of the corpus callosum associated with adipsic hypernatremia and hypothalamic hypogonadotropinism: a case report and review of the literature. Author(s): Komatsu H, Miyake H, Kakita S, Ikuta H. Source: Pediatrics International : Official Journal of the Japan Pediatric Society. 2001 December; 43(6): 683-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11737749
•
Hypoplasia of the corpus callosum in Niemann-Pick type C disease. Author(s): Palmeri S, Battisti C, Federico A, Guazzi GC. Source: Neuroradiology. 1994; 36(1): 20-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8107989
•
Hypoplasia of the corpus callosum: a study of 445 consecutive MRI scans. Author(s): Bodensteiner J, Schaefer GB, Breeding L, Cowan L. Source: Journal of Child Neurology. 1994 January; 9(1): 47-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8151082
•
Image-guided, frameless stereotactic sectioning of the corpus callosum in children with intractable epilepsy. Author(s): Hodaie M, Musharbash A, Otsubo H, Snead OC 3rd, Chitoku S, Ochi A, Holowka S, Hoffman HJ, Rutka JT. Source: Pediatric Neurosurgery. 2001 June; 34(6): 286-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11455228
58
Corpus Callosum
•
Images in clinical medicine. A fetus with hypogenesis of the corpus callosum. Author(s): Glastonbury CM, Kennedy AM. Source: The New England Journal of Medicine. 2003 August 7; 349(6): E6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12904533
•
Improving hand function in chronic stroke: topography of the lesion and role of the corpus callosum. Author(s): Derakhshan I. Source: Archives of Neurology. 2003 April; 60(4): 640; Author Reply 640-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12707086
•
In utero disappearance of the corpus callosum secondary to extensive brain injury. Author(s): Weinstein AS, Goldstein RB, Barkovich AJ. Source: Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 2003 August; 22(8): 837-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12901413
•
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. Author(s): Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Moller HJ. Source: Journal of Neural Transmission (Vienna, Austria : 1996). 2002 May; 109(5-6): 83755. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12111472
•
Influence of learning to read and write on the morphology of the corpus callosum. Author(s): Castro-Caldas A, Miranda PC, Carmo I, Reis A, Leote F, Ribeiro C, DuclaSoares E. Source: European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 1999 January; 6(1): 23-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10209345
•
Influences of chorion type on measurements of the corpus callosum in adult monozygotic male twins? Author(s): Reed T, Pfefferbaum A, Sullivan EV, Carmelli D. Source: American Journal of Human Biology : the Official Journal of the Human Biology Council. 2002 May-June; 14(3): 338-46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12001090
Studies
59
•
Insights into the functional specificity of the human corpus callosum. Author(s): Funnell MG, Corballis PM, Gazzaniga MS. Source: Brain; a Journal of Neurology. 2000 May; 123 ( Pt 5): 920-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10775537
•
Integration of brain activities: the roles of the diffusely projecting brainstem systems and the corpus callosum. Author(s): Berlucchi G. Source: Brain Research Bulletin. 1999 November 15-December; 50(5-6): 389-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10643449
•
Inter- and intra-hemispheric processing of visual event-related potentials in the absence of the corpus callosum. Author(s): Bayard S, Gosselin N, Robert M, Lassonde M. Source: Journal of Cognitive Neuroscience. 2004 April; 16(3): 401-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15072676
•
Interhemispheric glioependymal cyst associated with agenesis of the corpus callosum--case report. Author(s): Tange Y, Aoki A, Mori K, Niijima S, Maeda M. Source: Neurol Med Chir (Tokyo). 2000 October; 40(10): 536-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11098642
•
Interhemispheric neuroepithelial cyst associated with agenesis of the corpus callosum. A case report and review of the literature. Author(s): Uematsu Y, Kubo K, Nishibayashi T, Ozaki F, Nakai K, Itakura T. Source: Pediatric Neurosurgery. 2000 July; 33(1): 31-6. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11025420
•
Interhemispheric transfer of colour and shape information in the presence and absence of the corpus callosum. Author(s): Forster B, Corballis MC. Source: Neuropsychologia. 2000; 38(1): 32-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10617290
•
Interhemispheric transfer of visual, auditory, tactile, and visuomotor information in children with hydrocephalus and partial agenesis of the corpus callosum. Author(s): Klaas PA, Hannay JH, Caroselli JS, Fletcher JM. Source: J Clin Exp Neuropsychol. 1999 December; 21(6): 837-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10649538
60
Corpus Callosum
•
Interhemispheric transfer time in a patient with a partial lesion of the corpus callosum. Author(s): Tomaiuolo F, Nocentini U, Grammaldo L, Caltagirone C. Source: Neuroreport. 2001 May 25; 12(7): 1469-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11388432
•
Is a cortical spike discharge "transferred" to the contralateral cortex via the corpus callosum?: An intraoperative observation of electrocorticogram and callosal compound action potentials. Author(s): Ono T, Matsuo A, Baba H, Ono K. Source: Epilepsia. 2002 December; 43(12): 1536-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12460256
•
Is every sharply defined, symmetrical, necrotic-demyelinating lesion in the corpus callosum an actual manifestation of Marchiafava-Bignami disease? Author(s): Kollar J, Peter M, Fulesdi B, Sikula J. Source: European Journal of Radiology. 2001 September; 39(3): 151-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11566241
•
Isolated complete agenesis of corpus callosum. Author(s): Lu WH, Chen CC, Chiu PC, Chen YY, Lin SM, Cho FN, Lai PH, Yu CK, Hsieh KS. Source: Acta Paediatr Taiwan. 2003 January-February; 44(1): 5-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12800376
•
Ivemark syndrome with agenesis of the corpus callosum: a case report with a review of the literature. Author(s): Noack F, Sayk F, Ressel A, Berg C, Gembruch U, Reusche E. Source: Prenatal Diagnosis. 2002 November; 22(11): 1011-5. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12424766
•
Joubert syndrome with associated corpus callosum agenesis. Author(s): Zamponi N, Rossi B, Messori A, Polonara G, Regnicolo L, Cardinali C. Source: European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 2002; 6(1): 63-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11993957
•
Ketamine and agenesis of the corpus callosum. Author(s): Russell IF. Source: British Journal of Anaesthesia. 1979 October; 51(10): 983-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=518798
Studies
61
•
Konstantin M. Bykov and the discovery of the role of the corpus callosum. Author(s): Kanne SM, Finger S. Source: Journal of the History of Medicine and Allied Sciences. 1999 October; 54(4): 57290. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10575847
•
Koro secondary to a tumour of the corpus callosum. Author(s): Kumar HV, Moloney E. Source: The British Journal of Psychiatry; the Journal of Mental Science. 1988 November; 153: 711-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3255467
•
Koro secondary to a tumour of the corpus callosum. Author(s): Durst R, Rosca-Rebaudengo P. Source: The British Journal of Psychiatry; the Journal of Mental Science. 1988 August; 153: 251-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3255443
•
Landmark analysis of corpus callosum shape in schizophrenia. Author(s): DeQuardo JR. Source: Biological Psychiatry. 1999 December 15; 46(12): 1712-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10624557
•
Langerhans cell histiocytosis involving the corpus callosum and cerebellum: gadolinium-enhanced MRI. Author(s): Strottmann JM, Ginsberg LE, Stanton C. Source: Neuroradiology. 1995 May; 37(4): 289-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7666962
•
Lateralization of movement-related potentials and the size of corpus callosum. Author(s): Stancak A Jr, Lucking CH, Kristeva-Feige R. Source: Neuroreport. 2000 February 7; 11(2): 329-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10674480
•
Lesions of the corpus callosum in hydrocephalic patients with ventricular drainage--a CT-study. Author(s): Spreer J, Ernestus RI, Lanfermann H, Lackner K. Source: Acta Neurochirurgica. 1996; 138(2): 174-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8686541
62
Corpus Callosum
•
Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. Author(s): Bourekas EC, Varakis K, Bruns D, Christoforidis GA, Baujan M, Slone HW, Kehagias D. Source: Ajr. American Journal of Roentgenology. 2002 July; 179(1): 251-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12076946
•
Less developed corpus callosum in dyslexic subjects--a structural MRI study. Author(s): von Plessen K, Lundervold A, Duta N, Heiervang E, Klauschen F, Smievoll AI, Ersland L, Hugdahl K. Source: Neuropsychologia. 2002; 40(7): 1035-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11900755
•
Linkage of autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum to chromosome 15A13-15. Author(s): Shibasaki Y, Tanaka H, Iwabuchi K, Kawasaki S, Kondo H, Uekawa K, Ueda M, Kamiya T, Katayama Y, Nakamura A, Takashima H, Nakagawa M, Masuda M, Utsumi H, Nakamuro T, Tada K, Kurohara K, Inoue K, Koike F, Sakai T, Tsuji S, Kobayashi H. Source: Annals of Neurology. 2000 July; 48(1): 108-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10894224
•
Lipoma and agenesis of the corpus callosum with associated choroid plexus lipomas. In utero diagnosis. Author(s): Mulligan G, Meier P. Source: Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 1989 October; 8(10): 583-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2681831
•
Lipoma of corpus callosum associated with dysraphic lesions and trisomy 13. Author(s): Wainwright H, Bowen R, Radcliffe M. Source: American Journal of Medical Genetics. 1995 May 22; 57(1): 10-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7645586
•
Lipoma of the corpus callosum associated with distal anterior cerebral artery aneurysm. A case report. Author(s): Yamamoto M, Kuwabara S, Uozumi T. Source: Hiroshima J Med Sci. 1989 September; 38(3): 157-60. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2684922
Studies
63
•
Lipoma of the corpus callosum associated with frontal and facial anomalies. Author(s): de Villiers JC, Cluver PF, Peter JC. Source: Acta Neurochir Suppl (Wien). 1991; 53: 1-6. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1803864
•
Lipoma of the corpus callosum in a neonate: sonographic evaluation. Author(s): Auriemma A, Poggiani C, Menghini P, Bellan C, Colombo A. Source: Pediatric Radiology. 1993; 23(2): 155-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8516045
•
Lipoma of the corpus callosum. Author(s): Wallace D. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 1976 December; 39(12): 1179-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1011028
•
Lipomas of the corpus callosum associated with frontal dysraphism. Author(s): Zee CS, McComb JG, Segall HD, Tsai FY, Stanley P. Source: Journal of Computer Assisted Tomography. 1981 April; 5(2): 201-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7217446
•
Lissencephaly with agenesis of corpus callosum and rudimentary dysplastic cerebellum: a subtype of lissencephaly with cerebellar hypoplasia. Author(s): Miyata H, Chute DJ, Fink J, Villablanca P, Vinters HV. Source: Acta Neuropathologica. 2004 January; 107(1): 69-81. Epub 2003 October 18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14566414
•
Localization of functional projections from corpus callosum to cerebral cortex. Author(s): Tan YL, Chen BH, Yang JD, Zhang J, Wang YC, Chai SH, Wang ZY, Li QH. Source: Chinese Medical Journal. 1991 October; 104(10): 851-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1752144
•
Loss of left-sided volitional movements caused by a combined lesion of the corpus callosum and right hemisphere:'initiation pseudohemiakinesia'. Author(s): Yokoyama K, Hasegawa C, Kameyama M. Source: European Neurology. 2000; 44(2): 86-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10965159
64
Corpus Callosum
•
Loss of nerve fibres in the corpus callosum of progressive subcortical vascular encephalopathy. Author(s): Yamanouchi H, Sugiura S, Shimada H. Source: Journal of Neurology. 1990 February; 237(1): 39-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2319266
•
Lower interhemispheric coherence in a case of agenesis of the corpus callosum. Author(s): Nagase Y, Terasaki O, Okubo Y, Matsuura M, Toru M. Source: Clin Electroencephalogr. 1994 January; 25(1): 36-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8174290
•
Magnetic resonance and positron emission tomography imaging of the corpus callosum: size, shape and metabolic rate in unipolar depression. Author(s): Wu JC, Buchsbaum MS, Johnson JC, Hershey TG, Wagner EA, Teng C, Lottenberg S. Source: Journal of Affective Disorders. 1993 May; 28(1): 15-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8326077
•
Magnetic resonance imaging in foetuses with bilateral moderate ventriculomegaly and suspected anomaly of the corpus callosum on ultrasound scan. Author(s): Blaicher W, Prayer D, Mittermayer C, Pollak A, Bernert G, Deutinger J, Bernaschek G. Source: Ultraschall in Der Medizin (Stuttgart, Germany : 1980). 2003 August; 24(4): 25560. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14521152
•
Magnetic resonance imaging study of corpus callosum abnormalities in patients with bipolar disorder. Author(s): Brambilla P, Nicoletti MA, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Source: Biological Psychiatry. 2003 December 1; 54(11): 1294-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14643097
•
Mapping morphology of the corpus callosum in schizophrenia. Author(s): Narr KL, Thompson PM, Sharma T, Moussai J, Cannestra AF, Toga AW. Source: Cerebral Cortex (New York, N.Y. : 1991). 2000 January; 10(1): 40-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10639394
•
Marchiafava-Bignami disease: magnetic resonance imaging findings in corpus callosum and subcortical white matter. Author(s): Kawarabuki K, Sakakibara T, Hirai M, Yoshioka Y, Yamamoto Y, Yamaki T. Source: European Journal of Radiology. 2003 November; 48(2): 175-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14680909
Studies
65
•
Measurement of the corpus callosum using magnetic resonance imaging: analyses of methods and techniques. Author(s): Dorion AA, Capron C, Duyme M. Source: Percept Mot Skills. 2001 June; 92(3 Pt 2): 1075-94. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11565916
•
Measuring the corpus callosum in schizophrenia: a technique with neuroanatomical and cytoarchtectural basis. Author(s): Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Keshavan MS. Source: Neurology India. 2003 June; 51(2): 189-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14571000
•
Megalocornea, macrocephaly, mental and motor retardation: MMMM syndrome (Neuhauser syndrome) in two sisters with hypoplastic corpus callosum. Author(s): Balci S, Teksam O, Gedik S. Source: Turk J Pediatr. 2002 July-September; 44(3): 274-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12405447
•
Microcephaly with dysgenesis of corpus callosum and colpocephaly in the survivor after the first-trimester death of a monochorionic co-twin. Author(s): Chen CP, Lin SP, Chiu NC. Source: Prenatal Diagnosis. 2002 July; 22(7): 634-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12124705
•
Midline corpus callosum is a neuroanatomical focus of fetal alcohol damage. Author(s): Bookstein FL, Sampson PD, Connor PD, Streissguth AP. Source: The Anatomical Record. 2002 June 15; 269(3): 162-74. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12124903
•
Midline developmental anomalies with lipomas in the corpus callosum region. Author(s): Kieslich M, Ehlers S, Bollinger M, Jacobi G. Source: Journal of Child Neurology. 2000 February; 15(2): 85-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10695892
•
Monozygotic twin cases of the agenesis of the corpus callosum with schizophrenic disorder. Author(s): Motomura N, Satani S, Inaba M. Source: Psychiatry and Clinical Neurosciences. 2002 April; 56(2): 199-202. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11952925
66
Corpus Callosum
•
Morphological studies of the corpus callosum by MRI in children with malformative syndromes. Author(s): Gabrielli O, Salvolini U, Bonifazi V, Ciferri L, Lanza R, Rossi R, Coppa GV, Giorgi PL. Source: Neuroradiology. 1993; 35(2): 109-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8433784
•
Morphology and morphometry of the corpus callosum in Williams syndrome: a T1weighted MRI study. Author(s): Tomaiuolo F, Di Paola M, Caravale B, Vicari S, Petrides M, Caltagirone C. Source: Neuroreport. 2002 December 3; 13(17): 2281-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12488811
•
Morphometric comparison of the human corpus callosum in professional musicians and non-musicians by using in vivo magnetic resonance imaging. Author(s): Ozturk AH, Tascioglu B, Aktekin M, Kurtoglu Z, Erden I. Source: Journal of Neuroradiology. Journal De Neuroradiologie. 2002 March; 29(1): 2934. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11984475
•
Morphometry of the corpus callosum in patients with questionable and mild dementia. Author(s): Hensel A, Wolf H, Kruggel F, Riedel-Heller SG, Nikolaus C, Arendt T, Gertz HJ. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 2002 July; 73(1): 59-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12082047
•
MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1. Author(s): Dubovsky EC, Booth TN, Vezina G, Samango-Sprouse CA, Palmer KM, Brasseux CO. Source: Ajnr. American Journal of Neuroradiology. 2001 January; 22(1): 190-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11158908
•
MRI of the brain in the Cohen syndrome: a relatively large corpus callosum in patients with mental retardation and microcephaly. Author(s): Kivitie-Kallio S, Autti T, Salonen O, Norio R. Source: Neuropediatrics. 1998 December; 29(6): 298-301. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10029348
Studies
67
•
MRI/MRS of corpus callosum in patients with clinically isolated syndrome suggestive of multiple sclerosis. Author(s): Ranjeva JP, Pelletier J, Confort-Gouny S, Ibarrola D, Audoin B, Le Fur Y, Viout P, Cherif AA, Cozzone PJ. Source: Multiple Sclerosis (Houndmills, Basingstoke, England). 2003 December; 9(6): 554-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14664467
•
Multiple intracranial lipomas, hypogenetic corpus callosum and vestibular schwannoma: an unusual spectrum of MR findings in a patient. Author(s): Shah J, Srinivasa P, Gala B, Patkar D, Patankar T, Kale H. Source: Journal of Postgraduate Medicine. 1999 April-June; 45(2): 53-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10734334
•
Neural net simulation of the corpus callosum. Author(s): Anninos PA, Cook ND. Source: The International Journal of Neuroscience. 1988 February; 38(3-4): 381-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3372153
•
Neuroanatomical effects of neonatal transection of the corpus callosum in hamsters. Author(s): Lent R. Source: The Journal of Comparative Neurology. 1984 March 10; 223(4): 548-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6715571
•
Neuroanatomy, neurophysiology, and central auditory assessment. Part III: Corpus callosum and efferent pathways. Author(s): Musiek FE. Source: Ear and Hearing. 1986 December; 7(6): 349-58. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3792676
•
Neurodevelopmental vulnerability of the corpus callosum to childhood onset localization-related epilepsy. Author(s): Hermann B, Hansen R, Seidenberg M, Magnotta V, O'Leary D. Source: Neuroimage. 2003 February; 18(2): 284-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12595183
•
Neurofibromatosis and agenesis of the corpus callosum in identical twins: MR diagnosis. Author(s): Atlas SW, Zimmerman RA, Bruce D, Schut L, Bilaniuk LT, Hackney DB, Goldberg HI, Grossman RI. Source: Ajnr. American Journal of Neuroradiology. 1988 May-June; 9(3): 598-601. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3132837
68
Corpus Callosum
•
Neurological and neuroradiological progression in hereditary spastic paraplegia with a thin corpus callosum. Author(s): Okubo S, Ueda M, Kamiya T, Mizumura S, Terashi A, Katayama Y. Source: Acta Neurologica Scandinavica. 2000 September; 102(3): 196-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10987381
•
Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. Author(s): Foong J, Maier M, Clark CA, Barker GJ, Miller DH, Ron MA. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 2000 February; 68(2): 2424. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10644799
•
Neuroradiological findings in hereditary spastic paraplegia with a thin corpus callosum. Author(s): Ohnishi J, Tomoda Y, Yokoyama K. Source: Acta Neurologica Scandinavica. 2001 September; 104(3): 191-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11551243
•
Neurotransmitter receptors and voltage-dependent Ca2+ channels encoded by mRNA from the adult corpus callosum. Author(s): Matute C, Miledi R. Source: Proceedings of the National Academy of Sciences of the United States of America. 1993 April 15; 90(8): 3270-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7682696
•
New autosomal recessive multiple congenital abnormalities/mental retardation syndrome with craniofacial dysmorphism absent corpus callosum, iris colobomas and connective tissue dysplasia. Author(s): Temtamy SA, Salam MA, Aboul-Ezz EH, Hussein HA, Helmy SA, Shalash BA. Source: Clinical Dysmorphology. 1996 July; 5(3): 231-40. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8818452
•
New X-linked syndrome with seizures, acquired micrencephaly, and agenesis of the corpus callosum. Author(s): Proud VK, Levine C, Carpenter NJ. Source: American Journal of Medical Genetics. 1992 April 15-May 1; 43(1-2): 458-66. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1605226
Studies
69
•
NMR intensity of corpus callosum differs with age but not with diagnosis of autism. Author(s): Belmonte M, Egaas B, Townsend J, Courchesne E. Source: Neuroreport. 1995 June 19; 6(9): 1253-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7669980
•
No differences in corpus callosum size by sex and aging. A quantitative study using magnetic resonance imaging. Author(s): Pozzilli C, Bastianello S, Bozzao A, Pierallini A, Giubilei F, Argentino C, Bozzao L. Source: Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 1994 October; 4(4): 218-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7949560
•
No sex-related differences in human corpus callosum based on magnetic resonance imagery. Author(s): Oppenheim JS, Lee BC, Nass R, Gazzaniga MS. Source: Annals of Neurology. 1987 June; 21(6): 604-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3606048
•
Normal and abnormal morphology of the corpus callosum. Author(s): McLeod NA, Williams JP, Machen B, Lum GB. Source: Neurology. 1987 July; 37(7): 1240-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3601091
•
Normal postnatal development of the corpus callosum as demonstrated by MR imaging. Author(s): Barkovich AJ, Kjos BO. Source: Ajnr. American Journal of Neuroradiology. 1988 May-June; 9(3): 487-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3132822
•
Novel missense mutation in the L1 gene in a child with corpus callosum agenesis, retardation, adducted thumbs, spastic paraparesis, and hydrocephalus. Author(s): Sztriha L, Frossard P, Hofstra RM, Verlind E, Nork M. Source: Journal of Child Neurology. 2000 April; 15(4): 239-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10805190
•
Obstetrical three-dimensional ultrasound in the visualization of the intracranial midline and corpus callosum of fetuses with cephalic position. Author(s): Wang PH, Ying TH, Wang PC, Shih IC, Lin LY, Chen GD. Source: Prenatal Diagnosis. 2000 June; 20(6): 518-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10861721
70
Corpus Callosum
•
Occurrence of Andermann syndrome out of French Canada--agenesis of the corpus callosum with neuronopathy. Author(s): Hauser E, Bittner R, Liegl C, Bernert G, Zeitlhofer J. Source: Neuropediatrics. 1993 April; 24(2): 107-10. Erratum In: Neuropediatrics 1993 August; 24(4): 239. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8292134
•
Occurrence of Andermann syndrome out of French Canada--agenesis of the corpus callosum with neuronopathy. Author(s): Battistella PA. Source: Neuropediatrics. 1993 August; 24(4): 239. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8232787
•
On the neurons with dendrites intermingling with the fibers of the human corpus callosum: a Golgi picture. Author(s): Malobabic S, Bogdanovic D, Drekic D. Source: Gegenbaurs Morphol Jahrb. 1984; 130(4): 557-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6208078
•
On the role of the corpus callosum in cerebral laterality: a comment on Lassonde, Bryden, and Demers. Author(s): Cook ND, Brugger P, Regard M, Landis T. Source: Brain and Language. 1990 October; 39(3): 471-4; Discussion 475-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2285865
•
One hundred million years of interhemispheric communication: the history of the corpus callosum. Author(s): Aboitiz F, Montiel J. Source: Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas / Sociedade Brasileira De Biofisica. [et Al.]. 2003 April; 36(4): 409-20. Epub 2003 April 08. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12700818
•
Orofaciodigital syndrome type I associated with polycystic kidneys and agenesis of the corpus callosum. Author(s): Connacher AA, Forsyth CC, Stewart WK. Source: Journal of Medical Genetics. 1987 February; 24(2): 116-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3560170
•
Outcome in prenatally diagnosed fetal agenesis of the corpus callosum. Author(s): Goodyear PW, Bannister CM, Russell S, Rimmer S. Source: Fetal Diagnosis and Therapy. 2001 May-June; 16(3): 139-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11316928
Studies
71
•
Outcomes and indications of corpus callosum section for intractable seizure control. Author(s): Rayport M, Ferguson SM, Corrie WS. Source: Appl Neurophysiol. 1983; 46(1-4): 47-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6422848
•
Overnight polygraphic study of agenesis of the corpus callosum with seizures resembling infantile spasms. Author(s): Horita H, Kumagai K, Maekawa K, Endo S. Source: Brain & Development. 1980; 2(4): 379-86. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6261603
•
Parallel interhemispheric processing in aging and alcoholism: relation to corpus callosum size. Author(s): Schulte T, Pfefferbaum A, Sullivan EV. Source: Neuropsychologia. 2004; 42(2): 257-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14644111
•
Partial agenesis of corpus callosum in LEOPARD syndrome. Author(s): Bonioli E, Di Stefano A, Costabel S, Bellini C. Source: International Journal of Dermatology. 1999 November; 38(11): 855-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10583620
•
Pathologic quiz case: hypoplastic digit, diaphragmatic hernia, and agenesis of the corpus callosum in a 21(5/7)-week fetus. Fryns syndrome. Author(s): Mengshol SC, Ornvold K. Source: Archives of Pathology & Laboratory Medicine. 2003 November; 127(11): E425-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14567736
•
Possible phylogenetical significance of the corpus callosum with special reference to the dolphin brain (Stenella graffmani). Author(s): Nieto A, Nieto D, Pacheco P. Source: Acta Anatomica. 1976; 94(3): 397-402. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1032079
•
Posterior corpus callosum and interhemispheric transfer of somatosensory information: an fMRI and neuropsychological study of a partially callosotomized patient. Author(s): Fabri M, Polonara G, Del Pesce M, Quattrini A, Salvolini U, Manzoni T. Source: Journal of Cognitive Neuroscience. 2001 November 15; 13(8): 1071-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11784445
72
Corpus Callosum
•
Prenatal diagnosis of hypoplasia of the corpus callosum in association with nonketotic hyperglycinemia. Author(s): Paupe A, Bidat L, Sonigo P, Lenclen R, M M, Ville Y. Source: Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2002 December; 20(6): 616-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12493053
•
Prenatal diagnosis of partial agenesis of the corpus callosum in a fetus with thanatophoric dysplasia type 2. Author(s): Kalache KD, Lehmann K, Chaoui R, Kivelitz DE, Mundlos S, Bollmann R. Source: Prenatal Diagnosis. 2002 May; 22(5): 404-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12001196
•
Prenatal PCB exposure, the corpus callosum, and response inhibition. Author(s): Stewart P, Fitzgerald S, Reihman J, Gump B, Lonky E, Darvill T, Pagano J, Hauser P. Source: Environmental Health Perspectives. 2003 October; 111(13): 1670-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14527849
•
Problems with interhemispheric transfer of information in complete or partial agenesis of the corpus callosum. Author(s): Joseph RN, Bannister CM. Source: Neurorehabilitation and Neural Repair. 2001; 15(3): 197-202. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11944741
•
Progression of corpus callosum atrophy in Alzheimer disease. Author(s): Teipel SJ, Bayer W, Alexander GE, Zebuhr Y, Teichberg D, Kulic L, Schapiro MB, Moller HJ, Rapoport SI, Hampel H. Source: Archives of Neurology. 2002 February; 59(2): 243-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11843695
•
Quantification of corpus callosum and ventricles in schizophrenia with nuclear magnetic resonance imaging: a pilot study. Author(s): Rossi A, Stratta P, Gallucci M, Passariello R, Casacchia M. Source: The American Journal of Psychiatry. 1989 January; 146(1): 99-101. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2912255
•
Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging. Author(s): Simon JH, Schiffer RB, Rudick RA, Herndon RM. Source: Ajnr. American Journal of Neuroradiology. 1987 July-August; 8(4): 599-604. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3113196
Studies
73
•
Quantitative magnetic resonance imaging of the corpus callosum in childhood onset schizophrenia. Author(s): Jacobsen LK, Giedd JN, Rajapakse JC, Hamburger SD, Vaituzis AC, Frazier JA, Lenane MC, Rapoport JL. Source: Psychiatry Research. 1997 February 7; 68(2-3): 77-86. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9104755
•
Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Author(s): Giedd JN, Castellanos FX, Casey BJ, Kozuch P, King AC, Hamburger SD, Rapoport JL. Source: The American Journal of Psychiatry. 1994 May; 151(5): 665-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8166306
•
Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. Author(s): Kayl AE, Moore BD 3rd, Slopis JM, Jackson EF, Leeds NE. Source: Journal of Child Neurology. 2000 February; 15(2): 90-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10695893
•
Rapidly progressive dementia due to bilateral internal carotid artery occlusion with infarction of the total length of the corpus callosum. Author(s): Rabinstein AA, Romano JG, Forteza AM, Koch S. Source: Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 2004 April; 14(2): 176-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15095565
•
Reciprocal fusion transcripts of two novel Zn-finger genes in a female with absence of the corpus callosum, ocular colobomas and a balanced translocation between chromosomes 2p24 and 9q32. Author(s): Ramocki MB, Dowling J, Grinberg I, Kimonis VE, Cardoso C, Gross A, Chung J, Martin CL, Ledbetter DH, Dobyns WB, Millen KJ. Source: European Journal of Human Genetics : Ejhg. 2003 July; 11(7): 527-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12825074
•
Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Author(s): Teipel SJ, Bayer W, Alexander GE, Bokde AL, Zebuhr Y, Teichberg D, MullerSpahn F, Schapiro MB, Moller HJ, Rapoport SI, Hampel H. Source: Neurobiology of Aging. 2003 January-February; 24(1): 85-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12493554
74
Corpus Callosum
•
Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Author(s): Teipel SJ, Schapiro MB, Alexander GE, Krasuski JS, Horwitz B, Hoehne C, Moller HJ, Rapoport SI, Hampel H. Source: The American Journal of Psychiatry. 2003 October; 160(10): 1870-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14514503
•
Relationship between attentional performance and corpus callosum morphometry in patients with Alzheimer's disease. Author(s): Dorion AA, Sarazin M, Hasboun D, Hahn-Barma V, Dubois B, Zouaoui A, Marsault C, Duyme M. Source: Neuropsychologia. 2002; 40(7): 946-56. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11900746
•
Relationship between discrimination tasks of the cantab and the corpus callosum morphology in Alzheimer's disease. Author(s): Dorion AA, Duyme M, Zanca M, Dubois B, Beau J. Source: Percept Mot Skills. 2001 June; 92(3 Pt 2): 1205-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11565930
•
Relationships between sulcal asymmetries and corpus callosum size: gender and handedness effects. Author(s): Luders E, Rex DE, Narr KL, Woods RP, Jancke L, Thompson PM, Mazziotta JC, Toga AW. Source: Cerebral Cortex (New York, N.Y. : 1991). 2003 October; 13(10): 1084-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12967925
•
Reversible corpus callosum lesion in legionnaires' disease. Author(s): Morgan JC, Cavaliere R, Juel VC. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 2004 April; 75(4): 651-4. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15026520
•
Role of the corpus callosum in bimanual coordination: a comparison of patients with congenital and acquired callosal damage. Author(s): Serrien DJ, Nirkko AC, Wiesendanger M. Source: The European Journal of Neuroscience. 2001 December; 14(11): 1897-905. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11860484
Studies
75
•
Role of the corpus callosum in functional connectivity. Author(s): Quigley M, Cordes D, Turski P, Moritz C, Haughton V, Seth R, Meyerand ME. Source: Ajnr. American Journal of Neuroradiology. 2003 February; 24(2): 208-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12591635
•
Schizophrenia, neurodevelopment and corpus callosum. Author(s): Innocenti GM, Ansermet F, Parnas J. Source: Molecular Psychiatry. 2003 March; 8(3): 261-74. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12660799
•
Second trimester prenatal alcohol exposure alters development of rat corpus callosum. Author(s): Qiang M, Wang MW, Elberger AJ. Source: Neurotoxicology and Teratology. 2002 November-December; 24(6): 719-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12460654
•
Semiquantitative analysis of corpus callosum injury using magnetic resonance imaging indicates clinical severity in patients with diffuse axonal injury. Author(s): Takaoka M, Tabuse H, Kumura E, Nakajima S, Tsuzuki T, Nakamura K, Okada A, Sugimoto H. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 2002 September; 73(3): 289-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12185160
•
Sex differences in corpus callosum size: relationship to age and intracranial size. Author(s): Sullivan EV, Rosenbloom MJ, Desmond JE, Pfefferbaum A. Source: Neurobiology of Aging. 2001 July-August; 22(4): 603-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11445261
•
Sex differences in the corpus callosum of patients with schizophrenia. Author(s): Panizzon MS, Hoff AL, Nordahl TE, Kremen WS, Reisman B, Wieneke M, Harris D, Goodman C, Espinoza S, Liu W, Lim K. Source: Schizophrenia Research. 2003 July 1; 62(1-2): 115-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12765751
•
Sexual dimorphism in the corpus callosum: a characterization of local size variations and a classification driven approach to morphometry. Author(s): Pettey DJ, Gee JC. Source: Neuroimage. 2002 November; 17(3): 1504-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12414289
76
Corpus Callosum
•
Sister and brother with Vici syndrome: agenesis of the corpus callosum, albinism, and recurrent infections. Author(s): Chiyonobu T, Yoshihara T, Fukushima Y, Yamamoto Y, Tsunamoto K, Nishimura Y, Ishida H, Toda T, Kasubuchi Y. Source: American Journal of Medical Genetics. 2002 April 15; 109(1): 61-6. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11932994
•
Size of the human corpus callosum is genetically determined: an MRI study in mono and dizygotic twins. Author(s): Scamvougeras A, Kigar DL, Jones D, Weinberger DR, Witelson SF. Source: Neuroscience Letters. 2003 February 27; 338(2): 91-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12566160
•
Social processing deficits in agenesis of the corpus callosum: narratives from the Thematic Appreciation Test. Author(s): Paul LK, Schieffer B, Brown WS. Source: Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 2004 March; 19(2): 215-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15010087
•
Surgical removal of corpus callosum infiltrated by low-grade glioma: functional outcome and oncological considerations. Author(s): Duffau H, Khalil I, Gatignol P, Denvil D, Capelle L. Source: Journal of Neurosurgery. 2004 March; 100(3): 431-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15035278
•
The influence of handedness and gender on the microstructure of the human corpus callosum: a diffusion-tensor magnetic resonance imaging study. Author(s): Westerhausen R, Walter C, Kreuder F, Wittling RA, Schweiger E, Wittling W. Source: Neuroscience Letters. 2003 November 13; 351(2): 99-102. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14583391
•
The role of the corpus callosum in the coupling of bimanual isometric force pulses. Author(s): Diedrichsen J, Hazeltine E, Nurss WK, Ivry RB. Source: Journal of Neurophysiology. 2003 October; 90(4): 2409-18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14534269
•
The size of corpus callosum and functional connectivities of cortical regions in finger and shoulder movements. Author(s): Stancak A, Lucking CH, Kristeva-Feige R. Source: Brain Research. Cognitive Brain Research. 2002 February; 13(1): 61-74. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11867251
Studies
77
•
Therapy-related change of corpus callosum in a young patient with epilepsy. Author(s): Feitova V, Feit J, Krupa P. Source: European Radiology. 2002 February; 12(2): 345-7. Epub 2001 July 04. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11870432
•
Thrombocytopenia absent corpus callosum syndrome: third case of a distinct clinical entity. Author(s): Khabbaze Y, Karayalcin G, Paley C, Shende A, Valderrama E, Lipton JM. Source: Journal of Pediatric Hematology/Oncology : Official Journal of the American Society of Pediatric Hematology/Oncology. 2001 October; 23(7): 469-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11878585
•
Transient lesion in the splenium of the corpus callosum in acute cerebellitis. Author(s): Kato Z, Kozawa R, Hashimoto K, Kondo N. Source: Journal of Child Neurology. 2003 April; 18(4): 291-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12760432
•
Transient lesion in the splenium of the corpus callosum in an epileptic patient. Author(s): Mirsattari SM, Lee DH, Jones MW, Blume WT. Source: Neurology. 2003 June 10; 60(11): 1838-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12796545
•
Transient lesion in the splenium of the corpus callosum, possibly due to carbamazepine. Author(s): Narita H, Odawara T, Kawanishi C, Kishida I, Iseki E, Kosaka K. Source: Psychiatry and Clinical Neurosciences. 2003 October; 57(5): 550-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12950714
•
Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging. Author(s): Maeda M, Shiroyama T, Tsukahara H, Shimono T, Aoki S, Takeda K. Source: European Radiology. 2003 August; 13(8): 1902-6. Epub 2002 October 12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12942292
•
Two cases of Japanese CADASIL with corpus callosum lesion. Author(s): Iwatsuki K, Murakami T, Manabe Y, Narai H, Warita H, Hayashi T, Abe K. Source: The Tohoku Journal of Experimental Medicine. 2001 October; 195(2): 135-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11846209
78
Corpus Callosum
•
Ullrich-Turner syndrome with agenesis of the corpus callosum. Author(s): Kimura M, Nakajima M, Yoshino K. Source: American Journal of Medical Genetics. 1990 October; 37(2): 227-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2248289
•
Unilateral agraphia after section of the posterior half of the truncus of the corpus callosum. Author(s): Sugishita M, Toyokura Y, Yoshioka M, Yamada R. Source: Brain and Language. 1980 March; 9(2): 215-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7363066
•
Unilateral calcification in a lipoma of the corpus callosum. Author(s): Craddock WE, Riddervold HO. Source: J Can Assoc Radiol. 1972 September; 23(3): 192-4. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5084428
•
Unilateral photoconvulsive response in agenesis of the corpus callosum. Author(s): Brinciotti M, Matricardi M, Trasatti G. Source: Clin Electroencephalogr. 1990 April; 21(2): 101-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2335038
•
Unlayered polymicrogyria and agenesis of the corpus callosum: a relevant association? Author(s): Billette de Villemeur T, Chiron C, Robain O. Source: Acta Neuropathologica. 1992; 83(3): 265-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1557957
•
Unusual presentation of gastroesophageal reflux with corpus callosum agenesis, cleft palate and mental retardation. Author(s): Desai BN, Joshi SM, Malik S, Mittal S, Dandge VP. Source: Indian Pediatrics. 1991 November; 28(11): 1328-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1808058
•
US case of the day. Dandy-Walker variant with agenesis of the corpus callosum. Author(s): Wilson ME, Lindsay DJ, Levi CS, Ackerman TE, Gordon WL. Source: Radiographics : a Review Publication of the Radiological Society of North America, Inc. 1994 May; 14(3): 678-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8066281
Studies
79
•
US case of the day. Lipoma and hypogenesis of the corpus callosum. Author(s): Multz MA, Koenigsberg M, Lantos G. Source: Radiographics : a Review Publication of the Radiological Society of North America, Inc. 1996 September; 16(5): 1227-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8888404
•
Value of biplane computerized tomography in agenesis of the corpus callosum. A case history. Author(s): Versluis E, Klinkhamer AC, Veiga-Pires JA, van Waes PF. Source: Radiol Clin (Basel). 1978; 47(5): 346-56. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=704809
•
Variations in human corpus callosum do not predict gender: a study using magnetic resonance imaging. Author(s): Byne W, Bleier R, Houston L. Source: Behavioral Neuroscience. 1988 April; 102(2): 222-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3365317
•
Vascular malformation of the posterior corpus callosum: surgical treatment. Author(s): Kosary IZ, Braham J, Shacked I, Kronenberg Y. Source: Surgical Neurology. 1978 December; 10(6): 345-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=741355
•
Ventricular visualization on the brain scan associated with a corpus callosum tumour. Author(s): McKay WJ, Andrews JT. Source: Aust N Z J Med. 1976 April; 6(2): 149-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=788695
•
Visual discrimination after lesion of the posterior corpus callosum. Author(s): Rubens AB, Risse G, Selnes O. Source: Neurology. 1981 January; 31(1): 111-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7192820
•
Visual discrimination after lesion of the posterior corpus callosum. Author(s): Brown JW. Source: Neurology. 1980 November; 30(11): 1251-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7191524
•
Visual discrimination after lesion of the posterior corpus callosum. Author(s): Levine DN, Calvanio R. Source: Neurology. 1980 January; 30(1): 21-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7188631
80
Corpus Callosum
•
What is the role of the corpus callosum in intermanual transfer of motor skills? A study of three cases with callosal pathology. Author(s): Thut G, Halsband U, Regard M, Mayer E, Leenders KL, Landis T. Source: Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale. 1997 February; 113(2): 365-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9063723
•
When does human brain development end? Evidence of corpus callosum growth up to adulthood. Author(s): Pujol J, Vendrell P, Junque C, Marti-Vilalta JL, Capdevila A. Source: Annals of Neurology. 1993 July; 34(1): 71-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8517683
•
White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy. Author(s): Vermersch P, Roche J, Hamon M, Daems-Monpeurt C, Pruvo JP, Dewailly P, Petit H. Source: Journal of Neurology. 1996 March; 243(3): 231-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8936352
•
X linked recessive inheritance of agenesis of the corpus callosum. Author(s): Kaplan P. Source: Journal of Medical Genetics. 1983 April; 20(2): 122-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6682447
•
X-linked lissencephaly with absent corpus callosum and ambiguous genitalia (XLAG): clinical, magnetic resonance imaging, and neuropathological findings. Author(s): Bonneau D, Toutain A, Laquerriere A, Marret S, Saugier-Veber P, Barthez MA, Radi S, Biran-Mucignat V, Rodriguez D, Gelot A. Source: Annals of Neurology. 2002 March; 51(3): 340-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11891829
•
X-linked lissencephaly with absent corpus callosum and ambiguous genitalia. Author(s): Dobyns WB, Berry-Kravis E, Havernick NJ, Holden KR, Viskochil D. Source: American Journal of Medical Genetics. 1999 October 8; 86(4): 331-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10494089
•
X-linked mental retardation with agenesis of the corpus callosum. Author(s): Fryns JP. Source: American Journal of Medical Genetics. 1993 February 15; 45(4): 533. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8465865
Studies
81
•
X-linked pachygyria and agenesis of the corpus callosum: evidence for an X chromosome lissencephaly locus. Author(s): Berry-Kravis E, Israel J. Source: Annals of Neurology. 1994 August; 36(2): 229-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8053659
•
X-linked recessive inheritance of dysgenesis of corpus callosum in a Chinese family. Author(s): Kang WM, Huang CC, Lin SJ. Source: American Journal of Medical Genetics. 1992 November 15; 44(5): 619-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1481821
83
CHAPTER 2. NUTRITION AND CORPUS CALLOSUM Overview In this chapter, we will show you how to find studies dedicated specifically to nutrition and corpus callosum.
Finding Nutrition Studies on Corpus Callosum The National Institutes of Health’s Office of Dietary Supplements (ODS) offers a searchable bibliographic database called the IBIDS (International Bibliographic Information on Dietary Supplements; National Institutes of Health, Building 31, Room 1B29, 31 Center Drive, MSC 2086, Bethesda, Maryland 20892-2086, Tel: 301-435-2920, Fax: 301-480-1845, E-mail:
[email protected]). The IBIDS contains over 460,000 scientific citations and summaries about dietary supplements and nutrition as well as references to published international, scientific literature on dietary supplements such as vitamins, minerals, and botanicals.7 The IBIDS includes references and citations to both human and animal research studies. As a service of the ODS, access to the IBIDS database is available free of charge at the following Web address: http://ods.od.nih.gov/databases/ibids.html. After entering the search area, you have three choices: (1) IBIDS Consumer Database, (2) Full IBIDS Database, or (3) Peer Reviewed Citations Only. Now that you have selected a database, click on the “Advanced” tab. An advanced search allows you to retrieve up to 100 fully explained references in a comprehensive format. Type “corpus callosum” (or synonyms) into the search box, and click “Go.” To narrow the search, you can also select the “Title” field.
7
Adapted from http://ods.od.nih.gov. IBIDS is produced by the Office of Dietary Supplements (ODS) at the National Institutes of Health to assist the public, healthcare providers, educators, and researchers in locating credible, scientific information on dietary supplements. IBIDS was developed and will be maintained through an interagency partnership with the Food and Nutrition Information Center of the National Agricultural Library, U.S. Department of Agriculture.
84
Corpus Callosum
The following information is typical of that found when using the “Full IBIDS Database” to search for “corpus callosum” (or a synonym): •
GABA- and glutamate-activated currents in glial cells of the mouse corpus callosum slice. Author(s): Department of Neurobiology, University of Heidelberg, Germany. Source: Berger, T Walz, W Schnitzer, J Kettenmann, H J-Neurosci-Res. 1992 January; 31(1): 21-7 0360-4012
•
Heredity and alcohol-induced brain anomalies: effects of alcohol on anomalous prenatal development of the corpus callosum and anterior commissure in BALB/c and C57BL/6 mice. Source: Cassells, B Wainwright, P Blom, K Exp-Neurol. 1987 March; 95(3): 587-604 00144886
•
Karyometric studies of glial cells in corpus callosum of rats developing a fat deficient diet. Source: Wender, M Hejduk Hantke, H Godlewski, A Neuropatol-Pol. 1988; 26(3): 403-13 0028-3894
•
Maturation of the corpus callosum of the rat: I. Influence of thyroid hormones on the topography of callosal projections. Author(s): Department of Biochemistry, Faculty of Medicine, Laval University, Quebec, Canada. Source: Gravel, C Hawkes, R J-Comp-Neurol. 1990 January 1; 291(1): 128-46 0021-9967
•
Postnatal development of biotinylated dextran amine-labeled corpus callosum axons projecting from the visual and auditory cortices to the visual cortex of the rat. Author(s): Department of Anatomy and Neurobiology, The University of Tennessee at Memphis, 38163, USA. Source: Ding, S L Elberger, A J Exp-Brain-Res. 2001 January; 136(2): 179-93 0014-4819
•
Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers. Author(s): Department of Anatomy, Faculty of Medicine, National University of Singapore. Source: Xu, J Ling, E A J-Anat. 1994 April; 184 ( Pt 2)227-37 0021-8782
Federal Resources on Nutrition In addition to the IBIDS, the United States Department of Health and Human Services (HHS) and the United States Department of Agriculture (USDA) provide many sources of information on general nutrition and health. Recommended resources include: •
healthfinder®, HHS’s gateway to health information, including diet and nutrition: http://www.healthfinder.gov/scripts/SearchContext.asp?topic=238&page=0
•
The United States Department of Agriculture’s Web site dedicated to nutrition information: www.nutrition.gov
•
The Food and Drug Administration’s Web site for federal food safety information: www.foodsafety.gov
•
The National Action Plan on Overweight and Obesity sponsored by the United States Surgeon General: http://www.surgeongeneral.gov/topics/obesity/
Nutrition
85
•
The Center for Food Safety and Applied Nutrition has an Internet site sponsored by the Food and Drug Administration and the Department of Health and Human Services: http://vm.cfsan.fda.gov/
•
Center for Nutrition Policy and Promotion sponsored by the United States Department of Agriculture: http://www.usda.gov/cnpp/
•
Food and Nutrition Information Center, National Agricultural Library sponsored by the United States Department of Agriculture: http://www.nal.usda.gov/fnic/
•
Food and Nutrition Service sponsored by the United States Department of Agriculture: http://www.fns.usda.gov/fns/
Additional Web Resources A number of additional Web sites offer encyclopedic information covering food and nutrition. The following is a representative sample: •
AOL: http://search.aol.com/cat.adp?id=174&layer=&from=subcats
•
Family Village: http://www.familyvillage.wisc.edu/med_nutrition.html
•
Google: http://directory.google.com/Top/Health/Nutrition/
•
Healthnotes: http://www.healthnotes.com/
•
Open Directory Project: http://dmoz.org/Health/Nutrition/
•
Yahoo.com: http://dir.yahoo.com/Health/Nutrition/
•
WebMD®Health: http://my.webmd.com/nutrition
•
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
87
CHAPTER 3. ALTERNATIVE MEDICINE AND CORPUS CALLOSUM Overview In this chapter, we will begin by introducing you to official information sources on complementary and alternative medicine (CAM) relating to corpus callosum. At the conclusion of this chapter, we will provide additional sources.
National Center for Complementary and Alternative Medicine The National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (http://nccam.nih.gov/) has created a link to the National Library of Medicine’s databases to facilitate research for articles that specifically relate to corpus callosum and complementary medicine. To search the database, go to the following Web site: http://www.nlm.nih.gov/nccam/camonpubmed.html. Select “CAM on PubMed.” Enter “corpus callosum” (or synonyms) into the search box. Click “Go.” The following references provide information on particular aspects of complementary and alternative medicine that are related to corpus callosum: •
A computational analysis of mental image generation: evidence from functional dissociations in split-brain patients. Author(s): Kosslyn SM, Holtzman JD, Farah MJ, Gazzaniga MS. Source: Journal of Experimental Psychology. General. 1985 September; 114(3): 311-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3161979
•
A gelatin in situ-overlay technique localizes brain matrix metalloproteinase activity in experimental focal cerebral ischemia. Author(s): Loy M, Burggraf D, Martens KH, Liebetrau M, Wunderlich N, Bultemeier G, Nemori R, Hamann GF. Source: Journal of Neuroscience Methods. 2002 May 15; 116(2): 125-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12044662
88
Corpus Callosum
•
A left hemisphere basis for visual mental imagery? Author(s): Farah MJ, Gazzaniga MS, Holtzman JD, Kosslyn SM. Source: Neuropsychologia. 1985; 23(1): 115-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3974846
•
A preliminary single case magnetic resonance imaging investigation into maxillary frontal-parietal manipulation and its short-term effect upon the intercranial structures of an adult human brain. Author(s): Pick MG. Source: Journal of Manipulative and Physiological Therapeutics. 1994 March-April; 17(3): 168-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8006531
•
Alexithymia in an adolescent with agenesis of the corpus callosum and chronic pain. Author(s): Ernst H, Key JD, Koval MS. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 1999 October; 38(10): 1212-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10517052
•
Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Author(s): Platt B, Fiddler G, Riedel G, Henderson Z. Source: Brain Research Bulletin. 2001 May 15; 55(2): 257-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11470325
•
Asymmetry of the interhemispheric visuomotor integration in callosal agenesis. Author(s): Di Stefano M, Salvadori C. Source: Neuroreport. 1998 May 11; 9(7): 1331-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9631424
•
Auditory corticocortical interconnections in the cat: evidence for parallel and hierarchical arrangement of the auditory cortical areas. Author(s): Rouiller EM, Simm GM, Villa AE, de Ribaupierre Y, de Ribaupierre F. Source: Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale. 1991; 86(3): 483-505. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1722171
•
Bihemispheric malignant glioma: one size does not fit all. Author(s): Bauman GS, Fisher BJ, Cairncross JG, Macdonald D. Source: Journal of Neuro-Oncology. 1998 May; 38(1): 83-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9540061
Alternative Medicine 89
•
Binaural and commissural organization of the primary auditory cortex of the mustached bat. Author(s): Liu W, Suga N. Source: Journal of Comparative Physiology. A, Sensory, Neural, and Behavioral Physiology. 1997 December; 181(6): 599-605. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9449820
•
Binaural noise stimulation of auditory callosal fibers of the cat: responses to interaural time delays. Author(s): Poirier P, Lepore F, Provencal C, Ptito M, Guillemot JP. Source: Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale. 1995; 104(1): 30-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7621939
•
Brain lesions and hyperbaric oxygen convulsions. Author(s): Gowdey CW, Patel YJ, Stavraky GW. Source: Int J Neuropsychiatry. 1965 August; 1(4): 318-24. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5863508
•
Central core control of developmental plasticity in the kitten visual cortex: I. Diencephalic lesions. Author(s): Singer W. Source: Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale. 1982; 47(2): 209-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7117446
•
Chronological sequences and blood-brain barrier permeability changes in local injury as assessed by nuclear magnetic resonance (NMR) images from sliced rat brain. Author(s): Asato R, Handa H, Hashi T, Hatta J, Komoike M, Yazaki T. Source: Stroke; a Journal of Cerebral Circulation. 1983 March-April; 14(2): 191-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6836644
•
Clinical management] of canine seizures. Author(s): Parent JM. Source: The Veterinary Clinics of North America. Small Animal Practice. 1988 July; 18(4): 947-64. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3062879
•
Cognitive activity of the right hemisphere: possible contributions to psychological function. Author(s): Schiffer F.
90
Corpus Callosum
Source: Harvard Review of Psychiatry. 1996 September-October; 4(3): 126-38. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9384985 •
Competitive neuronal interactions underlying amblyopia. Author(s): Cynader MS. Source: Hum Neurobiol. 1982 March; 1(1): 35-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6764458
•
Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate. Author(s): Baker MJ, Brem S, Daniels S, Sherman B, Phuphanich S. Source: Journal of Neuro-Oncology. 2002 September; 59(3): 239-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12241121
•
Conditions for interhemispheric transfer of initially lateralized visual engrams in hooded rats. Author(s): Buresova O, Bures J, Rustova M. Source: J Comp Physiol Psychol. 1971 May; 75(2): 200-5. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5087376
•
Continuous c-fos expression precedes programmed cell death in vivo. Author(s): Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI. Source: Nature. 1993 May 13; 363(6425): 166-9. Erratum In: Nature 1993 September 16; 365(6443): 279. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8483500
•
Corpus callosum morphometry and dichotic listening performance: individual differences in functional interhemispheric inhibition? Author(s): Clarke JM, Lufkin RB, Zaidel E. Source: Neuropsychologia. 1993 June; 31(6): 547-57. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8341413
•
Deafferentation of the visual cortex: the effect on cortical cells in normal and in early monocularly deprived cats. Author(s): Yinon U, Podell M, Goshen S. Source: Experimental Neurology. 1984 March; 83(3): 486-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6698154
•
Defective revisualization: dissociation between cognitive and imagistic thought case report and short review of the literature. Author(s): Botez MI, Olivier M, Vezina JL, Botez T, Kaufman B.
Alternative Medicine 91
Source: Cortex. 1985 September; 21(3): 375-89. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4053625 •
Deficient brain development following colcemid treatment in postnatal rats. Author(s): Petit TL, Isaacson RL. Source: Brain Research. 1977 August 26; 132(2): 380-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=890489
•
Demonstration of amoeboid and ramified microglial cells in pre- and postnatal bovine brains by lectin histochemistry. Author(s): Hewicker-Trautwein M, Schultheis G, Trautwein G. Source: Anat Anz. 1996 January; 178(1): 25-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8717324
•
Dichotic studies. II. Two questions. Author(s): Studdert-Kennedy M. Source: Brain and Language. 1975 April; 2(2): 123-30. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1102062
•
Differences in binocular interactions between cortical areas 17 and 18 and superior colliculus of Siamese cats. Author(s): Antonini A, Berlucchi G, Di Stefano M, Marzi CA. Source: The Journal of Comparative Neurology. 1981 August 20; 200(4): 597-611. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7263961
•
'Direct' and 'crossed' modulation of human motor cortex excitability following exercise. Author(s): Bonato C, Zanette G, Manganotti P, Tinazzi M, Bongiovanni G, Polo A, Fiaschi A. Source: Neuroscience Letters. 1996 September 27; 216(2): 97-100. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8904792
•
Impact of in utero exposure to EtOH on corpus callosum development and paw preference in rats: protective effects of silymarin. Author(s): Moreland N, La Grange L, Montoya R. Source: Bmc Complementary and Alternative Medicine [electronic Resource]. 2002 November 11; 2(1): 10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12427259
•
Impaired sensory and motor differentiation with corpus callosum agenesis: a lack of callosal inhibition during ontogeny? Author(s): Dennis M.
92
Corpus Callosum
Source: Neuropsychologia. 1976; 14(4): 455-69. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=995239 •
Interhemispheric integration of sensory and motor functions in agenesis of the corpus callosum. Author(s): Sauerwein HC, Lassonde MC, Cardu B, Geoffroy G. Source: Neuropsychologia. 1981; 19(3): 445-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7266837
•
Karyometry and cytophotometry of oligodendroglial DNA in the corpus callosum of rats treated with vicristine during the second part of foetal life. Author(s): Kozik MB, Godlewski A. Source: J Hirnforsch. 1983; 24(3): 267-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6886395
•
Long latency evoked potentials in a case of corpus callosum agenesia. Author(s): Aiello I, Sotgiu S, Sau GF, Manca S, Conti M, Rosati G. Source: Italian Journal of Neurological Sciences. 1994 December; 15(9): 497-505. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7721553
•
Postnatal development of the visual corpus callosum: the influence of activity of the retinofugal projections. Author(s): Murphy EH, Grigonis AM. Source: Behavioural Brain Research. 1988 September 15; 30(2): 151-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3166714
•
Speech perception and auditory P300 potentials after section of the posterior half of the truncus of the corpus callosum. Author(s): Kaga K, Shindo M, Gotoh O, Tamura A. Source: Brain Topography. 1990 Fall; 3(1): 175-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2094305
•
Visual imagery and the corpus callosum: a theoretical note. Author(s): Prigatano GP. Source: Percept Mot Skills. 1983 February; 56(1): 296-8. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6844074
Alternative Medicine 93
Additional Web Resources A number of additional Web sites offer encyclopedic information covering CAM and related topics. The following is a representative sample: •
Alternative Medicine Foundation, Inc.: http://www.herbmed.org/
•
AOL: http://search.aol.com/cat.adp?id=169&layer=&from=subcats
•
Chinese Medicine: http://www.newcenturynutrition.com/
•
drkoop.com®: http://www.drkoop.com/InteractiveMedicine/IndexC.html
•
Family Village: http://www.familyvillage.wisc.edu/med_altn.htm
•
Google: http://directory.google.com/Top/Health/Alternative/
•
Healthnotes: http://www.healthnotes.com/
•
MedWebPlus: http://medwebplus.com/subject/Alternative_and_Complementary_Medicine
•
Open Directory Project: http://dmoz.org/Health/Alternative/
•
HealthGate: http://www.tnp.com/
•
WebMD®Health: http://my.webmd.com/drugs_and_herbs
•
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
•
Yahoo.com: http://dir.yahoo.com/Health/Alternative_Medicine/
General References A good place to find general background information on CAM is the National Library of Medicine. It has prepared within the MEDLINEplus system an information topic page dedicated to complementary and alternative medicine. To access this page, go to the MEDLINEplus site at http://www.nlm.nih.gov/medlineplus/alternativemedicine.html. This Web site provides a general overview of various topics and can lead to a number of general sources.
95
CHAPTER 4. DISSERTATIONS ON CORPUS CALLOSUM Overview In this chapter, we will give you a bibliography on recent dissertations relating to corpus callosum. We will also provide you with information on how to use the Internet to stay current on dissertations. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical dissertations that use the generic term “corpus callosum” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on corpus callosum, we have not necessarily excluded non-medical dissertations in this bibliography.
Dissertations on Corpus Callosum ProQuest Digital Dissertations, the largest archive of academic dissertations available, is located at the following Web address: http://wwwlib.umi.com/dissertations. From this archive, we have compiled the following list covering dissertations devoted to corpus callosum. You will see that the information provided includes the dissertation’s title, its author, and the institution with which the author is associated. The following covers recent dissertations found when using this search procedure: •
Idiom comprehension: Typical development, and atypical function and relations with corpus callosum dysmorphology in children with spina bifida and hydrocephalus by Huber Okrainec, Joelene Frieda Harder, PhD from UNIVERSITY OF TORONTO (CANADA), 2003, 232 pages http://wwwlib.umi.com/dissertations/fullcit/NQ78051
•
Inhibition of information transfer across the corpus callosum : neuropsychological investigation of motivated forgetting by Hwryluk, Garry A; PhD from THE UNIVERSITY OF MANITOBA (CANADA), 1977 http://wwwlib.umi.com/dissertations/fullcit/NK35841
•
Maternal environment and deficiency of corpus callosum in BALB/c mice by BulmanFleming, Mary Barbara; PhD from UNIVERSITY OF WATERLOO (CANADA), 1988 http://wwwlib.umi.com/dissertations/fullcit/NL45386
96
Corpus Callosum
•
Plasticity of neural projections from cerebral cortex in mice with hereditary agenesis of corpus callosum : a lesion-degeneration study by Jones, George Brian; PhD from UNIVERSITY OF WATERLOO (CANADA), 1979 http://wwwlib.umi.com/dissertations/fullcit/NK42369
•
Sex differences in the corpus callosum of Macaca fascicularis and Pan troglodytes by Broadfield, Douglas C., PhD from CITY UNIVERSITY OF NEW YORK, 2001, 306 pages http://wwwlib.umi.com/dissertations/fullcit/3024765
•
The production and fate of astrocytes and oligodendrocytes in the brain of the adult and aged mouse as shown by radioautography of the corpus callosum following pulse injection and continuous 3H-thymidine infusion by McCarthy, Gerald Francis; PhD from MCGILL UNIVERSITY (CANADA), 1985 http://wwwlib.umi.com/dissertations/fullcit/NL24047
Keeping Current Ask the medical librarian at your library if it has full and unlimited access to the ProQuest Digital Dissertations database. From the library, you should be able to do more complete searches via http://wwwlib.umi.com/dissertations.
97
CHAPTER 5. PATENTS ON CORPUS CALLOSUM Overview Patents can be physical innovations (e.g. chemicals, pharmaceuticals, medical equipment) or processes (e.g. treatments or diagnostic procedures). The United States Patent and Trademark Office defines a patent as a grant of a property right to the inventor, issued by the Patent and Trademark Office.8 Patents, therefore, are intellectual property. For the United States, the term of a new patent is 20 years from the date when the patent application was filed. If the inventor wishes to receive economic benefits, it is likely that the invention will become commercially available within 20 years of the initial filing. It is important to understand, therefore, that an inventor’s patent does not indicate that a product or service is or will be commercially available. The patent implies only that the inventor has “the right to exclude others from making, using, offering for sale, or selling” the invention in the United States. While this relates to U.S. patents, similar rules govern foreign patents. In this chapter, we show you how to locate information on patents and their inventors. If you find a patent that is particularly interesting to you, contact the inventor or the assignee for further information. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical patents that use the generic term “corpus callosum” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on corpus callosum, we have not necessarily excluded nonmedical patents in this bibliography.
Patent Applications on Corpus Callosum As of December 2000, U.S. patent applications are open to public viewing.9 Applications are patent requests which have yet to be granted. (The process to achieve a patent can take several years.) The following patent applications have been filed since December 2000 relating to corpus callosum:
8Adapted
from the United States Patent and Trademark Office: http://www.uspto.gov/web/offices/pac/doc/general/whatis.htm. 9 This has been a common practice outside the United States prior to December 2000.
98
•
Corpus Callosum
Novel gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof Inventor(s): Hageshita, Hiroaki; (Zama, JP), Hayasawa, Hirotoshi; (Zama, JP), Nomaguchi, Kouji; (Zama, JP), Suzu, Shinya; (Zama, JP), Yamada, Muneo; (Zama, JP) Correspondence: Knobbe Martens Olson & Bear Llp; 2040 Main Street; Fourteenth Floor; Irvine; CA; 92614; US Patent Application Number: 20030119778 Date filed: December 6, 2002 Abstract: Aplasia of the corpus callosum or aspermatogenesis is diagnosed by investigating existence or expression of the BT-IgSF gene with use of a primer for PCR or probe for hybridization comprising a DNA coding for a novel cell adhesion molecule (BT-IgSF) defined in the following (A) or (B) or a partial sequence thereof:(A) a protein comprising the amino acid sequence of the amino acid numbers 1 to 409 of SEQ ID NO: 2;(B) a protein comprising an amino acid sequence of the amino acid numbers 1 to 409 of SEQ ID NO: 2 including substitution, deletion, insertion or addition of one or several amino acids and having a function as a cell adhesion molecule. Excerpt(s): The present invention relates to a novel protein estimated to be a cell adhesion molecule involved in development of the corpus callosum and spermatogenesis and a gene coding for the same as well as use of the protein and the gene. The protein and the gene of the present invention are useful in pharmaceutical and diagnostic fields. It is well known that, upon development of various organs of organisms, protein molecules on surfaces of cells constituting organs (cell adhesion molecules) play an important role. It has been found that these cell adhesion molecules are closely associated with important reactions in organisms such as recognition of immune cells, inflammation and metastasis of cancer. The cell adhesion molecules are primarily classified into integrin, cadherin, selectin, immunoglobulin superfamily and CD44 family depending on their structures. Of these, the immunoglobulin superfamily is a group of molecules that have a structure similar to immunoglobulin, and an enormous number of proteins belong to this family and exert a wide variety of functions. For example, molecules that carry out signal transduction associated with cell adhesion are known. There are also protein molecules known as cytokine receptors and protein molecules known as virus receptors. Some are also known as protein molecules existing on cell surfaces that regulate cell functions, typically immunological functions. Further, many proteins belonging to the immunoglobulin superfamily are expected to play important roles in morphogenesis and development of organs in organisms as cell adhesion molecules. However, tissues or cells constituting a tissue in which each protein is expressed significantly differ depending on individual proteins and cannot be easily inferred by analysis of primary sequence (amino acid sequence) of the proteins. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
Patents 99
•
Novel human Delta3 compositions and therapeutic and diagnostic uses therefor Inventor(s): Gearing, David P.; (East Doncaster, AU), McCarthy, Sean A.; (San Diego, CA) Correspondence: Millennium Pharmaceuticals, INC.; 75 Sidney Street; Cambridge; MA; 02139; US Patent Application Number: 20030180784 Date filed: April 17, 2003 Abstract: The invention provides nucleic acids encoding Delta3 proteins. Also provided are derivatives of Delta3 nucleic acids, polypeptides encoded thereby, and antibodies. Delta3 therapeutics, which are either antagonists or agonists of a Delta3 activity and which are capable of modulating the growth and/or differentiation of a cell, e.g., endothelial cell, are also provided herein. Furthermore, methods for treating or preventing diseases associated with an aberrant Delta3 activity and/or associated with abnormal cellular growth and/or differentiation, e.g., neurological disease or vascular disease, such as Agenesis of the Corpus Callosum with Peripheral Neuropathy (ACCPN), as well as diagnostic methods for detecting these diseases are disclosed. Excerpt(s): This application is a continuation of U.S. Ser. No. 09/568,218 filed May 9, 2000 which is a continuation-in-part of U.S. Ser. No. 08/872,855 filed Jun. 11, 1997, which is a continuation-in-part of U.S. Ser. No. 08/832,633 filed Apr. 4, 1997, abandoned, the entire contents of each of which is incorporated herein by reference. Notch, first identified in Drosophila, is the founding member of a family of transmembrane receptor proteins that mediate cell responses to intrinsic and/or extrinsic developmental cues. The cellular response to Notch signaling can be differentiation, proliferation and/or apoptosis depending on the specific developmental program. In addition to its role as a signal-transducing cell surface protein, Notch can exert its function by directly regulating gene transcription. The Notch signaling pathway comprises Notch proteins: Drosophila Notch, LIN-12 and GLP-1 in C. elegans and Notch 1-4 in mammals; ligands: Delta, Delta-1, Delta-like 1 and 3, Jagged 1 and Jagged 2 (Serrate 1 and 2 in Drosophila, respectively); intracellular effectors: CBF-1, Deltex and NF-kappa B; target genes: HES, bHLH and TLE; processing molecules: Kuzbanian; and modifiers: lunatic fringe, manic fringe, radical fringe, numb, numb-like and disheveled 1,2 3. Structural conservation of Notch family members and their ligands are seen throughout phylogeny suggesting a conserved role for this signaling pathway in various species. The product of the Delta gene, acting as a ligand, and that of the Notch gene, acting as a receptor, are key components in a lateral-inhibition signaling pathway that regulates the detailed patterning of many different tissues in Drosophila (Bray (1998) Semin Cell Dev Biol 9:591). In humans, it has recently been shown that the Notch3 gene, located on chromosome 19, is mutated in CADASIL (for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) patients (Joutel et al., (1996) Nature 383: 707-710). CADASIL causes a type of stroke and dementia whose key features include recurrent subcortical ischemic events, progressive vascular dementia, craniofacial paralysis, migraine and mood disorders with severe depression (Chabriat et al. (1995) Lancet 346: 934-939). Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
100
Corpus Callosum
Keeping Current In order to stay informed about patents and patent applications dealing with corpus callosum, you can access the U.S. Patent Office archive via the Internet at the following Web address: http://www.uspto.gov/patft/index.html. You will see two broad options: (1) Issued Patent, and (2) Published Applications. To see a list of issued patents, perform the following steps: Under “Issued Patents,” click “Quick Search.” Then, type “corpus callosum” (or synonyms) into the “Term 1” box. After clicking on the search button, scroll down to see the various patents which have been granted to date on corpus callosum. You can also use this procedure to view pending patent applications concerning corpus callosum. Simply go back to http://www.uspto.gov/patft/index.html. Select “Quick Search” under “Published Applications.” Then proceed with the steps listed above.
101
APPENDICES
103
APPENDIX A. PHYSICIAN RESOURCES Overview In this chapter, we focus on databases and Internet-based guidelines and information resources created or written for a professional audience.
NIH Guidelines Commonly referred to as “clinical” or “professional” guidelines, the National Institutes of Health publish physician guidelines for the most common diseases. Publications are available at the following by relevant Institute10: •
Office of the Director (OD); guidelines consolidated across agencies available at http://www.nih.gov/health/consumer/conkey.htm
•
National Institute of General Medical Sciences (NIGMS); fact sheets available at http://www.nigms.nih.gov/news/facts/
•
National Library of Medicine (NLM); extensive encyclopedia (A.D.A.M., Inc.) with guidelines: http://www.nlm.nih.gov/medlineplus/healthtopics.html
•
National Cancer Institute (NCI); guidelines available at http://www.cancer.gov/cancerinfo/list.aspx?viewid=5f35036e-5497-4d86-8c2c714a9f7c8d25
•
National Eye Institute (NEI); guidelines available at http://www.nei.nih.gov/order/index.htm
•
National Heart, Lung, and Blood Institute (NHLBI); guidelines available at http://www.nhlbi.nih.gov/guidelines/index.htm
•
National Human Genome Research Institute (NHGRI); research available at http://www.genome.gov/page.cfm?pageID=10000375
•
National Institute on Aging (NIA); guidelines available at http://www.nia.nih.gov/health/
10
These publications are typically written by one or more of the various NIH Institutes.
104
Corpus Callosum
•
National Institute on Alcohol Abuse and Alcoholism (NIAAA); guidelines available at http://www.niaaa.nih.gov/publications/publications.htm
•
National Institute of Allergy and Infectious Diseases (NIAID); guidelines available at http://www.niaid.nih.gov/publications/
•
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); fact sheets and guidelines available at http://www.niams.nih.gov/hi/index.htm
•
National Institute of Child Health and Human Development (NICHD); guidelines available at http://www.nichd.nih.gov/publications/pubskey.cfm
•
National Institute on Deafness and Other Communication Disorders (NIDCD); fact sheets and guidelines at http://www.nidcd.nih.gov/health/
•
National Institute of Dental and Craniofacial Research (NIDCR); guidelines available at http://www.nidr.nih.gov/health/
•
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); guidelines available at http://www.niddk.nih.gov/health/health.htm
•
National Institute on Drug Abuse (NIDA); guidelines available at http://www.nida.nih.gov/DrugAbuse.html
•
National Institute of Environmental Health Sciences (NIEHS); environmental health information available at http://www.niehs.nih.gov/external/facts.htm
•
National Institute of Mental Health (NIMH); guidelines available at http://www.nimh.nih.gov/practitioners/index.cfm
•
National Institute of Neurological Disorders and Stroke (NINDS); neurological disorder information pages available at http://www.ninds.nih.gov/health_and_medical/disorder_index.htm
•
National Institute of Nursing Research (NINR); publications on selected illnesses at http://www.nih.gov/ninr/news-info/publications.html
•
National Institute of Biomedical Imaging and Bioengineering; general information at http://grants.nih.gov/grants/becon/becon_info.htm
•
Center for Information Technology (CIT); referrals to other agencies based on keyword searches available at http://kb.nih.gov/www_query_main.asp
•
National Center for Complementary and Alternative Medicine (NCCAM); health information available at http://nccam.nih.gov/health/
•
National Center for Research Resources (NCRR); various information directories available at http://www.ncrr.nih.gov/publications.asp
•
Office of Rare Diseases; various fact sheets available at http://rarediseases.info.nih.gov/html/resources/rep_pubs.html
•
Centers for Disease Control and Prevention; various fact sheets on infectious diseases available at http://www.cdc.gov/publications.htm
Physician Resources
105
NIH Databases In addition to the various Institutes of Health that publish professional guidelines, the NIH has designed a number of databases for professionals.11 Physician-oriented resources provide a wide variety of information related to the biomedical and health sciences, both past and present. The format of these resources varies. Searchable databases, bibliographic citations, full-text articles (when available), archival collections, and images are all available. The following are referenced by the National Library of Medicine:12 •
Bioethics: Access to published literature on the ethical, legal, and public policy issues surrounding healthcare and biomedical research. This information is provided in conjunction with the Kennedy Institute of Ethics located at Georgetown University, Washington, D.C.: http://www.nlm.nih.gov/databases/databases_bioethics.html
•
HIV/AIDS Resources: Describes various links and databases dedicated to HIV/AIDS research: http://www.nlm.nih.gov/pubs/factsheets/aidsinfs.html
•
NLM Online Exhibitions: Describes “Exhibitions in the History of Medicine”: http://www.nlm.nih.gov/exhibition/exhibition.html. Additional resources for historical scholarship in medicine: http://www.nlm.nih.gov/hmd/hmd.html
•
Biotechnology Information: Access to public databases. The National Center for Biotechnology Information conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information for the better understanding of molecular processes affecting human health and disease: http://www.ncbi.nlm.nih.gov/
•
Population Information: The National Library of Medicine provides access to worldwide coverage of population, family planning, and related health issues, including family planning technology and programs, fertility, and population law and policy: http://www.nlm.nih.gov/databases/databases_population.html
•
Cancer Information: Access to cancer-oriented databases: http://www.nlm.nih.gov/databases/databases_cancer.html
•
Profiles in Science: Offering the archival collections of prominent twentieth-century biomedical scientists to the public through modern digital technology: http://www.profiles.nlm.nih.gov/
•
Chemical Information: Provides links to various chemical databases and references: http://sis.nlm.nih.gov/Chem/ChemMain.html
•
Clinical Alerts: Reports the release of findings from the NIH-funded clinical trials where such release could significantly affect morbidity and mortality: http://www.nlm.nih.gov/databases/alerts/clinical_alerts.html
•
Space Life Sciences: Provides links and information to space-based research (including NASA): http://www.nlm.nih.gov/databases/databases_space.html
•
MEDLINE: Bibliographic database covering the fields of medicine, nursing, dentistry, veterinary medicine, the healthcare system, and the pre-clinical sciences: http://www.nlm.nih.gov/databases/databases_medline.html
11
Remember, for the general public, the National Library of Medicine recommends the databases referenced in MEDLINEplus (http://medlineplus.gov/ or http://www.nlm.nih.gov/medlineplus/databases.html). 12 See http://www.nlm.nih.gov/databases/databases.html.
106
Corpus Callosum
•
Toxicology and Environmental Health Information (TOXNET): Databases covering toxicology and environmental health: http://sis.nlm.nih.gov/Tox/ToxMain.html
•
Visible Human Interface: Anatomically detailed, three-dimensional representations of normal male and female human bodies: http://www.nlm.nih.gov/research/visible/visible_human.html
The NLM Gateway13 The NLM (National Library of Medicine) Gateway is a Web-based system that lets users search simultaneously in multiple retrieval systems at the U.S. National Library of Medicine (NLM). It allows users of NLM services to initiate searches from one Web interface, providing one-stop searching for many of NLM’s information resources or databases.14 To use the NLM Gateway, simply go to the search site at http://gateway.nlm.nih.gov/gw/Cmd. Type “corpus callosum” (or synonyms) into the search box and click “Search.” The results will be presented in a tabular form, indicating the number of references in each database category. Results Summary Category Journal Articles Books / Periodicals / Audio Visual Consumer Health Meeting Abstracts Other Collections Total
Items Found 8913 38 11 5 232 9199
HSTAT15 HSTAT is a free, Web-based resource that provides access to full-text documents used in healthcare decision-making.16 These documents include clinical practice guidelines, quickreference guides for clinicians, consumer health brochures, evidence reports and technology assessments from the Agency for Healthcare Research and Quality (AHRQ), as well as AHRQ’s Put Prevention Into Practice.17 Simply search by “corpus callosum” (or synonyms) at the following Web site: http://text.nlm.nih.gov.
13
Adapted from NLM: http://gateway.nlm.nih.gov/gw/Cmd?Overview.x.
14
The NLM Gateway is currently being developed by the Lister Hill National Center for Biomedical Communications (LHNCBC) at the National Library of Medicine (NLM) of the National Institutes of Health (NIH). 15 Adapted from HSTAT: http://www.nlm.nih.gov/pubs/factsheets/hstat.html. 16 17
The HSTAT URL is http://hstat.nlm.nih.gov/.
Other important documents in HSTAT include: the National Institutes of Health (NIH) Consensus Conference Reports and Technology Assessment Reports; the HIV/AIDS Treatment Information Service (ATIS) resource documents; the Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Treatment (SAMHSA/CSAT) Treatment Improvement Protocols (TIP) and Center for Substance Abuse Prevention (SAMHSA/CSAP) Prevention Enhancement Protocols System (PEPS); the Public Health Service (PHS) Preventive Services Task Force's Guide to Clinical Preventive Services; the independent, nonfederal Task Force on Community Services’ Guide to Community Preventive Services; and the Health Technology Advisory Committee (HTAC) of the Minnesota Health Care Commission (MHCC) health technology evaluations.
Physician Resources
107
Coffee Break: Tutorials for Biologists18 Coffee Break is a general healthcare site that takes a scientific view of the news and covers recent breakthroughs in biology that may one day assist physicians in developing treatments. Here you will find a collection of short reports on recent biological discoveries. Each report incorporates interactive tutorials that demonstrate how bioinformatics tools are used as a part of the research process. Currently, all Coffee Breaks are written by NCBI staff.19 Each report is about 400 words and is usually based on a discovery reported in one or more articles from recently published, peer-reviewed literature.20 This site has new articles every few weeks, so it can be considered an online magazine of sorts. It is intended for general background information. You can access the Coffee Break Web site at the following hyperlink: http://www.ncbi.nlm.nih.gov/Coffeebreak/.
Other Commercial Databases In addition to resources maintained by official agencies, other databases exist that are commercial ventures addressing medical professionals. Here are some examples that may interest you: •
CliniWeb International: Index and table of contents to selected clinical information on the Internet; see http://www.ohsu.edu/cliniweb/.
•
Medical World Search: Searches full text from thousands of selected medical sites on the Internet; see http://www.mwsearch.com/.
18 Adapted 19
from http://www.ncbi.nlm.nih.gov/Coffeebreak/Archive/FAQ.html.
The figure that accompanies each article is frequently supplied by an expert external to NCBI, in which case the source of the figure is cited. The result is an interactive tutorial that tells a biological story. 20 After a brief introduction that sets the work described into a broader context, the report focuses on how a molecular understanding can provide explanations of observed biology and lead to therapies for diseases. Each vignette is accompanied by a figure and hypertext links that lead to a series of pages that interactively show how NCBI tools and resources are used in the research process.
109
APPENDIX B. PATIENT RESOURCES Overview Official agencies, as well as federally funded institutions supported by national grants, frequently publish a variety of guidelines written with the patient in mind. These are typically called “Fact Sheets” or “Guidelines.” They can take the form of a brochure, information kit, pamphlet, or flyer. Often they are only a few pages in length. Since new guidelines on corpus callosum can appear at any moment and be published by a number of sources, the best approach to finding guidelines is to systematically scan the Internet-based services that post them.
Patient Guideline Sources The remainder of this chapter directs you to sources which either publish or can help you find additional guidelines on topics related to corpus callosum. Due to space limitations, these sources are listed in a concise manner. Do not hesitate to consult the following sources by either using the Internet hyperlink provided, or, in cases where the contact information is provided, contacting the publisher or author directly. The National Institutes of Health The NIH gateway to patients is located at http://health.nih.gov/. From this site, you can search across various sources and institutes, a number of which are summarized below. Topic Pages: MEDLINEplus The National Library of Medicine has created a vast and patient-oriented healthcare information portal called MEDLINEplus. Within this Internet-based system are “health topic pages” which list links to available materials relevant to corpus callosum. To access this system, log on to http://www.nlm.nih.gov/medlineplus/healthtopics.html. From there you can either search using the alphabetical index or browse by broad topic areas. Recently, MEDLINEplus listed the following when searched for “corpus callosum”:
110
Corpus Callosum
Brain Diseases http://www.nlm.nih.gov/medlineplus/braindiseases.html Epilepsy http://www.nlm.nih.gov/medlineplus/epilepsy.html Head and Brain Injuries http://www.nlm.nih.gov/medlineplus/headandbraininjuries.html Head and Brain Malformations http://www.nlm.nih.gov/medlineplus/headandbrainmalformations.html You may also choose to use the search utility provided by MEDLINEplus at the following Web address: http://www.nlm.nih.gov/medlineplus/. Simply type a keyword into the search box and click “Search.” This utility is similar to the NIH search utility, with the exception that it only includes materials that are linked within the MEDLINEplus system (mostly patient-oriented information). It also has the disadvantage of generating unstructured results. We recommend, therefore, that you use this method only if you have a very targeted search. The NIH Search Utility The NIH search utility allows you to search for documents on over 100 selected Web sites that comprise the NIH-WEB-SPACE. Each of these servers is “crawled” and indexed on an ongoing basis. Your search will produce a list of various documents, all of which will relate in some way to corpus callosum. The drawbacks of this approach are that the information is not organized by theme and that the references are often a mix of information for professionals and patients. Nevertheless, a large number of the listed Web sites provide useful background information. We can only recommend this route, therefore, for relatively rare or specific disorders, or when using highly targeted searches. To use the NIH search utility, visit the following Web page: http://search.nih.gov/index.html. Additional Web Sources A number of Web sites are available to the public that often link to government sites. These can also point you in the direction of essential information. The following is a representative sample: •
AOL: http://search.aol.com/cat.adp?id=168&layer=&from=subcats
•
Family Village: http://www.familyvillage.wisc.edu/specific.htm
•
Google: http://directory.google.com/Top/Health/Conditions_and_Diseases/
•
Med Help International: http://www.medhelp.org/HealthTopics/A.html
•
Open Directory Project: http://dmoz.org/Health/Conditions_and_Diseases/
•
Yahoo.com: http://dir.yahoo.com/Health/Diseases_and_Conditions/
•
WebMD®Health: http://my.webmd.com/health_topics
Patient Resources
111
Associations and Corpus Callosum The following is a list of associations that provide information on and resources relating to corpus callosum: •
Agenesis of Corpus Callosum (ACC) Network Telephone: (207) 581-3119 Fax: (207) 581-3120 Email:
[email protected] Background: The Agenesis of Corpus Callosum (ACC) Network is a not-for-profit selfhelp organization dedicated to providing information and support to families of children with Agenesis of the Corpus Callosum. This is a rare condition characterized by absence of the thick band of nerve fibers that connects the two cerebral hemispheres. Established in 1990, the Agenesis of Corpus Callosum Network also provides support to families of children with other disorders or conditions that are similar to ACC. The Agenesis of Corpus Callosum Network enables affected families to exchange information, support, and resources through its networking programs.
Finding Associations There are several Internet directories that provide lists of medical associations with information on or resources relating to corpus callosum. By consulting all of associations listed in this chapter, you will have nearly exhausted all sources for patient associations concerned with corpus callosum. The National Health Information Center (NHIC) The National Health Information Center (NHIC) offers a free referral service to help people find organizations that provide information about corpus callosum. For more information, see the NHIC’s Web site at http://www.health.gov/NHIC/ or contact an information specialist by calling 1-800-336-4797. Directory of Health Organizations The Directory of Health Organizations, provided by the National Library of Medicine Specialized Information Services, is a comprehensive source of information on associations. The Directory of Health Organizations database can be accessed via the Internet at http://www.sis.nlm.nih.gov/Dir/DirMain.html. It is composed of two parts: DIRLINE and Health Hotlines. The DIRLINE database comprises some 10,000 records of organizations, research centers, and government institutes and associations that primarily focus on health and biomedicine. To access DIRLINE directly, go to the following Web site: http://dirline.nlm.nih.gov/. Simply type in “corpus callosum” (or a synonym), and you will receive information on all relevant organizations listed in the database.
112
Corpus Callosum
Health Hotlines directs you to toll-free numbers to over 300 organizations. You can access this database directly at http://www.sis.nlm.nih.gov/hotlines/. On this page, you are given the option to search by keyword or by browsing the subject list. When you have received your search results, click on the name of the organization for its description and contact information. The Combined Health Information Database Another comprehensive source of information on healthcare associations is the Combined Health Information Database. Using the “Detailed Search” option, you will need to limit your search to “Organizations” and “corpus callosum”. Type the following hyperlink into your Web browser: http://chid.nih.gov/detail/detail.html. To find associations, use the drop boxes at the bottom of the search page where “You may refine your search by.” For publication date, select “All Years.” Then, select your preferred language and the format option “Organization Resource Sheet.” Type “corpus callosum” (or synonyms) into the “For these words:” box. You should check back periodically with this database since it is updated every three months. The National Organization for Rare Disorders, Inc. The National Organization for Rare Disorders, Inc. has prepared a Web site that provides, at no charge, lists of associations organized by health topic. You can access this database at the following Web site: http://www.rarediseases.org/search/orgsearch.html. Type “corpus callosum” (or a synonym) into the search box, and click “Submit Query.”
113
APPENDIX C. FINDING MEDICAL LIBRARIES Overview In this Appendix, we show you how to quickly find a medical library in your area.
Preparation Your local public library and medical libraries have interlibrary loan programs with the National Library of Medicine (NLM), one of the largest medical collections in the world. According to the NLM, most of the literature in the general and historical collections of the National Library of Medicine is available on interlibrary loan to any library. If you would like to access NLM medical literature, then visit a library in your area that can request the publications for you.21
Finding a Local Medical Library The quickest method to locate medical libraries is to use the Internet-based directory published by the National Network of Libraries of Medicine (NN/LM). This network includes 4626 members and affiliates that provide many services to librarians, health professionals, and the public. To find a library in your area, simply visit http://nnlm.gov/members/adv.html or call 1-800-338-7657.
Medical Libraries in the U.S. and Canada In addition to the NN/LM, the National Library of Medicine (NLM) lists a number of libraries with reference facilities that are open to the public. The following is the NLM’s list and includes hyperlinks to each library’s Web site. These Web pages can provide information on hours of operation and other restrictions. The list below is a small sample of
21
Adapted from the NLM: http://www.nlm.nih.gov/psd/cas/interlibrary.html.
114
Corpus Callosum
libraries recommended by the National Library of Medicine (sorted alphabetically by name of the U.S. state or Canadian province where the library is located)22: •
Alabama: Health InfoNet of Jefferson County (Jefferson County Library Cooperative, Lister Hill Library of the Health Sciences), http://www.uab.edu/infonet/
•
Alabama: Richard M. Scrushy Library (American Sports Medicine Institute)
•
Arizona: Samaritan Regional Medical Center: The Learning Center (Samaritan Health System, Phoenix, Arizona), http://www.samaritan.edu/library/bannerlibs.htm
•
California: Kris Kelly Health Information Center (St. Joseph Health System, Humboldt), http://www.humboldt1.com/~kkhic/index.html
•
California: Community Health Library of Los Gatos, http://www.healthlib.org/orgresources.html
•
California: Consumer Health Program and Services (CHIPS) (County of Los Angeles Public Library, Los Angeles County Harbor-UCLA Medical Center Library) - Carson, CA, http://www.colapublib.org/services/chips.html
•
California: Gateway Health Library (Sutter Gould Medical Foundation)
•
California: Health Library (Stanford University Medical Center), http://wwwmed.stanford.edu/healthlibrary/
•
California: Patient Education Resource Center - Health Information and Resources (University of California, San Francisco), http://sfghdean.ucsf.edu/barnett/PERC/default.asp
•
California: Redwood Health Library (Petaluma Health Care District), http://www.phcd.org/rdwdlib.html
•
California: Los Gatos P